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ABSTRACT 
Membrane proteins are important targets that represent more than 50% of current drug 
targets. However, characterisation of membrane proteins falls behind compared to their 
soluble counterparts. The most challenging part of membrane protein research is finding 
a suitable membrane mimetic that stabilises them in solution and maintains their native 
structure and function. The recently developed saposin-A (SapA) based lipid 
nanoparticle system seems to be advantageous over existing membrane mimetic system. 
It provides a native-like lipid bilayer, high incorporation yield and more importantly 
size adaptability. SapA lipid nanoparticles have been applied to structural studies and 
two high-resolution structures of membrane proteins were previously obtained using 
cryo-electron microscopy. This thesis aimed to study small-to-medium sized membrane 
proteins in SapA lipid nanoparticles using NMR spectroscopy. 
We first explore the mechanism of SapA lipid nanoparticle formation for the purpose of 
establishing an incorporation protocol that can be applied to most membrane proteins. 
The effect of pH and the presence of detergents on the opening of SapA was 
investigated in Chapter 2. A proposed energy diagram describing the mechanism of 
SapA opening is reported with which we were able to develop a protocol that can 
generate different sizes of SapA-1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) 
nanoparticles. In addition, we also showed that SapA can form lipid nanoparticles with 
various lipid compositions, showing the versatility of the system.  
In Chapter 3, we validated the ability of SapA lipid nanoparticles to be used as a 
membrane mimetic. A b-barrel model protein, bacterial outer membrane protein X 
(OmpX), was incorporated into SapA-DMPC nanoparticles and a 2D 15N-1H correlation 
NMR spectrum was recorded. Our result was compared to the NMR parameters of the 
same protein in MSP nanodiscs from the literature, and it was concluded that SapA lipid 
nanoparticles indeed provide a lipid bilayer environment similar to MSP nanodiscs. 
Because of high incorporation yield, we were able to incorporate OmpX into different 
lipid compositions to investigate the effect of lipid head groups and aliphatic chains on 
the membrane protein’s chemical environment. 
Next, the applicability of SapA lipid nanoparticles was expanded to a-helical 
transmembrane proteins in Chapter 4. Two microbial rhodopsins, Anabaena sensory 
rhodopsin (ASR) and Natronomonas pharaonis sensory rhodopsin II (pSRII), were 
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tested. The parameters for expression and purification of ASR were first screened for 
the optimal yield. Although incorporation of ASR resulted in inhomogeneous particles 
due to imperfect experimental procedure, pSRII in SapA-DMPC nanoparticles showed 
high sample quality. The 2D NMR spectrum of pSRII in SapA-DMPC nanoparticles 
shows distinct differences to pSRII in detergent micelles, suggesting substantial effects 
from the membrane mimetic on the conformation of the membrane protein. Despite the 
good NMR spectral quality considering the large particle size, perdeuteration of pSRII 
and the lipids will be necessary for further investigation. 
With the SapA lipid nanoparticles established, we aimed to use it for the study of a 
biologically important G protein-coupled receptor, b1-adrenergic receptor (b1AR), 
discussed in Chapter 5. The possibility of expressing b1AR using a cell-free expression 
system was explored first. Although a good amount of the protein was obtained, only a 
fraction of it was functional. Therefore, a conventional baculovirus-insect cell 
expression system was used to produce selective isotope labelled b1AR for NMR 
studies. NMR spectra of b1AR in SapA-DMPC nanoparticles with activating ligands 
and an intracellular binding partner were recorded and compared to the spectra of the 
same protein in detergents. This revealed a more active-like conformation of ligand-
bound b1AR in the lipid bilayer, suggesting that certain parts of the protein are sensitive 
to the membrane mimetic used. This emphasises the importance of using a native-like 
membrane mimetic to capture the full properties of membrane proteins. 
In conclusion, I demonstrate in this thesis that SapA lipid nanoparticles are a versatile 
membrane mimetic system that can accommodate membrane proteins with different 
sizes and folds. This system is also compatible with solution NMR spectroscopy 
enabling structure and dynamics studies of biologically important membrane proteins. 
We believe SapA lipid nanoparticles will have a significant impact on membrane 
protein research in the future. 
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1 INTRODUCTION 
1.1 Transmembrane proteins 
An integral membrane protein is a type of protein that permanently locates in the 
biological membrane. Integral membrane proteins can be further divided into two 
categories: integral monotopic proteins that attach to one side of the membrane and 
transmembrane proteins, also called integral polytopic proteins, that span the entire 
membrane.1 Transmembrane proteins, with an arrangement that connects two sides of 
the membrane, often function as a bridge between the intra- and extracellular 
environments across the hydrophobic lipid bilayer. They frequently undergo large 
conformational changes in order to perform their function in transport or signal 
transduction across the membrane. 
1.1.1 Biological functions of transmembrane proteins 
Transmembrane proteins carry out many biological functions such as signal 
transduction, bioenergetics, transporting substances, cell adhesion, enzymatic reactions, 
cellular structure and support. More than 60% of the human membrane protein family 
belong to three major functional groups: membrane receptors, membrane transport 
proteins, and membrane enzymes.2 
Membrane receptors function as signal transducers transferring a signal across the 
membrane to mediate a cellular response to external stimuli e.g. upon ligand binding. G 
protein-coupled receptors (GPCRs) are the largest member in this category, as about 
800 human genes are predicted to be GPCRs.2 Their mechanism often involves a large 
conformational change of the receptor induced by binding extracellular ligands which 
can be hormones, neurotransmitters, cytokines, or growth factors. The conformational 
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change in the receptor induces the recognition of effector proteins on the intracellular 
side, thus passing the signal to its destination.  
Membrane transport proteins move substances such as ions, small molecules, or 
macromolecules across the membrane. They can be further categorized into three major 
classes: ATP-powered pumps, channel proteins, and transporters.3 ATP-powered pumps 
use the energy of ATP hydrolysis to transport ions or small molecules across the 
membrane against a concentration gradient or electric potential. This process is referred 
to as active transport. In contrast, channel proteins move water or ions down their 
concentration gradient or electric potential, a spontaneous reaction that does not need an 
energy input, hence it is referred to as passive transport. When the channel protein is 
open, multiple molecules can travel across the channel protein simultaneously with a 
rate of up to 108 per second.3 Transporters, on the other hand, bind only one substrate 
molecule at a time and undergo a significant conformational change such that the bound 
substrate is transported across the membrane. Because of this, the whole process is 
much slower than that of channel proteins with a rate of 102–104 molecules per second.3  
Membrane enzymes are membrane proteins with the ability to catalyse a specific 
chemical reaction. Six types of reaction were found that are performed by human 
membrane enzymes: oxidoreductases, transferases, hydrolases, lyases, isomerases, and 
ligases.2 
1.1.2 Structures of transmembrane proteins 
Transmembrane proteins can be classified into two types based on their structures, a-
helical and b-barrel transmembrane proteins.4  
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Figure 1-1: Two types of transmembrane proteins. 
Examples of A) a-helical transmembrane protein (PDB code: 2CYW) and B) b-
barrel transmembrane protein (PDB code: 2M06). Lipid bilayer regions are 
predicted by a computational approach5 and are shown in grey spheres. 
a-helical transmembrane proteins are the major category of transmembrane proteins 
that can be found in the inner membrane of bacterial cells or the plasma membrane of 
eukaryotes. It has been predicted that 27% of all human proteins are a-helical 
transmembrane proteins.2 a-helical transmembrane proteins contain one or more 
membrane-spanning helices, which consist mostly of hydrophobic amino acids (Figure 
1-1 A).6 Individual helices are formed by hydrogen bonds between the amide group of 
an amino acid and the carbonyl group of the amino acid four residues earlier in the 
sequence. The typically hydrophobic side chains of the amino acids are exposed to the 
lipid bilayer hydrocarbon core in order to stabilise the protein in a membrane 
environment. The individual helices are in general very stable on their own in a 
hydrophobic environment, therefore it is unclear what is the main driving force for the 
formation of helical bundles. Since hydrophobic interactions, which drive the folding of 
soluble proteins, cannot account for the folding of transmembrane proteins, it is thought 
that Van der Waals interactions between specific side chain pairs are important for a-
helical transmembrane proteins to pack to their functional structure.7 Much efforts has 
been devoted to the prediction of transmembrane helix region from amino acid sequence 
information. A simple rule that searches for ~20 continuous hydrophobic amino acids 
A B
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was used to predict transmembrane helices 35 years ago.8 Since then, the prediction has 
been further improved by combining information from solved high-resolution 
membrane protein structures. There are more than 12 programs available to predict the 
presence of transmembrane helices from a protein sequence.9 
b-barrel membrane proteins, also known as outer membrane proteins (OMPs) are found 
only in the outer membrane of gram-negative bacteria, mitochondria, and chloroplasts, 
as well as the cell wall of gram-positive bacteria.10 There are around 100 non-
homologous structures of OMPs in the PDB showing the fundamental design of 
OMPs.11 b-barrel strands are amphipathic and are generally oriented in an antiparallel 
fashion (Figure 1-1 B). The strands are held together by hydrogen bonds between 
backbone amide groups, causing the side chains to alternate in direction between the 
hydrophilic side chains pointing inward to the pore and the hydrophobic side chains 
pointing outward to the membrane.11 The number of strands ranges from 8 to 24, and 
almost all OMPs contain an even number of strands except VDAC-1.10 Despite 
adopting the same b-barrel fold, OMPs are involved in a variety of biological functions 
including transporting substances across membranes,12 signaling,13 and membrane 
biogenesis.14 There is growing interest in OMPs because of their role in antibiotic 
resistance and their location which makes them accessible for drug targeting.11 
1.2 Structural studies of transmembrane proteins 
Obtaining a molecular structure is essential to understand the function and detailed 
mechanism of a protein. The structural elucidation of membrane proteins has proven to 
be difficult. This can be clearly seen in that less than 3% of all PDB structures are for 
membrane proteins15 even though 20–30% of all genes are predicted to be membrane 
proteins.16 There are currently 2619 PDB coordinates of membrane protein structures of 
which 817 are unique structures, excluding mutants, different bound substrates, or 
different sample conditions (September 2018, http://blanco.biomol.uci.edu/mpstruc/). 
Nevertheless, the number of membrane protein structures is increasing dramatically; 74 
unique membrane protein structures had been determined by September in 2018 
whereas only about 30 structures per year were deposited ten years ago. This increase is 
due to the recent technological developments in the three main techniques used for 
structure determination, X-ray crystallography, nuclear magnetic resonance (NMR) 
spectroscopy, and cryo-electron microscopy (cryo-EM), which I will discuss in more 
detail in the following sections.  
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1.2.1 X-ray crystallography 
X-ray crystallography remains the most frequently used technique for membrane protein 
structure determination as more than 85% of all membrane protein structures in the 
PDB were solved by X-ray crystallography.15 The most difficult part of this technique is 
obtaining a protein crystal that diffracts well. Protein crystallization is often a trial-and-
error and iterative process that involves construct design, protein production, and 
screening for the optimal conditions to produce quality crystals.17 Crystallization of 
membrane proteins is even more difficult because the hydrophobic molecules such as 
detergents or lipids, which are necessary to keep the membrane proteins in solution, 
might make the formation of crystal contacts between two membrane proteins more 
complicated. Several strategies can be used to stabilise membrane proteins in a 
particular conformation including stabilisation by antibodies or nanobodies,18 insertion 
of a fusion protein to increase crystal contacts,19 and thermostabilisation by mutagenesis 
and the truncation of flexible regions.20 These strategies have allowed several 
membrane protein structures including some of the difficult GPCR targets to be 
determined. Two approaches are currently used to crystalize membrane proteins.21 The 
in surfo approach generates crystals of a protein-detergent complex in which crystal 
contacts form only between hydrophilic parts of the protein.22 Alternatively, the in meso 
approach incorporates the membrane protein in a lipidic mesophase such as lipidic cubic 
phase,23 lipidic sponge phase,24 connected-bilayer gel,25 etc. The in meso approach in 
general leads to better ordered crystals and higher resolution diffraction compared to the 
in surfo approach. X-ray crystallography in general produces molecular structures with 
the highest resolution compared to other techniques used to investigate protein 
structures. However, the whole protein crystallisation process is rather unpredictable. 
1.2.2 NMR spectroscopy 
Characterising the structure and function of membrane proteins by solution and solid-
state NMR bypasses the need for obtaining a good quality protein crystal, but the 
technique has its own challenges as well. Solution NMR can only applied to small to 
medium sized macromolecules that tumble fast with correlation times smaller than 100 
ns.26 Slow tumbling increases the transverse relaxation rate leading to reduced signal-to-
noise ratios. This would make the interpretation and analysis of the NMR spectra 
extremely difficult. Many efforts have been made to tackle this problem, and the most 
revolutionary development was transverse relaxation optimized spectroscopy (TROSY). 
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TROSY is an NMR experiment that was designed for studying large molecules such as 
biomolecules.27 In a conventional 2D-HSQC spectrum without decoupling, peaks 
appear as multiplets because of scalar J-coupling (Figure 1-2 A). Each of the multiplet 
components shows dramatically different linewidths because of constructive or 
destructive interaction between two dominant relaxation mechanisms; the dipole-dipole 
mechanism and the chemical shift anisotropy mechanism. To reduce spectral 
complexity, decoupling is normally employed in 2D-HSQC experiments to produce a 
single peak with averaged linewidths (Figure 1-2 B). The TROSY experiment is 
designed to select the sharpest component (Figure 1-2 C) for which the two relaxation 
mechanisms almost cancel each other, increasing the spectral resolution and sensitivity. 
The dipole-dipole mechanism is a result of interaction between two nuclear spins, 
therefore it is field-independent. On the other hand, chemical shift anisotropy is a result 
of an anisotropic electronic environment, meaning the chemical shift depends on the 
orientation of a molecule with respect to the external magnetic field, therefore it is field-
dependent. Therefore, there is an optimal field strength at which the cancellation 
between the two relaxation mechanisms is maximal. For example, an external magnetic 
field of around 1 GHz produces the maximal TROSY effect for 15N/1H correlation.27,28 
Since the dipole-dipole mechanism and chemical shift anisotropy mechanism are the 
two most dominant factors in transverse relaxation for large proteins, the TROSY effect 
becomes advantageous in studying large proteins and significantly increases the size 
limit of NMR spectroscopy. 
 
Figure 1-2: Schematic representation of 2D 1H, 15N correlation HSQC. 
Demonstration of the effect of a TROSY experiment. A) HSQC spectrum without 
decoupling. B) HSQC spectrum with decoupling. C) TROSY experiment. 
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With the development of TROSY and advances in NMR instrumentation, small 
membrane proteins are feasible targets for solution NMR studies, including structure 
determination, using similar methods as for soluble proteins. Uniformly [2H, 13C, 15N]-
labelled membrane proteins are often used for the best spectral quality. The first 
membrane protein backbone structure solved by solution NMR was bacterial outer 
membrane protein A, a 19 kDa b-barrel protein.29 Since then, several strategies have 
been developed to improve the determination of membrane protein structures. For 
example, selectively methyl-protonated labelling of isoleucine, leucine and valine in a 
perdeuterated background allows 140 out of 141 methyl side chains to be assigned and 
the identification of a large number of nuclear Overhauser effect (NOE) distances, 
leading to structure determination of a seven-transmembrane helical protein.30 
Paramagnetic relaxation enhancement (PRE),31 residual dipolar couplings (RDC),32 and 
pseudocontact shifts (PCS)33 were employed in several solution NMR studies for further 
improvements in membrane protein structure determination. Because of the size 
limitation of solution NMR, most of the studies used detergent micelles for membrane 
protein stabilisation to reduce the overall particle sizes. Nanodiscs are well-defined 
particles with lipid bilayer environments which have been used in several solution NMR 
studies and will be discussed in more detail in Chapter 3. 
The transverse relaxation that causes the size limitation of solution NMR is not an issue 
in solid-state NMR because of magic angle spinning. By mechanically spinning the 
sample at a high speed, the three main transverse relaxation mechanisms, namely 
dipolar, chemical shift anisotropy, and quadrupolar interactions, are averaged out. This 
produces narrower line shapes and higher resolution spectra. Nevertheless, solid-state 
NMR spectra of uniformly labelled protein samples are in general complex and have a 
large number of overlapped peaks. As a result, selectively labelled samples are 
necessary.34 Magic angle spinning solid-state NMR has been shown to be useful for 
determination of membrane protein structures in a native lipid environment. An atomic-
resolution structure of the sensory rhodopsin from the cyanobacterium Anabaena was 
obtained by combining torsional and internuclear distance restraints with PRE 
constraints.35 The structure of the transmembrane domain of the Yersinia enterocolitica 
adhesin A was determined using a single uniformly [13C,15N]-labelled microcrystal that 
diffracts poorly.36 Recently, the same strategy was used to solve the structure of the 14-
strand outer membrane protein G from Escherichia coli in a lipid bilayer.37 
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1.2.3 Cryo-EM 
Cryo-EM has become very popular recently for structure determination with many 
advantages over conventional techniques. This is because of recent technical advances 
and the development of image-processing software. The first breakthrough was the 
development of a sample preparation method that prevents water-soluble samples from 
drying out in the vacuum. A protein solution is flash-frozen using liquid ethane quick 
enough that water molecules, instead of forming ice, remain in a vitreous state.38 
Secondly, a methodology that aligns experimental images of biological samples with 
low signal-to-noise ratio produces higher quality averaged images, which greatly 
improves the results of structure reconstruction.39 Lastly, development of a direct 
electron detector enables high data-throughput and corrections of beam-induced particle 
movement.40  The advantage of using cryo-EM is that large quantities and a high level 
of homogeneity of the protein sample are not necessary, unlike NMR or X-ray 
crystallography. Only µg amounts of sample are needed for grid preparation and small 
amounts of inhomogeneous particles or impurities can be excluded during particle 
picking. This is particularly useful in membrane protein studies because it is even more 
difficult, compared to soluble proteins, to express and purify membrane proteins to meet 
the high standards that NMR and X-ray crystallography require.  
With all the technical advancements described above, the structure of the TRPV1 ion 
channel, a medium sized membrane protein, was solved to a resolution of 3.4 Å.41 Since 
then, many other membrane proteins have been determined using cryo-EM including 
the protease γ-secretase at 3.4 Å resolution,42 Slo2.2 potassium channel at 4.5 Å 
resolution,43 and recently several GPCR-G-protein complex structures were solved at 
close to 4 Å resolution.44–47 Although the resolution is in general not as good as that of 
X-ray crystallography, cryo-EM certainly opens a way to investigate membrane proteins 
that are difficult to crystallise.  
1.3 G protein-coupled receptors 
GPCRs are seven-transmembrane proteins which can be activated by interacting with a 
wide range of extracellular signalling molecules including hormones, neurotransmitters, 
peptides. Activated GPCRs initiate signalling through classical heterotrimeric G 
proteins, as well as through G protein-independent pathways by interactions with G 
protein-coupled receptor kinases (GRKs) and b-arrestins.48 The human genome encodes 
nearly 800 GPCRs,49 and they can be classified into four groups on the basis of 
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sequence and structural similarity, A: Rhodopsin family, B: Secretin family, C: 
Glutamate family, and F: Frizzled family.50 All four groups share the same seven-
transmembrane helical architecture. Class B, C, and F have large extracellular N-
terminal domains which the class A receptors do not have.51–53  
 
Figure 1-3: Ligand induced biological activity of a GPCR. 
GPCRs are involved in a wide range of biological functions including vision, taste, 
smell, mood regulation, and nervous system transmission. Because of their critical role 
in physiological functions and high druggability as cell surface exposed membrane 
proteins, GPCRs represent the target of approximately 34% of all modern drugs.54 
Many GPCRs show basal activity which can be modulated by endogenous ligands or 
synthetic drugs. For example, b-blockers are synthetic drugs developed to inhibit b-
adrenergic receptors for the treatment of arrhythmia, hypertension, and cardiac 
dysfunction.55 All the agonists are classified as full agonists, partial agonists, 
antagonists, and inverse agonists depending on the cellular response (Figure 1-3). By 
binding to antagonists, the activity of GPCRs remain at the basal level, the same as in 
the absence of ligand. Antagonists block the binding site and prevent further activation 
from other ligands. Full agonists activate GPCRs to the maximal signalling response, 
while partial agonists only partially induce GPCRs. In contrast, inverse agonists reduce 
the activity of GPCRs below the basal level.  
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Figure 1-4: Schematic representation of classical GPCR signalling.  
Agonist binding to a GPCR leads to G protein binding to GPCR on the 
intracellular side which induces nucleotide exchange. The GTP bound Ga 
dissociates from Gbγ dimer and both of them can bind to effector proteins for 
further signalling. Hydrolysis of GTP in the Ga subunit leads to reformation of the 
heterotrimeric G protein complex. 
1.3.1 G protein-mediated signalling 
The classical GPCR signal transduction pathway involves activation of a heterotrimeric 
G protein complex. In contrast to the wide variety of GPCRs in the human genome, 
there are only four G protein families, Gs, Gi/o, Gq/11, G12/13, identified based on 
sequence homology.56 The observation that a limited number of G proteins can be 
activated by a large number of GPCRs suggests a conserved activation mechanism. G 
protein-mediated GPCR signalling is outlined in Figure 1-4. The activation process is 
initiated either by light or binding to activating ligands or agonists, outside the cell 
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membrane. Upon binding of activating ligands, the receptor undergoes a large 
conformational change on the intracellular side that enables the GPCR to bind to a 
heterotrimeric G protein complex (Ga, Gb, Gγ subunits) inside the cell. The GPCR then 
activates the bound G protein by exchanging the GDP on the Ga subunit for GTP and 
this exchange triggers the dissociation of the heterotrimeric G protein into its Ga subunit 
and Gbγ dimer, both of which can interact with other intracellular effector proteins and 
ultimately modulate cellular responses through secondary messenger downstream 
signalling. Effector binding may result in hydrolysis of GTP on the Ga via an effector’s 
GAP (GTPase activating protein) activity which allows the reformation of the 
heterotrimeric G protein complex and completes the signalling cycle.  
1.3.2 Structural studies of b2-adrenergic receptors 
So far, a total of 52 unique GPCR structures have been published, 45 of which are class 
A GPCRs (September 2018, http://gpcrdb.org/structure/statistics). These structures 
reveal a common seven-transmembrane helical bundle architecture connected by three 
extracellular loops (ECL 1-3) and three intracellular loops (ICL 1-3) in GPCR family. 
The N-terminus and the ECLs are responsible for agonist binding whereas the 
intracellular side and the ICLs recognise G proteins, b-arrestins, and GRKs for 
downstream signalling. Based on the structures of active and inactive GPCRs, a detailed 
structural change is observed upon receptor activation. The most common feature of 
receptor activation is a significant conformational reorganisation on the intracellular 
side, where a large outward movement of transmembrane helix 6 (TM6) and 
rearrangements of other helices open a cavity for recognition of G proteins, GRKs, or b-
arrestins. 
The b2-adrenergic receptor (b2AR), a member of b-adrenergic receptor (bAR) family, is 
a class A GPCR which can activate intracellular heterotrimeric G proteins upon binding 
to adrenaline or noradrenaline to modulate heart muscle contraction and smooth muscle 
relaxation. b2AR is also one of the most structurally characterised GPCRs in the 
literature, representing 21 out of total 270 available GPCR structures. The crystal 
structure of human b2AR was determined more than a decade ago using an engineered 
b2AR-T4 lysozyme fusion construct, in which the ICL3 of b2AR was also removed 
(Figure 1-5 A, yellow).57 Fusion with T4 lysozyme increases the hydrophilic surface for 
more crystal contacts while the removal of ICL3 reduces the flexibility of the protein. 
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Since then, several crystal structures of b2AR bound to different antagonists or inverse 
agonists have been solved.18,58 However, the crystallisation of full agonist-bound b2AR 
was difficult due to the rapid off-rate of the agonist and perhaps the highly dynamic 
nature of the complex.59 This difficulty was overcome by using a covalently bound full 
agonist, which shows the capability of activating a heterotrimeric G protein. The crystal 
structure of the covalent b2AR-full agonist complex was solved (Figure 1-5 A, pink),59 
but the structure does not show fully activated states, and in particular, lacks the 
characteristic outward movement of TM6 that was previously observed in activated 
rhodopsin.60,61 Instead, the structures of b2AR bound to full agonist, antagonist, and 
inverse agonist overlaid very well and all show the inactive structure (Figure 1-5 A). It 
was realised that binding to both the extracellular ligand and intracellular binding 
partner are required to stabilise the active conformation for crystallisation.59,62 A 
camelid antibody fragment (nanobody Nb80) was generated to the b2AR that binds to 
the intracellular side of b2AR and shows G protein-like binding behaviour.62 The 
structure of the agonist bound, b2AR-nanobody complex (Figure 1-5 B) shows an 11 Å 
outward movement of the cytoplasmic end of TM6 that is similar to those observed in 
rhodopsin activation.62 Finally, the structure of the full agonist-b2AR-Gs protein 
complex (where the Ga subunit is trapped in a non-exchangeable nanobody-bound 
(Nb35) form that mimics the GDP bound state) was eventually solved, showing an even 
more significant conformational change, a 14 Å outward movement of TM6 (Figure 1-5 
C).63  
 
 
 
Figure 1-5 (opposite): Crystal structures of b2AR.  
A) Overlay of the crystal structures of inverse agonist bound b2AR (green) (PDB 
ID: 3NY8), antagonist bound b2AR (yellow) (PDB ID: 2RH1), and irreversible 
agonist bound b2AR (pink) (PDB ID: 3PDS). B) Overlay of the crystal structures of 
irreversible agonist bound b2AR (pink) (PDB ID: 3PDS) and full agonist and G 
protein mimicking nanobody (Nb80) bound b2AR (blue) (PDB ID: 3P0G). C) 
Crystal structure of b2AR (green) in complex with Gs protein (PDB ID: 3SN6). All 
the components in the complex are coloured and indicated.  
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limitations of this method, e.g. flexible states are invisible in the crystals and only the 
conformation of the lowest energy state will be revealed. Crystal structures of b2AR 
bound to agonist and antagonist show similar conformations which is counter-intuitive. 
One possible explanation is that X-ray crystallography can only provide snapshots of 
the most stable state, i.e. the inactive conformation, but not of any conformational 
ensemble present during the activation. There is no information on the presence of 
alternative conformations that are energetically less favourable but nevertheless might 
be substantially populated. Further, detailed mechanistic insight for the activation 
process of b2AR between extracellular agonist binding and cytoplasmic G protein 
recognition has still not yet been obtained. 
Nuclear magnetic resonance (NMR) spectroscopy provides a powerful technique to 
study the dynamics of biological macromolecules over a wide range of timescales from 
picosecond to days, potentially providing more knowledge about this important 
question.64 15N T1, T2 and heteronuclear NOE relaxation experiments are commonly 
used to investigate protein motion on the ps-ns timescale, with the relaxation rates 
determined by the internal motions of the amide bonds and the overall tumbling rate of 
the protein.64 However, the investigation of GPCR activation using NMR spectroscopy 
is limited by the large apparent molecular size in the micelle environment making 
samples prone to signal broadening due to slow overall tumbling. Moreover, GPCRs are 
a-helical transmembrane proteins, so the amide resonances tend to appear in a relatively 
narrow chemical shift window. As a result, peak overlap becomes a difficulty in 
analysing NMR spectra of GPCRs. Also, conventional uniform labelling is only 
possible and not prohibitively expensive in E. coli and yeast protein expression systems 
which normally are not able to produce functional GPCRs. Selective labelling strategies, 
instead of uniform labelling, offer one possible solution that can decrease the 
complexity of the NMR spectrum. In this strategy, only residues of interest are labelled 
with NMR active isotopes, e.g. 13C, 15N; thus the number of the peaks in the spectrum is 
considerably reduced.65  
Several NMR studies of b2AR using selective isotope labelling strategies have been 
reported, all aiming to decipher the activation mechanism of the receptor and to observe 
the activated state that is invisible in crystallography. By monitoring the NMR signals 
of residue M82 from methionine-labelled b2AR, a conformational equilibrium between 
the antagonist-bound and the full agonist-bound states is observed, and the population 
Development of a saposin A based native-like phospholipid bilayer system for NMR studies 
Chih-Ta Chien- September 2018   15 
of the latter is proposed to reflect the efficacy of the ligand.66,67 The same model was 
supported by another 19F NMR study of b2AR, in which the residue C265 located at the 
cytoplasmic end of TM6 was labelled with a trifluoroacetanilide probe.68 Selectively 
13C labelled lysine side chains have also been employed to monitor extracellular surface 
conformations of b2AR in different states.69  
1.4 Membrane mimetics 
The biggest challenge for in vitro studies of membrane proteins is finding a suitable 
mimic of the native lipid membrane bilayer. The ideal membrane mimetic should be 
sufficiently stabilising for structural studies and also maintain the protein’s biological 
function and ability for interaction with ligands and other protein partners.70 Detergents 
are generally the first choice because they are the most straightforward systems. 
However, several other mimetics that have a lipid bilayer structure are becoming more 
popular due to technological advances. Membrane mimetics that are often used in 
membrane protein studies, namely detergent micelles, amphipols, bicelles, SMALPs, 
MSP nanodiscs and SapA nanoparticles, are reviewed in the following sections (Figure 
1-6). 
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Figure 1-6: Schematic representation of six membrane mimetic systems. 
Micelles, amphipols, bicelles, SMALPs, MSP nanodiscs, and SapA nanoparticles 
are shown in cartoon representation. Top view and side view for each system are 
shown. Legends for each component are shown at the bottom. 
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1.4.1 Detergent micelles 
Detergents are the most commonly used membrane mimetic for MP characterisation 
due to the range available, their simplicity of use, and for NMR spectroscopy, the 
relatively small size of the resulting protein-detergent complex (Figure 1-6).71,72 
Although the use of detergents has contributed a lot to our understanding of membrane 
proteins’ structure and function, there are some drawbacks of using detergents as a 
membrane mimetic. First, there is no universal rule that can predict which detergent 
provides the best stabilising environment for a membrane protein that has not been 
characterised. It requires an extensive and empirical screening process to find a suitable 
detergent, if any, for each membrane protein of interest. Second, detergents may exhibit 
denaturing properties and remove native lipid molecules that might be important to a 
membrane protein’s functionality. Therefore, using detergents may interfere with ligand 
binding and down-stream functional assays,73 disrupt protein-protein interactions,74 lack 
crucial protein-lipid contacts,75 interfere with protein dynamics,76,77 and may denature 
soluble binding partners78 making it difficult to study signalling across the membrane 
such as GPCR signalling. Third, detergent micelles are not a very good membrane 
mimetic either geometrically or physicochemically. Detergent molecules with a single 
hydrophobic chain form spherical micelles with high curvature which is very different 
from the native lipid bilayer. In addition, detergent molecules exchange rapidly between 
micellar and monomeric states, which may produce unfavourable dynamics very 
different from the native environment.  
1.4.2 Amphipols 
Amphipols are another membrane mimetic, a class of short amphiphilic polymers 
developed to keep membrane proteins in the solution without the need for detergents. 
Amphipols carry a large number of hydrophobic chains that bind strongly to the 
membrane protein of interest and never dissociate (Figure 1-6). This desirable 
characteristic allows one to handle membrane proteins without detergent and without 
free amphipols.79 Another advantage of using amphipols is the presence of a variety of 
functional groups on the sidechains which can be utilised for chemical modification or 
labelling.80 One of the first amphipols developed, called A8-35,81 has become the most 
often used amphipol. A8-35 has a relatively short polyacrylate chain with around 35 
acrylate residues. Some of the carboxylates on the acrylate residues are randomly 
replaced by octylamine (25%) or isopropylamine (40%) making the average molecular 
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weight of A8-35 around 4.3 kDa. The ~12 remaining acid groups on the acrylate 
residues remain charged and therefore make the polymer highly soluble in water while 
the octylamine groups provide a hydrophobic moiety to interact with membrane 
proteins. 
1.4.3 Bicelles 
Bicelles are composed of a planar lipid bilayer and detergent molecules to cover the 
edge of the bilayer (Figure 1-6).  The membrane protein of interest would be 
incorporated into the centre of the bicelles which provides a native-like lipid bilayer 
environment; therefore bicelles are considered to be a good membrane mimetic. The 
size of the bicelles is determined by the lipid:detergent ratio (q-ratio). Too low a q-ratio 
would result in forming a mixed micelle instead of a bicelle, thus losing the desired 
bilayer structure. A higher q-ratio generates larger bicelles that better mimic the native 
cell membrane. However, large particle size is not compatible with solution NMR 
studies because of unfavourable transverse relaxation. In general, q-values of 0.5–0.8 
provide a good balance between solution NMR spectral quality and membrane 
mimicking ability.82,83 Bicelles are also compatible with X-ray crystallography with q-
values in a range 2.2–2.8 commonly used.84 Many of these structures have been 
determined to high resolution with an average resolution of 2.5 Å.84 Despite the 
promising characteristics of the bicelle system, small amounts of detergent remain in the 
sample, including free (non-bicelle bound) detergent, which might have the same 
negative effect as detergent micelles.  
1.4.4 Styrene-maleic acid copolymer-lipid particles (SMALPs) 
Styrene-maleic acid copolymer (SMA) is amphipathic because it is composed of two 
components: hydrophobic styrene and charged, hydrophilic maleic acid.85 There are 
different ratios of SMA polymers available, and both 2:1 and 3:1 styrene:maleic acid 
ratios have been successfully used in membrane protein studies.85 The polymer 
spontaneously forms discoidal particles with synthetic lipids or biological lipid extracts 
with a diameter of ~10 nm (Figure 1-6), named Styrene-maleic acid copolymer-lipid 
particles (SMALPs).86 The most novel feature of SMALPs is the possibility to directly 
extract the membrane protein of interest and its associated lipids from a native 
biological membrane. The proteins in SMALPs can be purified using conventional 
chromatography without any other additives. This means membrane proteins can be 
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extracted and purified without ever leaving their original lipid environment. Similar to 
amphipols, SMA is used for the initial solubilisation step and is not required in the 
buffers for the remaining purification steps. SMALPs have been proven to be 
compatible with structural tools including X-ray crystallography,87 Cryo-electron 
microscopy,88,89 and solid-state NMR spectroscopy.90 Despite the success in many 
structural studies of membrane proteins using, intolerance of low pH and divalent metal 
ions significantly limits the applicability of SMALPs. With pKas of ~6 and ~10 for the 
two carboxyl groups of maleic acid,91 SMA is neutralised at low pH, losing its 
hydrophilic property, and therefore precipitates out of solution. A similar principle is 
that the carboxyl groups interact with divalent cations through electrostatic interactions, 
which also causes SMA precipitation.86 This limits the application of SMALPs in 
membrane proteins that require cofactor ions such as Mg2+. As solution NMR 
spectroscopy prefers a low pH due to backbone amide proton exchange, using SMALPs 
in NMR studies needs to be performed within a narrow pH range of 6.8–7.5.92 Several 
researchers are developing alternative copolymers that have the same ability as SMA 
but with improved buffer compatibility.93–96  
1.4.5 MSP nanodiscs  
The nanodisc system was developed recently by Sligar and co-workers.97 These disc-
like particles consist of a small patch of phospholipid bilayer enclosed by two belt-like 
membrane-scaffold proteins (MSPs),97 with the MP of interest incorporated into the 
centre of the discs, making it a native-like lipid bilayer suitable for MP characterisation 
(Figure 1-6).98 MSPs are engineered amphipathic helical proteins derived from human 
apolipoprotein A-I which originally has a specific function in lipid metabolism.97 The 
first version of MSP was called MSP1, with the N-terminal globular domain of 
apolipoprotein A-I truncated.97 MSP1 nanodiscs are about 9.7 nm in diameter. Several 
extended or truncated MSP constructs were designed by changing the length of the 
amphipathic helical part of the MSP.99 One, two, or three additional 22-amino acid 
amphipathic helices were inserted into MSP1, creating MSP1E1, MSP1E2, and 
MSP1E3 proteins respectively, resulting in nanodiscs with a diameter of 10.4 nm, 11.1 
nm, and 12.0 nm respectively.99 MSP1D1, with the first 11 amino acids of MSP1 
deleted, generates nanodiscs with a diameter of 9.5 nm.99 In order to make even smaller 
nanodiscs for solution NMR studies, further truncations were designed including 
MSP1D1ΔH5 (9.2 nm), MSP1D1ΔH4 (9.1 nm) and MSP1D1ΔH4H5 (7.8 nm), without 
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MSP1D1 helix 5 and/or 4 respectively.77 With all these MSP variants developed, the 
MSP nanodisc system has become a complete tool set for studying different sizes of 
membrane proteins. 
Nanodiscs seem to be generally applicable regardless of the type of protein and are 
widely used as a detergent-free environment; more than 800 papers using the key-words 
“Nanodisc-membrane protein” were returned in a literature search.100 The broad range 
of applications involves structural studies, analytical and functional studies, 
biotechnology and medical applications.98 The suitability of the MSP nanodisc system 
for solution NMR has been demonstrated,101,102 along with the functional relevance of 
lipid bilayer mimetics demonstrated for conformational equilibria of receptors and ion 
channels.103–105 More detailed developments and applications of the nanodisc 
technology for NMR studies will be reviewed in Chapter 3. 
1.4.6 Saposin A lipid nanoparticles 
There are other apolipoproteins or peptides available that can be used as scaffold 
proteins to form disc-like lipid particles.106–108 Among all the reported scaffold proteins, 
saposin A (SapA) is arguably the most promising system because of its size adaptability. 
Instead of a belt-like arrangement of MSPs, multiple SapA molecules interact with the 
exposed hydrophobic surface of the lipid bilayer (Figure 1-6), therefore the size of the 
resulting particles is determined by the number of SapA molecules surrounding them. 
This characteristic makes SapA an attractive tool that could potentially be a universal 
system which is able to accommodate different sizes of membrane proteins. 
The idea of using SapA as an alternative membrane scaffold protein was first realised in 
a cryo-EM study where an archaeal mechanosensitive channel T2 (32.9 kDa), which is a 
putative homopentamer, and a bacterial homotetramer peptide transporter PepTSo2 
(56 kDa) were both incorporated into SapA lipid nanoparticles at pH 7.4.109 In the case 
of the PepTSo2, it was significantly more stable in the SapA lipid nanoparticles than 
when in nonyl-b-D-maltopyranoside detergent micelles, resulting in a 29 ºC increase in 
melting temperature. This study yielded a single-particle cryo-EM structure of PepTSo2 
with a resolution of 6.5 Å. The crystal structure of the transporter PepTSo2 could be 
docked into the EM density. However, the electron density of four SapA molecules 
could only be observed at a lower isosurface level probably due to their high flexibility. 
This study demonstrated that SapA lipid nanoparticles can be used as a membrane 
mimetic to study 150–200 kDa membrane proteins with cryo-EM, providing a 
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stabilising, native-like lipid bilayer in a detergent-free environment. This study also 
demonstrated direct solubilisation of HIV-1 spike protein from the membrane of virus-
like particles using SapA. Another detailed protocol for reconstitution of sarco-
endoplasmic reticulum calcium ATPase into SapA lipid nanoparticles was reported.110  
It was also reported in the literature that SapA is the least lipid specific of the four 
human saposins.111 This makes SapA lipid nanoparticles the perfect membrane mimetic 
because it can be used to study membrane proteins in various lipid compositions. Four 
membrane proteins containing 14 to 56 transmembrane a helices were successfully 
reconstituted in to SapA lipid nanoparticles and studied using small angle X-ray 
scattering.111 Overall, SapA lipid nanoparticles seem to be a versatile tool for membrane 
protein studies. 
1.5 Aims 
Solution NMR spectroscopy is a powerful tool which provides valuable information 
about the conformation and dynamics of membrane proteins. In addition, it is clear that 
the lipid bilayer environment is important for membrane protein structure and functions. 
Therefore a membrane mimetic system that faithfully mimics the native membrane and 
is compatible with solution NMR spectroscopy is needed in the membrane protein field. 
The MSP nanodisc system, well established and verified in many NMR studies, fits the 
criteria. However, the incorporation procedure in MSP nanodiscs needs intensive 
screening for the optimal condition and the yield is generally low. An alternative bilayer 
membrane mimetic that overcomes these barriers would be welcome. The newly 
developed SapA lipid nanoparticle system seems very promising with several 
advantages over conventional MSP nanodiscs. The promising size flexibility of this 
system enables us to study membrane proteins with different sizes using the same SapA 
scaffold protein and should be applicable to a wide range of membrane proteins. Despite 
its promising properties, this is a relatively new approach and its applicability to other 
structural tools such as NMR spectroscopy still remains unclear. We hoped to expand 
the applicability of SapA lipid nanoparticles to investigate small-to-medium sizes of 
membrane proteins using NMR spectroscopy. Therefore, my PhD thesis focuses on the 
application of the SapA system in membrane protein studies using NMR spectroscopy.  
In order to design a protocol that can be used to incorporate membrane proteins into 
SapA lipid nanoparticles, we must first understand the formation mechanism. This will 
be discussed in Chapter 2. With the knowledge of how these particles are formed in 
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hand, the suitability of using SapA lipid nanoparticles as a membrane mimetic will be 
explored in Chapter 3. A b-barrel model protein is used to confirm that SapA lipid 
nanoparticles really provide a lipid bilayer environment. Next, a-helical membrane 
proteins in SapA lipid nanoparticles will be explored in Chapter 4 using microbial 
rhodopsins. Finally, the ultimate goal is to combine the SapA system with NMR 
spectroscopy to study biologically important membrane proteins. In Chapter 5, the b1-
adrenergic receptor, a GPCR, will be incorporated into SapA lipid nanoparticles and 
conformational changes in the receptor will be monitored using NMR spectroscopy.  
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2 MECHANISM OF SAPOSIN A 
LIPID NANOPARTICLE 
FORMATION 
2.1 Introduction 
2.1.1 Biological function of sphingolipid activator proteins  
SapA is a member of the family of sphingolipid activator proteins (SAPs) which are 
non-enzymatic proteins participating in the breakdown of certain sphingolipids in the 
lysosome.112 Five SAPs are found in human lysosomes: GM2 activator and saposins A, 
B, C, D.113 The four saposins are proteolytic cleavage products from a single precursor 
molecule prosaposin.114 In the absence of saposins, lipid degradation is completely 
disrupted.115 The function of the four saposins is different as they interact with a 
specific hydrolase and cannot compensate for the loss of other saposins,116,117 therefore 
causing different diseases. Accumulation of galactosylceramide was found in saposin A 
(SapA) mutated mice.118 Loss of functional SapA in humans results in Krabbe disease, a 
rare and fatal disease which progressively damages the nervous system.119 Loss of 
saposin C (SapC) causes Gaucher disease, a rare autosomal recessive lysosomal storage 
disorder.120 
It has been proposed that saposins act as a ‘solubiliser’ that completely extracts lipids 
out of the membrane and presents them to glycosyl hydrolases.121 For example, the 
crystal structure of SapA and the b-galactocerebrosidase heterotetramer shows how a 
soluble hydrolase can cleave the polar glycosyl headgroups from their hydrophobic tails 
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with the help of SapA.121 On the contrary, other saposin-like proteins function in a 
‘liftase’ model that improves lipid accessibility by membrane distortion, destabilisation 
or localised remodelling for degradation to take place on the membrane. Acid 
sphingomyelinase (ASM) is believed to be in this category.122–124 It is composed of a N-
terminal saposin domain, a proline-rich linker, and a catalytic domain. In acidic 
conditions, ASM is positively charged and subsequently binds to negatively charged 
membranes which contain bis(monoacylglycerol)phosphate. The saposin domain could 
open up and expose its hydrophobic surface to the membrane. This would cause a local 
disruption of lipid packing and allow the substrate headgroup to enter the enzyme active 
site.124 
2.1.2 The structure of SapA and its interaction with lipids  
The crystal structure of SapA, a 9.2 kDa protein, in its apo form was solved to a 2.0 Å 
resolution,125 revealing a general saposin fold that comprises three pairs of disulphide 
bonds holding four amphipathic a-helices together (Figure 2-1 A).125 Helices 2 and 3 
are disulphide linked to form the first segment, a helical hairpin, whereas two disulphide 
bonds hold helices 1 and 4 together to form the second segment. The conserved 
hydrophobic residues point inward holding the two segments together, while the non-
conserved charged residues are located on the surface. This typical saposin fold is 
shared with all the other saposin-like proteins. This is later defined as the closed 
conformation.126  
SapA has been observed to form 35–45 kDa particles, hereafter called SapA lipid 
nanoparticles, in the presence of liposomes of varying lipid composition or several non-
denaturing detergents at pH 4.8.126 Although the crystallisation of SapA with lipids was 
not successful, a crystal of detergent Lauryldimethylamine-N-Oxide (LDAO)-bound 
SapA was obtained and the model was refined to 1.9 Å resolution.126 The structure 
revealed an open form, in which the two segments of SapA open up into a V shape with 
an angle of 115º (Figure 2-1 B,C). Two open SapA molecules hold the LDAO 
minibilayer, composed of 40 LDAO molecules, in the middle.126 Notably, the two V-
shaped SapA are in an asymmetric manner in which the first segment of one SapA is 
close to the second segment of the other one, hence a head-to-tail arrangement. 
Moreover, no saposin-saposin contacts were observed in the crystal structure, indicating 
the particle is held together entirely by the hydrophobic interaction between detergents 
and SapA. With these characteristics, unlike the continuous belt-like MSP nanodiscs 
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that were discussed in Chapter 1, SapA has the potential to form lipid nanoparticles of 
various sizes by altering the number of SapA molecules per nanoparticle. Compositions 
of SapA lipid nanoparticles at different pH values have been explored using 
electrospray ionization mass spectroscopy and multiangle laser light scattering.127 
SapA-POPC nanoparticles were predominantly SapA2-POPC23-29 at pH 4.8, but were 
SapA4-POPC37-60 at pH 6.8. However, SapA4-POPC37-60 species at pH 6.8 were found to 
be unstable and converted to SapA3-POPC29-36 over a period of hours. 
 
Figure 2-1: Crystal structures of SapA. 
SapA in A) closed form (PDB: 2DOB) and in B) open form (PDB: 4DDJ) when 
bound to detergent LDAO shown in grey spheres. C) The monomer SapA in open 
form extracted from the aforementioned PDB structure in B) for comparison with 
the closed form. The disulphide bonds are shown in yellow sticks. The cartoon 
representations are shown at the bottom.  
closed open
first segment
second segment
A C
B
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The size flexibility of SapA lipid nanoparticles is a very attractive characteristic for a 
membrane mimetic system. Membrane proteins with different sizes could be 
incorporated into SapA lipid nanoparticles using a single scaffold protein, SapA. This 
would be advantageous over the conventional MSP nanodisc system, because it would 
no longer be necessary to screen multiple scaffold protein constructs. However, the 
requirement of low pH significantly limits the potential of SapA because most 
membrane proteins would not be stable in this extreme environment. This limitation 
was overcome later.109 It was shown that SapA lipid nanoparticles can be generated at 
physiological pH 7.4 using DDM-solubilised lipids.109 Although the role of DDM in 
SapA lipid nanoparticle formation at neutral pH was not explored in this paper, it 
significantly extended the applicability of the SapA lipid nanoparticles in the membrane 
protein field.  
2.1.3 Aims 
Using SapA lipid nanoparticles as a membrane mimetic system was discussed in section 
1.4.6. This approach has the advantage of size adaptability that can accommodate 150–
200 kDa proteins and has resulted in cryo-EM structures of membrane transporters.109 
Inspired by this previous work, we hoped to use SapA to stabilise small to medium size 
membrane proteins in solution for NMR studies. Preliminary investigations 
demonstrated that using DDM solubilised lipids can bypass the low pH requirement for 
SapA opening,109 enabling a wider application as a membrane mimetic. However, the 
detailed mechanism of how DDM promotes SapA lipid nanoparticle formation at 
neutral pH remains unexplored. In order to fully utilise the potential of this system, we 
aimed to further understand the mechanism of SapA opening at different pH values. 
Therefore we explored the relationship between SapA, lipids, and DDM in various 
conditions, with the intention of establishing a defined protocol for making SapA lipid 
nanoparticles. The size flexibility and the ability of SapA to interact with various lipid 
compositions are also investigated in this chapter. The work presented in this chapter 
lays a foundation for further development of the incorporation of a membrane protein of 
interest in later chapters. 
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2.2 Results and discussion 
2.2.1 Expression and purification of SapA 
In order to maximise the yield of SapA production, expression conditions and the 
purification protocol were screened and optimised. Since SapA contains three pairs of 
disulphide bonds, a SHuffle® T7 competent cell (New England Biolabs; a kind gift from 
the Hyvönen group, University of Cambridge, Biochemistry Department) was used for 
protein expression. This strain is a derivative of E. coli K12 cells, engineered to 
promote disulphide bond formation in the cytoplasm. We tested two temperatures (37 
ºC and 30 ºC) for growing SHuffle® T7 cells and two for protein expression after IPTG 
induction (30 ºC and 16 ºC). The cells were lysed using BugBuster® (Merck) and the 
SapA expression level was checked by SDS-PAGE (Figure 2-2). The result showed that 
30 ºC in the cell-growing phase slightly increased the SapA yield when compared to 
that at 37 ºC, while low temperature during the protein production phase seemed to be 
essential for optimising the yield. Therefore, initial cell growth at 30 ºC followed by 
growth at 16 ºC after induction was chosen for the final protocol.  
 
Figure 2-2: Screening optimal condition for SapA expression.  
SHuffle® T7 cells containing SapA plasmid were grown in one mL LB culture at 
the indicated temperature for four hours before the addition of 1 mM IPTG and 
incubation at the indicated temperature for another two hours. Cells were lysed 
using BugBuster® (Merck) and checked by SDS-PAGE. 
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Figure 2-3: Chromatography purification of SapA. 
Cell lysate containing expressed SapA was purified by A) anion exchange 
chromatography followed by B) size-exclusion chromatography. SDS-PAGE 
analysis of the corresponding fractions is shown at the bottom.   
In order to purify SapA, we adopted a protocol reported previously (discussed in more 
detail below).128 The SapA construct we used did not contain a purification tag because 
a heating step, an anion exchange (AEX) chromatography, and a size-exclusion 
chromatography (SEC) were sufficient to produce pure SapA. In addition, we preferred 
to use scaffold proteins that did not possess an affinity purification tag so that 
membrane protein incorporated in the lipid nanoparticles could be separated from empty 
lipid nanoparticles using an affinity tag on the target membrane protein. The first 
purification step after cell lysis was a 85 ºC incubation to precipitate out most of other 
proteins. This was only possible because SapA, with three pairs of disulphide bonds, is 
a very stable protein. This step produced a lysate that was sufficiently clean for further 
purification. The next step involved AEX chromatography (Figure 2-3 A). SapA, with a 
pI of 4.2, is negatively charged therefore should bind to an AEX column. It is worth 
mentioning that the capacity of a 5 mL HiTrap QSepharose column (GE Healthcare) 
was only able to purify lysate from 3 L culture at most. It can be clearly observed from 
SDS-PAGE analysis that there was still SapA in the flow-through fractions when lysate 
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from 6 L culture was loaded on the column (Figure 2-3 A). This was probably due to all 
the other impurities and residual DNA fragments that were able to bind to the AEX 
column competing with SapA, as suggested by the many other protein bands in the 
SDS-PAGE gel. The elution fractions from the AEX column were checked by SDS-
PAGE, and the fractions containing SapA were pooled and concentrated down to 1 mL, 
followed by a SEC purification step using a HiPrep Sephacryl S-200 column (GE 
Healthcare) (Figure 2-3 B). The final sample purity was higher than 95% judging from 
SDS-PAGE and the yield was approximately 10 mg/L culture in general. 
2.2.2 Mechanism of SapA lipid nanoparticle formation 
It has been shown that SapA can interact with liposomes at pH 4.8 to form disc-like 
particles,126 but n-Dodecyl b-D-maltoside (DDM) is required to achieve the same at pH 
7.4.109 However, the role of DDM in SapA lipid nanoparticle formation remains elusive. 
If the presence of DDM is solely to increase the solubility of the lipid, this would not 
explain why it is not necessary at lower pH. Therefore, we hypothesised that the pH can 
regulate the interaction between SapA and lipid molecules and the presence of DDM 
effectively achieves the same as acidic pH. In order to reduce the variables in the 
system, we designed experiments to look at only two parameters at a time. We first 
investigated the interactions between SapA and DMPC, a model lipid often used in 
nanodisc systems, at various pH values. We also performed experiments to confirm the 
potential interactions between SapA and DDM at neutral pH.  
We first characterised SapA in its apo form at pH 7.4 using analytical SEC. The peak 
eluted at 17.5 mL corresponding to 17 kDa (Figure 2-4 A, red). This species was 
probably dimeric, as monomeric SapA has a molecular weight of 9.2 kDa, and in closed 
form based on the available structural information for SapA.126 Next, SapA was 
incubated with DMPC solution, which remained cloudy due to low solubility without 
detergents, in different pH buffers at 37 ºC for 10 min and the resulting particles were 
analysed by size-exclusion chromatography (Figure 2-4 A). Most of the SapA at pH 6 
and pH 7.4 remained the same size as in the apo form, indicating that SapA remained in 
a closed conformation under these conditions and was not able to recruit DMPC to form 
nanoparticles (Figure 2-4 A, green and blue). On the contrary, SapA-DMPC 
nanoparticles with a molecular weight of 37 kDa, consistent with the value reported 
previously,126 were observed at pH 4.8 (Figure 2-4 A, purple). Interestingly, a negative 
control experiment that included apo SapA at pH 4.8 showed that SapA crashed out of 
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solution in the absence of DMPC (Figure 2-4 A, inset). This data suggests that acidic 
pH values destabilise SapA and the presence of DMPC compensates for this 
destabilisation by forming SapA-DMPC nanoparticles. 
 
Figure 2-4: SEC of SapA and the mixture of SapA and DMPC at various pH.  
A) Free SapA in the absence of DMPC at pH 7.4 (red), after incubation with a 10-
fold molar ratio of DMPC at pH 7.4 (blue), pH 6 (green), and pH 4.8 (purple). 
Molecular weight standards are indicated above in kilodaltons. The proposed 
SapA conformation is indicated next to the peak. Precipitated SapA at pH 4.8 is 
shown in the inset photograph. Incubation time of 10 min (solid line) and overnight 
(dashed line) are compared for B) pH 6 and C) pH 7.4. 
Although SapA at pH 6 and pH 7.4 seemed unable to form SapA-DMPC nanoparticles, 
we found that the process was actually time-dependent. If the samples were incubated at 
37 ºC overnight, instead of 10 min, more nanoparticles were observed as the peak at 
around 16.5 mL for pH 6 and a broad peak at 15 mL for pH 7.4 increased with longer 
incubation time (Figure 2-4 B,C). This result indicates that the presence of a kinetic 
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barrier makes the formation of SapA lipid nanoparticles extremely slow, and therefore 
SapA lipid nanoparticles cannot be observed in a reaction time as short as 10 min. This 
also shows that the SapA lipid nanoparticle state remains energetically favourable as it 
still formed spontaneously over time.  
With all the data together, we hypothesised that there is a kinetic barrier prevents the 
formation of SapA-DMPC nanoparticles. Low pH environments destabilise the closed 
form, possibly by opening up SapA, causing either recruitment of DMPC to form SapA-
DMPC nanoparticles or insolubility, due to intermolecular interactions, in the absence 
of lipids.  
Next, we investigated the interaction of SapA with DDM at pH 7.4. The idea was to 
check if DDM, which, unlike lipids, is soluble in water, could encourage the opening of 
SapA at pH 7.4. We observed a significant peak shift in size-exclusion chromatography 
indicating the formation of a stable SapA-DDM complex with a molecular weight of 30 
kDa (Figure 2-5 A). The introduction of DDM induces a different conformation of 
SapA which forms a particle larger than the closed conformation (17 kDa) and smaller 
than the fully open conformation observed in SapA-DMPC nanoparticles at pH 4.8 
(37 kDa). 
The SapA-DDM sample together with the SapA-DMPC nanoparticles at pH 4.8 and the 
apo SapA sample were further characterised using intrinsic fluorescence (Figure 2-5 B) 
and 1D proton NMR (Figure 2-5 C). A significant blue-shift and increased intensity in 
intrinsic fluorescence for SapA lipid nanoparticles can be observed (Figure 2-5 B) and 
this is consistent with previous observations in the literature.126 Based on the crystal 
structure of the closed and open forms of SapA in the literature (Figure 2-5 D), the only 
tryptophan in SapA should be completely solvent exposed in the closed form, but buried 
in the lipid bilayer in the open form. Therefore, any observed changes in intrinsic 
fluorescence should correlate with the opening of SapA. Interestingly, SapA-DDM 
(Figure 2-5 B, green) showed a characteristic fluorescence signal in between those of 
closed SapA and SapA-DMPC nanoparticles. We propose that SapA adopts an open-
like conformation in complex with DDM at pH 7.4. This suggestion is supported by 1D 
1H NMR spectra, which show a trend of downfield shift of the tryptophan side-chain 
signal indicated by * in Figure 2-5 C from apo SapA to SapA-DDM to SapA-DMPC. 
This downfield shift is probably due to movement into a more hydrophobic 
environment, consistent with the observation in the intrinsic fluorescence data (Figure 
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2-5 B). There are two tryptophan side-chain peaks in the SapA-DDM spectrum and both 
of them shift downfield compared to the spectrum for apo SapA. It is unlikely that one 
of them corresponds to apo SapA because the peak position and the peak width are very 
different from that in the apo SapA spectrum. Therefore, these results suggest that the 
tryptophan residue exchanges slowly between two conformations in the SapA-DDM 
complex. The broader linewidth of the Trp signal observed in the SapA-DDM complex 
is in line with the generally broader lines of signals from the amide backbone as would 
be expected due to the increased molecular weight of the detergent bound protein.  We 
also observed different 1D NMR profiles in the amide region (6–10 ppm) in all three 
samples indicating different conformations of SapA in these conditions. Peaks became 
broader following the trend of apo SapA, SapA-DDM, and SapA-DMPC due to a larger 
particle size, which is consistent with the SEC data. Overall, all our data suggests that 
SapA is able to form an open-like conformation in complex with DDM at neutral pH.  
 
 
 
 
 
 
 
 
 
Figure 2-5 (opposite): Biophysical characterisation of free SapA, SapA-DDM, and 
SapA-DMPC nanoparticles.  
Free SapA (blue), SapA-DDM (green), and SapA-DMPC nanoparticles (red) were 
analysed using A) analytical size-exclusion chromatography, B) intrinsic 
fluorescence spectroscopy using an excitation wavelength of 280 nm, and C) 1D 1H 
NMR spectroscopy. Tryptophan indole proton signals are indicated by *. D) 
Crystal structures of SapA in apo form (PDB: 2DOB) and LDAO-bound form 
(PDB: 4DDJ). Tryptophan residues are shown in spheres. 
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Figure 2-6 A shows an illustrative free energy diagram to summarise our observations. 
A high free energy barrier separates the closed form of SapA from the transition state, 
the open form of SapA at pH 7.4, which slows down the formation of SapA lipid 
nanoparticles dramatically (Figure 2-6 A, blue). When SapA is in an acidic environment, 
the closed conformation of SapA is destabilised (Figure 2-6 A, red). This effectively 
removes the energy barrier, thus SapA interacts with lipids and forms nanoparticles 
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spontaneously in a short period of time. We think that the open form of SapA is a 
transition state that is not stable without other hydrophobic molecules. This model also 
explains the observation of SapA precipitating when incubated with pH 4.8 buffer. The 
acidic pH forces SapA to open, exposing the hydrophobic surface, therefore SapA 
aggregates and precipitates. On the other hand, SapA spontaneously interacts with 
DDM and forms a stable open-like conformation as an intermediate state (Figure 2-6 B 
green). This effectively lowers the energy barrier at neutral pH, allowing efficient 
formation of SapA-DMPC nanoparticles. However, detergent removal becomes 
important if this route is used to generate SapA-DMPC nanoparticles because there 
would be a mixture of side products such as open-like SapA, mixed micelles, and 
potentially nanoparticles with mixed DMPC and DDM. 
 
Figure 2-6: Proposed free energy diagram of SapA-DMPC nanoparticle formation.  
The reaction at neutral pH (dark blue) shows two stable states: closed SapA and 
SapA-DMPC nanoparticles. A) Acidic pH destabilises the closed form. B) DDM 
induces a stable intermediate state containing open-like SapA and DMPC-DDM 
mixed micelles.  
During the preparation and characterisation of free SapA without detergents and lipids, 
we found that sequential size-exclusion chromatograms of the same apo SapA sample 
showed different profiles. We observed not only the usual apo SapA peak at around 
17.5 mL but also a larger particle, which eluted at around 16 mL. However, the second 
peak decreased when we ran the same sample again and almost disappeared in the third 
run (Figure 2-7). This irreproducibility indicates that the results, instead of showing the 
properties of the sample, were affected by the variables introduced during the 
closed SapA
open SapA
SapA-DMPC nanoparticles
fre
e 
en
er
gy
pH 4.8 destabilises 
closed SapA
closed SapA
open-like SapA
DMPC-DDM
mixed micelles
open SapA
DDM induces open-like 
SapA and increases the 
solubility of DMPC
SapA-DMPC nanoparticles
A B
neutral pH
acidic pH
neutral pH + DDM
Development of a saposin A based native-like phospholipid bilayer system for NMR studies 
Chih-Ta Chien- September 2018   35 
experiments. This phenomenon was only observed after the column was used by other 
group member using a buffer that contained detergent. Therefore, we think the peak at 
around 16 mL must correspond to SapA in complex with the residual detergent 
molecules left in the column, which essentially are ‘cleaned’ from the column after two 
SapA runs. This data shows that even when the column was washed and equilibrated 
with large volumes of water and buffer, detergent molecules can still remain in the 
column.  It also demonstrates that the interactions between SapA and detergents are 
strong. 
 
Figure 2-7: Sequential SEC of the same SapA sample. 
Same SapA samples with 120 µM concentration were loaded to the S200 10/300 
column that was previously used with a detergent buffer. The putative SapA-
detergent complex is indicated by *. 
2.2.3 Detergent removal by Amberlite XAD2 beads 
We have established that DDM is required for making SapA lipid nanoparticles at non-
acidic pH. However, the detergents must be removed completely during the formation 
of SapA lipid nanoparticles to rule out the formation of mixed detergent-lipid 
nanoparticles. We also observed strong binding of detergents to SapA, indicating that 
even a small amount of residual detergent can be picked up by SapA (Figure 1-7). With 
these data, we suspected it would be difficult to remove detergents using passive 
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methods such as dialysis or dilution and concentration. A proactive detergent binding 
method that could compete with SapA would therefore be necessary to remove 
detergents efficiently. We decided to test a detergent absorbent widely known as Bio-
beads, which are frequently used in the well-established nanodisc technology.129 
We used Amberlite XAD2 beads (Merck) as the detergent absorbent. In order to 
confirm the performance of this material before applying it to our system, the efficiency 
of DDM and LMNG removal by Amberlite XAD2 beads was investigated. We focused 
on these two detergents because they are most frequently used in our laboratory for 
membrane extraction and purification of membrane proteins and also because they both 
have sugar-based head groups. The advantage of the sugar head group is that the 
amount of the detergent can be quantified using a 2,6-dimethylphenol assay.130,131 This 
is an improved version of phenol-sulfuric acid methods for carbohydrate 
quantification.132 In this method, concentrated sulfuric acid breaks down 
polysaccharides to dehydrated monosaccharides which then react with 2,6-
dimethylphenol to produce an orange color. The color can be quantified by UV 
absorbance at 510 nm. A standard curve for each detergent was generated by applying 
the assay to samples with known concentration (Figure 2-8). Each sample was tested in 
triplicate for accuracy. The UV absorbance at 510 nm was plotted against detergent 
concentration and fitted by linear regression. The fitting quality for both was good, R2 > 
0.98, therefore the resulting formulae were used to determine the detergent 
concentration of unknown samples. It is noteworthy to mention that the slope in the 
formula we obtained for LMNG is approximately two times that for DDM. This is 
because LMNG has double the number of the sugar head groups compared to DDM. 
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Figure 2-8: Standard curve for detergent quantification. 
A) DDM and B) LMNG samples with known concentration were quantified using 
2,6-dimethylphenol assay. The fitting results and the quality of the fit are shown. 
The chemical structure of the corresponding detergents are shown above. 
With a validated assay that can accurately determine detergent concentration, we 
investigated the performance of Amberlite XAD2 beads. In the literature, the proportion 
of detergent removal beads required membrane protein incorporation into the MSP 
nanodisc system is within the range of 50%–100% (w/v).129 Therefore, we decided to 
test the detergent removal rate using 80% beads. Detergent samples with various 
starting concentrations were mixed with the beads and incubated at 25 ºC with gentle 
agitation. Samples were taken every 30 min for determination of detergent 
concentration using the 2,6-dimethylphenol assay. The result for DDM shows that 
initial concentrations of up to 0.2% detergent can be completely removed in 2 h. With 
higher initial concentrations, 1% and 0.5%, less than 10% of the original concentration 
was detected after incubation with Amberlite XAD2 beads. A single exponential decay 
was fitted to the data, resulting in a rate constant of approximately 0.02 min-1. In 
contrast, LMNG was much more difficult to remove, with a rate constant of 
approximately 0.003 min-1, taking 22 hr to remove 0.01% LMNG. The very low critical 
micelle concentration of LMNG (0.001%) should significantly reduce the population of 
single detergent molecules in solution, thus leading to a very slow detergent removal 
rate. This may also be the reason for the inconsistent readout from the assay for high 
concentrations of LMNG. LMNG in micelle form may not be able to react with the 2,6-
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dimethylphenol completely, so the phenomenon becomes obvious when using a high 
concentration of LMNG.   
 
Figure 2-9: Detergent removal by 80% w/v Amberlite XAD2 beads. 
The concentration of A) DDM and B) LMNG was measured by 2,6-dimethylphenol 
assay.  
The results above show that DDM is much easier to remove. Thus, it is the preferred 
detergent for membrane protein purification for the purpose of incorporation into MSP 
nanodiscs or SapA nanoparticles. Calculation of removal rates gives us information 
about the interaction of the beads for a specific detergent which is useful to design the 
protocol for incorporation for different membrane proteins into SapA nanoparticles. 
2.2.4 Size-tuneable characteristic of SapA lipid nanoparticle 
Based on our knowledge of SapA lipid nanoparticle formation, we attempted to make 
SapA-DMPC nanoparticles using the procedure described below and illustrated in 
Figure 2-10. Calculated amounts of SapA and DMPC depending on the testing ratio 
were mixed in a 1.5 mL eppendorf. In order to assist SapA-DMPC nanoparticle 
formation, 0.2% DDM was included in the assembly mixture. The buffer with the 
desired pH was then added to the mixture to a final volume of 500 µL. Table 2-1 shows 
the detailed composition of the mixture. The assembly mixture was incubated at 37 ºC 
for 10 min before the removal of DDM using 80% w/v Amberlite XAD2 beads, 
equivalent to 400 mg in 500 µL sample. Complete detergent removal was confirmed by 
2,6-dimethylphenol assay. The size of the resulting particles was measured by analytical 
SEC.  
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Figure 2-10: Illustration of the SapA-DMPC nanoparticle formation. 
Table 2-1: Composition of a SapA-DMPC (1:10) assembly mixture. 
	 Volume	 Final	concentration	SapA	(3	mM)	 20	µL	 120	µM	DMPC	(10	mM)	 60	µL	 1.2	mM†	DDM	(10%)	 10	µL	 0.2%	Buffer‡	 410	µL	 	Total	volume	 500	µL	 	
‡ The buffer used in the assembly mixture depends on the desired pH for the experiments. Three buffers 
were used in this section: 50 mM sodium acetate (pH 4.8), 50 mM sodium acetate (pH 6), and 50 mM 
Tris-HCl (pH 7.4), all with 150 mM NaCl. 
† The final concentration of DMPC depends on the ratio used in the experiments. This table shows a 
SapA:DMPC molar ratio of 1:10 as an example. 
Different SapA:DMPC ratios, namely 1:0, 1:5, 1:10, 1:20, and 1:30, were screened to 
see if the particle size increased with more DMPC in the initial assembly mixture. The 
data revealed the formation of two sizes of SapA-DMPC nanoparticles when different 
SapA:DMPC ratios were screened at pH 4.8, pH 6, and pH 7.4 (Figure 2-11). The 1:0 
ratio at pH 4.8 did not show any absorbance at 280 nm (Figure 2-11 A, black) because 
all SapA precipitated as described previously (2.2.2), consistent with the model for 
SapA opening (Figure 2-6). A 1:5 ratio converted all the SapA to SapA-DMPC 
nanoparticles with a molecular weight of 37 kDa (Figure 2-11 A, red), determined by 
molecular weight markers for the size-exclusion column. As the DMPC ratio increased, 
a second size of SapA-DMPC nanoparticles appeared at around 135 kDa (Figure 2-11 
A, purple). The behaviour for pH 6 and pH 7.4 was quite different from that for pH 4.8. 
An additional peak at 17.5 mL which corresponds to free SapA could be observed 
(Figure 2-11 B,C, black), whereas the 37 kDa nanoparticles disappeared. As for pH 6, a 
insoluble DMPC
closed SapA
DDM
DMPC-DDM
mixed micelles
open-like SapA
DDM removed 
by Amberlite XAD2 beads
SapA-DMPC nanoparticles
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1:10 ratio converted approximately 80% of SapA to SapA-DMPC nanoparticles with a 
molecular weight of about 70 kDa (Figure 2-11 B, blue). We observed a large overlap 
of two peaks in 1:20 and 1:30 ratio at pH 6 (Figure 2-11 B, green and purple), which 
prevented accurate determination of the peak position. In the case of pH 7.4, the elution 
profile was mostly similar to that at pH 6 with the exception of a little shoulder at 15 
mL in the 1:5 and 1:10 ratio profiles (Figure 2-11 C, red and blue). This peak was not 
stable as we only observed the free SapA at 17.5 mL when we reran the fractions. 
Therefore, we suspect it was some residual detergent on the column that interacted and 
broke down the SapA-DMPC nanoparticles into smaller particles. Overall, the results 
show that SapA is only able to form the 37 kDa SapA-DMPC nanoparticles at acidic 
pH. In all cases, SapA and DMPC assembled into nanoparticles of fixed sizes. In the pH 
7.4 case, for example, SapA-DMPC nanoparticles with 73 kDa or 135 kDa sizes were 
observed. With increasing amounts of DMPC, the population shifted from 73 kDa size 
to 135 kDa size instead of forming a SapA-DMPC nanoparticle with a size in between 
73 kDa and 135 kDa. This indicates that SapA-DMPC nanoparticles have defined 
compositions that are determined by the number of SapA molecules per nanoparticle. 
Our results also show that we can tune the size of SapA-DMPC nanoparticles by 
altering the SapA:DMPC ratio in the initial mixture. If the mixing ratio is exactly 
correct, uniformly sized SapA-DMPC nanoparticles are generated. Otherwise, a mixture 
of two particle sizes was observed. Therefore, we sought to find the optimal ratio that 
generates only one size of SapA-DMPC nanoparticle, which would allow us to 
characterise them further. 
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Figure 2-11: Analytical SEC of SapA-DMPC nanoparticles with different ratio.  
Assembly particle sizes were assessed at A) pH 4.8, B) pH 6, and C) pH 7.4. The 
proposed SapA arrangements of each species are shown in cartoon representation. 
We aimed to generate a uniform size of SapA-DMPC nanoparticles with an optimal 
assembly ratio at pH 6. Previous results (Figure 2-11 B) revealed that the 1:10 ratio 
sample still contained apo SapA, whereas the 1:20 sample already contained larger 
nanoparticles, indicating that the optimal ratio must lie between these two boundaries. 
Indeed, we found that a ratio of 1:15 generated a single peak in SEC with a molecular 
weight of about 64 kDa (Figure 2-12 A, blue; Table 2-2). The optimal ratio for larger 
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nanoparticles was also screened, showing a homogeneous single peak at a ratio of 1:45 
with a molecular weight of about 170 kDa (Figure 2-12 A, red; Table 2-2). Although 
these two optimal initial mixture ratios of 1:15 and 1:45 generated nanoparticles of a 
single size, the SapA:DMPC ratio in the final nanoparticles was not defined by these 
experiments. A molybdate assay, often used for phospholipid quantification,131 was 
performed to quantify the amount of DMPC in the fractions from SEC (Figure 2-12 A, 
open circle). In combination with the absorbance at 280 nm, a measurement of SapA 
concentration, the SapA:DMPC ratio could be determined experimentally for the final 
product. The results showed ratios of 1:14 and 1:45 respectively, very close to the ratio 
provided in the initial mixtures, 1:15 and 1:45. By considering the ratios and the 
apparent molecular weights of the two particles, we propose that the 1:14 ratio 
generated nanoparticles consisting of three SapA and 42 DMPC, hereafter called SapA3-
DMPC, and the 1:45 ratio species comprised four SapA and 180 DMPC, termed SapA4-
DMPC. 
The expected disc-like shapes were confirmed by negative-stain electron microscopy for 
both SapA3-DMPC and SapA4-DMPC. A side view of SapA3-DMPC nanoparticles 
stacked together can be seen (Figure 2-12 B, red arrow), as well as a top view of single 
nanoparticles (Figure 2-12 B, blue arrow). Stacking is likely to be an artefact during 
grid preparation and is also often observed in EM images of MSP nanodiscs.133,134 A 
similar artefact was observed in images of SapA4-DMPC nanoparticles (Figure 2-12 C). 
The larger particle size of SapA4-DMPC allows us to pick out some representative top-
down views showing the uniform size. 
The same SapA:DMPC ratio of 1:15 also generated a single size of SapA-DMPC 
nanoparticles at pH 7.4, showing as a single peak in the SEC elution profile (Figure 
2-13, dark blue; Table 2-2). We did not measure the final SapA:DMPC ratio by the 
molybdate assay, which we used for characterisation of SapA-DMPC at pH 6, because 
the assay was not yet established at the time this experiment was performed. However, 
the corresponding molecular weight was about 100 kDa, 50% larger than the particles 
generated at pH 6 (64 kDa). This suggests that the optimal ratio leading to a single 
particle is pH independent, but the size of the resulting particle is pH dependent. It is 
highly likely that the lipid bilayer packed much more loosely at pH 7.4. The reason for 
this behaviour is unclear. SapA at pH 7.4 might have a more flexible opening hinge, i.e. 
a wider range of inter-helical angles may be available, potentially leading to a more 
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dynamic bilayer in the middle and hence a larger particle size. However, this theory will 
need further experiments to be confirmed. 
 
Figure 2-12: Characterisation of SapA-DMPC nanoparticles at pH 6.  
A) Size-exclusion chromatography of SapA-DMPC with the SapA:DMPC ratio of 
1:15 (blue) and 1:45 (red). DMPC was quantified by the molybdate assay (open 
circle). The proposed compositions and the arrangement of the SapA-DMPC 
particles are indicated. B) Negative-stain images of SapA3-DMPC. Scale bar, 50 
nm. C) Negative-stain images of SapA4-DMPC. Scale bar, 50 nm. The insets show 
top-down views of representative SapA4-DMPC nanoparticle images in a 20 nm 
box. 
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It has been shown recently that SapA has a low lipid specificity for nanoparticle 
formation, meaning that SapA can interact with a wide range of lipids to form SapA 
lipid nanoparticles.111 This could be an advantage for further studies on the impact of 
lipid composition on the structure and dynamics of membrane proteins. Using the same 
SapA:lipid ratio of 1:15 at pH 7.4, we tested several lipid mixtures other than DMPC 
that were previously used in MSP nanodiscs including DMPC:DMPG (3:1) and 
POPC:POPG (2:1).77,105,135 The SEC elution profiles show that homogeneous particle 
sizes were formed with all the lipid mixtures tested (Figure 2-13). Interestingly, doping 
with lipids that possess phosphatidylglycerol (PG) headgroups results in smaller 
particles. This can be observed by comparing the profiles for DMPC (102 kDa) and 
DMPC:DMPG (3:1) (93 kDa) and the profile of POPC (77 kDa) and POPC:POPG (2:1) 
(70 kDa). In addition, doping with 10% cholesteryl hemisuccinate (CHS), a soluble 
homologue of cholesterol, generates larger particles. It is possible that these added lipid 
molecules can change the liquidity of the bilayer, therefore affecting the size of the lipid 
nanoparticles. 
 
Figure 2-13: SEC of SapA-lipid mixture nanoparticles. 
Sample was prepared by mixing SapA, lipid mixture, and DDM at pH 7.4 followed 
by detergent removal step. Different lipid mixtures were used; DMPC (blue), 
DMPC:DMPG (3:1) (cyan), POPC (red), POPC:POPG (2:1) (orange), and POPC 
with 10% CHS (purple). 
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Table 2- 2: Size determ
ination of SapA
 lipid nanoparticles. 
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2.3 Conclusions 
We proposed in this chapter a mechanism for the formation of SapA lipid nanoparticles. 
SapA can spontaneously open up to interact with lipids and subsequently form 
nanoparticles in acidic environments, whereas detergents are needed to facilitate SapA 
opening at neutral pH. Moreover, we found that SapA can form a stable complex with 
DDM in an open-like conformation. In order to completely remove DDM during SapA 
lipid nanoparticle formation, Amberlite XAD2 beads were used to actively remove 
detergents from the assembly mixture. A 2,6-dimethylphenol assay was used to quantify 
DDM left in the sample through a time course and eventually to confirm that the 
detergent had been completely removed. Based on our proposed mechanism for SapA 
opening, we established a protocol for making SapA-DMPC nanoparticles over a range 
of pH values. Variation in the ratio of SapA to DMPC present in the initial mixture was 
used to make different sizes of SapA-DMPC nanoparticles, showing the size-flexibility 
of this system. At pH 6, optimal ratios of 1:15 and 1:45 generate SapA-DMPC 
nanoparticles with molecular weights of 64 kDa and 170 kDa, respectively. The 
compositions of the two sizes of SapA-DMPC nanoparticles were confirmed using A280 
and a molybdate assay, and the disc-like shapes were observed in negative-stain EM 
images. We also tested the ability of SapA to form lipid nanoparticles with various lipid 
compositions. With the same 1:15 ratio of SapA to the total amount of lipid, particles 
using DMPC, DMPC/DMPG, POPC, POPC/POPG and POPC/CHS, respectively, 
showed as single homogeneous species but varied in their molecular sizes, according to 
their SEC elution profiles. While the exact reason for this size variation has not yet been 
established, there is a possibility that lipid composition may affect the compactness of 
the SapA lipid nanoparticles hence leading to assemblies with different apparent 
molecular weights. In summary, SapA lipid nanoparticles appear to be highly versatile 
and size-adaptable small lipid rafts. In the next chapters their properties as lipid 
membrane mimetics are used to investigate membrane proteins embedded in a native-
like lipid bilayer environment. 
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3 USING SAPA LIPID 
NANOPARTICLES AS A 
MEMBRANE MIMETIC FOR 
NMR SPECTROSCOPY: A 
CASE STUDY OF BACTERIAL 
OUTER MEMBRANE PROTEIN 
X 
3.1 Introduction 
3.1.1 Application of MSP nanodiscs in solution NMR studies 
It is important to study membrane proteins in a membrane mimetic system that suitably 
imitates their natural environment. However, it is very difficult to find a membrane 
mimetic that at the same time stabilises a membrane protein sufficiently, has native-like 
membrane properties, and is compatible with a range of analytical tools. Solution NMR 
spectroscopy is a very powerful tool that can provide structure and dynamics 
information about proteins, however, its size limitation puts considerable limitations on 
the suitability of many membrane mimetic systems. As discussed in Chapter 1, MSP 
nanodiscs among others show the most promising properties in view of NMR 
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compatibility. In this section, I review some of the solution NMR studies of membrane 
proteins using MSP nanodiscs including several modifications to the system that greatly 
improve its NMR compatibility. A detailed experimental procedure for membrane 
protein incorporation is included. Finally, I discuss some of the issues with MSP 
nanodiscs that are still in need of improvement. 
MSP nanodiscs consist of a small patch of phospholipid bilayer surrounded by two units 
of the engineered apolipoprotein A-I (ApoA-I), also known as membrane scaffold 
protein, creating a well-defined, membrane-like particle. A membrane protein of interest 
can be reconstituted into the lipid patch of an MSP nanodisc, which emulates the native 
membrane environment. This technology has been widely employed for membrane 
protein studies using various biological assays and biophysical tools including solution 
NMR spectroscopy.98 Several membrane proteins were successfully incorporated into 
the first version of MSP nanodiscs, MSP1D1 nanodiscs, for 2D heteronuclear NMR 
measurements, such as VDAC-1,101 VDAC-2,136 CD4mut,137 Aam-I,138 KvAP.138 
However, the large particle size of MSP nanodiscs, about 120 kDa, severely limits their 
applicability and also makes multidimensional NMR data, which is required for peak 
assignment and structure determination, extremely difficult to obtain. To improve the 
suitability of MSP nanodiscs for NMR studies further, Hagn et al. developed a set of 
truncated MSP constructs that resulted in a reduced nanodisc molecular weight as 
discussed in Chapter 1.77 This enabled the 3D backbone resonance assignment and 
structure determination of an integral membrane protein.77 The development of these 
shorter MSP constructs also facilitated many NMR studies of other small-to-medium 
sized membrane proteins.139–141 Moreover, the availability of the truncated MSP 
construct also prompted a solution structure determination of the scaffold proteins in an 
MSP nanodisc, showing the detailed antiparallel arrangement of the double belt scaffold 
proteins.134 Further improvements have been achieved through the introduction of 
covalently circularised nanodiscs, which result in a well-defined particle size rather than 
a broad distribution in sizes that require additional separation through multiple 
chromatographic methods.142 These developments undoubtedly expanded the 
application of nanodiscs in the field of NMR studies of membrane proteins. 
A detailed protocol was published recently describing all the critical points that have to 
be considered when optimising nanodisc preparations for NMR spectroscopy.129 The 
general procedure involves mixing MSP, lipids solubilised in cholate buffer and 
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detergent-micelles containing the membrane protein in a ratio that needs to be 
empirically optimized. The assembly mixture is then incubated for 1-2 h followed by a 
detergent-removal step either using detergent absorbent beads or dialysis. The self-
assembly of membrane protein embedded nanodiscs is thought to be initiated by 
removing the detergent. The incubation temperature used in this step is also important, 
with the nanodiscs forming most efficiently near the phase-transition temperature of the 
lipids being used. The reason for this temperature requirement is still not clear but it 
may be explained by an effect of the phase behaviour of the phospholipid on the 
organisation of the phospholipid/detergent micelle during nanodisc formation.143 
Presumably, being close to the phase transition temperature allows lipid molecules to 
exchange between the liquid and gel phase, so small patches of lipid bilayer can 
associate or dissociate until a well-defined structure becomes encircled by scaffold 
proteins. After nanodisc assembly, an optional affinity column can be applied to remove 
any empty discs provided there is an affinity tag on the embedded membrane protein, 
while the scaffold protein is typically free of tag. Finally, the size of the assembled 
particles can be checked, and their homogeneity improved by size-exclusion 
chromatography. 
Despite this well-established procedure for MSP nanodisc assembly and membrane 
protein incorporation, there are several screening steps required that are time-consuming 
and costly. One example is the need to screen for suitable MSP constructs: there are 
currently six MSP constructs of different lengths and which one gives the most 
desirable properties, in terms of NMR spectral quality, needs to be screened for every 
membrane protein of interest. Using a construct that is too long will result in particles 
with a molecular weight that is too high, making them incompatible with NMR studies, 
whereas using a construct that is too short will result in insufficient lipid molecules to 
stabilise the membrane protein or to represent a native lipid environment. The MSP-to-
lipid ratio also needs to be optimised for every study. Although the ratio for empty 
nanodiscs is defined by the size of the MSP construct, the number of lipid molecules 
that incorporated membrane protein will replace needs to be determined. Provided a 
structure of the target protein is known, the likely ratio can be approximated based on 
geometrical arguments,129 otherwise, the ratio needs to be determined empirically by a 
series of small-scale tests. Using an incorrect ratio can generate inhomogeneous 
particles or aggregates.  This also means it is difficult to incorporate lipid extract from 
natural sources such as brain lipid extract or E. coli lipid extract, as the molar 
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concentration of the lipid mixture is either unknown or likely to be inaccurate. Due to 
these reasons, incorporation of membrane proteins into MSP nanodiscs is still a 
laborious process that may take months for full optimization, and often needs multiple 
SEC steps to result in homogeneous samples. The latter can substantially reduce the 
yield of incorporation, as 10% is typically lost in each size-exclusion run at our hands. 
3.1.2 Using SapA as an alternative scaffold protein for NMR studies 
We have shown the size flexibility of SapA phospholipid nanoparticles by altering the 
SapA:lipid ratio in Chapter 2. This adaptability makes SapA an attractive system 
because a single scaffold protein should be able to accommodate a wide range of 
membrane proteins of different molecular sizes, removing the need to screen for the 
optimal MSP construct. Chapter 2 also elaborated that although SapA lipid 
nanoparticles have size flexibility, all the particles formed are disc-shaped and 
homogeneous. Accordingly, this means that it is not necessary to maintain an accurate 
SapA:lipid ratio during the assembly process, unlike with MSP nanodiscs. A slight 
deviation of the SapA:lipid ratio from the ideal will generate a second size of 
nanoparticle without compromising the homogeneity of the primary, desired species. As 
such, the SapA system should be capable of assembling lipid nanoparticles without the 
need for a time-consuming screening process. We have also shown in Chapter 2 that 
SapA3-DMPC nanoparticles possess an apparent molecular weight of about 70 kDa. 
This is smaller than the particles formed by the most commonly used MSP construct in 
NMR studies, MSP1D1DH5 at 107 kDa. In view of its size the SapA system could 
potentially be competitive, assuming that there is an approximate inverse correlation 
between spectral quality and size of the overall particle into which the membrane 
protein is embedded. 
3.1.3 Structure, function and related NMR studies of OmpX 
Gram-negative bacteria are surrounded by two layers of membrane, the cytoplasmic 
membrane and the outer membrane.144 The outer membrane protects the bacterial cell 
from the outside environment. About 50% of the outer membrane mass consists of 
membrane proteins, either integral membrane proteins or membrane associated 
proteins.144 These proteins carry out essential cellular functions such as nutrient uptake, 
cell adhesion, cell signalling and waste export.145 Many of these outer membrane 
proteins are also characterised as virulence factors for nutrient scavenging and evasion 
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of the host defence system, including OmpX.146 The molecular structure of OmpX was 
first determined at 1.9 Å resolution by X-ray crystallography (Figure 3-1 A).147 The 
structure shows an eight-stranded antiparallel b-barrel with a barrel height of 
approximately 32 Å.147 The four b-strands found protruding at the extracellular side 
were proposed to function as a ‘fishing rod’ to form hydrogen bonds with binding 
partners, therefore being responsible for cell adhesion and invasion.  
 
Figure 3-1: Molecular structure of OmpX. 
A) Structure of OmpX in n-octyltetraoxyethylene determined by X-ray 
crystallography (PDB ID: 1QJ8147). B) Solution structure of OmpX in 
dodecylphosphocholine (DPC) determined by NMR spectroscopy (PDB ID: 
2M0777). C) Solution structure of OmpX in MSP1D1DH5-DMPC/DMPG nanodiscs 
(PDB: 2M0677). 
NMR studies of OmpX became reachable due to the development of transverse 
relaxation-optimized spectroscopy (TROSY) experiments.27 The solution NMR 
structure of OmpX in detergent micelles was solved, revealing the same fold as in the 
crystal structure (Figure 3-1 B).148,149 Comparing the results of the two methods, it is 
clear that the crystal structure shows the extracellular regions as extended b-sheets, 
while the solution NMR structure reports them as random coil. The extended b-sheets 
are probably artefacts due to crystal packing.  
Several desirable characteristics make OmpX a good model system for NMR studies, 
such as its small size (15 kDa), its high expressability in E. coli and its high thermal 
A B C
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stability. Not surprisingly, OmpX was used as a model protein for the development of 
shorter MSP constructs.77 Using the shorter construct MSP1D1DH5 (DH5) the solution 
structure of lipid-nanodisc embedded deuterated OmpX was determined by NMR 
spectroscopy (Figure 3-1 C).77 No protruding b-strands, as seen in the crystal structure 
(Figure 3-1 A), were found in this structure. The b-barrel assembly is composed of 
longer b-strands with shorter extracellular and intracellular loops, compared to the 
structure in detergent (Figure 3-1 C). In addition, the 15N heteronuclear NOE data 
suggests increased dynamics of the loop regions in the nanodisc structure.77 In another 
NMR study, OmpX was used to demonstrate the effect of membrane mimetics, namely 
micelles, bicelles, and nanodiscs, on backbone dynamics.76 The relaxation data suggests 
that the inherent flexibility of this b-barrel membrane protein is largely compromised in 
the detergent micelles.76 These studies emphasise the importance of choosing a native-
like membrane environment when conducting structural studies.  
In view of the considerable amounts of NMR data that are available for OmpX in many 
different environments, it is convenient to use this protein as a model system to 
investigate the performance of SapA lipid nanoparticles as a native-like membrane 
mimetic. 
3.1.4 Aims 
The existing MSP nanodisc technology in combination with solution NMR 
spectroscopy has been very powerful and has made several important breakthroughs in 
the membrane protein field. However, there are still some difficulties in using MSP 
nanodiscs including the long screening process and the low incorporation yield. 
Therefore, an alternative system would be welcome. SapA lipid nanoparticles have been 
used as a new membrane mimetic system in cryo-EM studies.109,110 Inspired by this 
cryo-EM study, we hoped to extend the application of the SapA system to study small-
to-medium size membrane proteins of less than 50 kDa using solution NMR 
spectroscopy.  
In Chapter 2, we showed that our established protocol can generate SapA lipid 
nanoparticles with the desired size-flexibility characteristic. In order to use SapA lipid 
nanoparticles for studying biologically important proteins, we have to validate the 
ability of SapA to be used as an alternative membrane scaffold protein. OmpX seems to 
be a good candidate as a model protein for validation because OmpX in MSP nanodiscs 
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has been previously studied extensively by solution NMR spectroscopy, providing a 
good point of comparison.76,77,150 The 2D NMR spectra of OmpX in detergent and in 
MSP nanodiscs are very different in terms of the peak positions because the two 
chemical environments are distinctly different. Therefore, we hypothesised that if SapA 
lipid nanoparticles can provide a similar lipid bilayer environment to MSP nanodiscs 
then their 2D NMR spectra should look very similar. A comparison should therefore 
allow us to validate the suitability of using SapA lipid nanoparticles as a native-like 
membrane mimetic for NMR studies.  
SapA has been shown to be able to bind a variety of lipids,111 making the SapA lipid 
nanoparticle a versatile platform to study the effect of lipid composition on membrane 
proteins. Consequently, we sought to incorporate OmpX into various lipid compositions 
and investigate the effect of the lipid headgroup, the length of the aliphatic chain, and 
the degree of unsaturation on the incorporated membrane protein. 2D NMR experiments 
were then used to report on the structure and dynamics of OmpX in different lipid 
environments with atomic resolution. We expected the outcome of these proof-of-
concept investigations to facilitate further applications to biologically relevant 
molecules. 
3.2 Results and discussion 
3.2.1 Incorporation of OmpX into SapA-DMPC nanoparticles 
In Chapter 2, we proposed the mechanism for the formation of SapA lipid nanoparticles 
in which DDM is required in the process. We also showed the existence of a stable 
SapA-DDM complex, and that detergent absorbent beads must be included in the 
incorporation procedure to proactively remove detergents. Here, we demonstrate the 
incorporation of OmpX using our developed protocol to show that SapA lipid 
nanoparticles can be used as a membrane mimetic for NMR studies. 
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Figure 3-2: Illustration of OmpX incorporation into SapA-DMPC nanoparticles. 
The procedure for OmpX incorporation is illustrated in Figure 3-2. OmpX was 
originally solubilised in the detergent DPC. As DDM is the only detergent we ever 
tested to promote the open conformation of SapA, it was not clear if other detergents 
such as DPC would have the same ability. Consequently, we always supplemented 0.2% 
DDM, the same amount used in making SapA-DMPC nanoparticles, in the initial 
mixture for OmpX incorporation. The initial mixture consisted of SapA, DMPC and 
OmpX at a ratio of 10:50:1 at pH 6 in the presence of 0.2% DDM (Table 3-1). A ten-
fold excess of SapA over OmpX was chosen to increase the rate of protein 
incorporation. In comparison, an excess amount of MSP is often used for the same 
reason during nanodisc assembly, next to decreasing the incorporation of more than one 
protein per nanodisc.129 The 1:5 ratio of SapA:DMPC was the result of a rough initial 
estimate. Accordingly, as shown in Chapter 2, the composition of empty SapA3-DMPC 
nanoparticles was three SapA and 42 DMPC molecules. In the literature it has been 
shown that OmpX displaces about 20 DMPC molecules.77 Therefore, we estimated that 
the composition of OmpX containing SapA3-DMPC nanoparticles would be one OmpX, 
three SapA, and 22 DMPC, leading to a SapA:DMPC ratio of 1:7. Our first 
experimental attempts used a 1:5 ratio, which gave excellent results. Due to the size-
adaptability of SapA lipid nanoparticles we did not have to carefully screen for the 
optimal ratio, unlike with MSP nanodiscs.  
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Table 3-1: Composition of an OmpX incorporation assembly mixture. 
	 Volume	 Final	concentration	SapA	(3	mM)	 20	µL	 120	µM	DMPC	(10	mM)	 30	µL	 600	µM	OmpX	(1	mM)	 6	µL	 12	µM	DDM	(10%)	 10	µL	 0.2%	Buffer‡	 434	µL	 	Total	volume	 500	µL	 	
‡ The buffer used in the OmpX incorporation is 50 mM sodium acetate (pH 6), 150 mM NaCl. 
After mixing all the components, the mixture was incubated at 37 ºC for 10 min. At this 
point the cloudy sample converted into a clear solution. The sample was then subjected 
to a detergent removal step through incubation with 80% w/v Amberlite XAD2 beads at 
25 ºC for 2 h. Although efficient detergent removal was expected, at this stage of the 
nanoparticle formation procedure we were not able to estimate the DPC concentration 
as the 2,6-dimethylphenol assay only responds to sugar-based detergents.130 1D proton 
NMR was ambiguous in this case because both DPC and DMPC yield signals from 
choline protons that we usually use for detecting the phosphatidylcholine (PC) 
headgroup. However, in one experiment which is discussed in section 3.2.4, OmpX was 
incorporated into DMPG nanoparticles and the corresponding 1D proton NMR showed 
negligible PC signal indicating almost quantitative removal of DPC by the established 
protocol.  
Nevertheless, after final detergent removal, OmpX remained in solution and showed a 
symmetrical elution peak at 14.1 mL (84 kDa) by SEC (Figure 3-3 A), which appeared 
to be significantly larger than OmpX in DPC micelles (15.5 mL; 44 kDa). The SDS-
PAGE gel of the corresponding fractions from the SEC confirmed the presence of both 
OmpX and SapA in the major peak (Figure 3-3 B). It was likely that OmpX had been 
successfully incorporated into SapA3-DMPC nanoparticles based on the molecular 
weight (Table 3-2). 
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Figure 3-3: Incorporation of OmpX into SapA-DMPC nanoparticles. 
A) SEC of OmpX in SapA-DMPC nanoparticles (solid blue) and in detergent DPC 
micelles (red dotted). B) The fractions from OmpX in SapA-DMPC indicated by 
f1–f6 were analysed by SDS-PAGE (bottom) showing the presence of both OmpX 
and SapA in the main elution peak. The fractions containing OmpX (f1–f3) were 
pooled and concentrated for further investigation. 
The incorporation yield was generally higher than 80% judging by the OmpX band in 
the SDS-PAGE analysis. Moreover, the resulting particle size of 84 kDa was smaller 
than for OmpX in MSP1D1∆H5 (∆H5) nanodiscs (107 kDa).77 Guided by these 
observations, it seemed reasonable to expect that 2D [1H,15N] TROSY NMR 
experiments could be collected without the need to produce highly deuterated, 15N-
labelled OmpX.  
3.2.2 NMR studies of OmpX in SapA-DMPC nanoparticles  
A 2D [1H,15N]-SOFAST-TROSY spectrum was recorded using non-deuterated 15N 
labelled OmpX to assess its structural integrity in SapA3-DMPC nanoparticles (Figure 
3-4 A). The resulting spectrum was of good quality even without deuteration, indicative 
of the sample being homogeneous. Clearly the quality of the spectrum of the ∆H5-
DMPC/DMPG nanodiscs in the literature150 is superior due to the use of deuterated 
OmpX. However, rotational correlation time measurements using 1D 15N TRACT151 
indicated that SapA nanoparticle embedded OmpX was smaller in size (𝜏c	=	 28 ns, 
calculated MW of 87 kDa) compared to that in ∆H5 nanodiscs (𝜏c = 34 ns, calculated 
MW of 107 kDa). Accordingly, using deuterated protein should result in further 
improvements, and based on the quality of the spectrum shown in Figure 3-4 A one 
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would anticipate high-quality data for OmpX in SapA nanoparticles. Nevertheless, 121 
out of 131 backbone assignments from the literature150 could be transferred 
unambiguously to our spectrum based on peak proximity, allowing us to investigate the 
chemical environment of OmpX without the need for a complete reassignment. 
Table 3-2: Proposed compositions of OmpX in SapA-DMPC nanoparticles. 
	 SEC†	 Rotational	diffusion	 Proposed	
compositions	
Calc.	MW	
(kDa)§		 Ve	(mL)	 MW	(kDa)	 𝜏c	(ns)#	 MW	(kDa)	OmpX	in	DPC	 15.5	 44	 -	 -	 -	 -	
OmpX	in	SapA3-DMPC	 14.1	 84	 28	 87	 3xSapA	+	42xDMPC	+	1xOmpX	 71	
OmpX	in	∆H5-DMPC/DMPG	(3:1)‡	 -	 -	 34	 107	
2x∆H5	+	60xDMPC	+	20xDMPG	+	1xOmpX	 115	
† Ve = elution volume. The molecular weights were calculated based on the calibration curve obtained 
from protein standards. Details and the formula can be found in section 6.2.3. 
# Correlation time (𝜏c) was measured by 1D 15N TRACT151 at 318 K.  
§ The molecular weights were calculated based on the proposed compositions with 9.2 kDa for SapA, 
677.5 Da for DMPC, 15 kDa for OmpX, 22.1 kDa for ∆H5, and 0.688 kDa for DMPG. 
‡ Data was obtained from the literature.77 
Chemical shifts are very sensitive to the chemical environment of the molecules under 
investigation. Similarities in chemical shift should indicate similar membrane protein 
environments. The chemical shift assignment datasets of both OmpX in detergent DPC 
(BMRB: 18797) and OmpX in ∆H5-DMPC/DMPG nanodiscs (BMRB: 18796) are 
available.150 Therefore, we compared our spectrum, OmpX in SapA3-DMPC, to these 
two chemical shift assignments to confirm the chemical environment of OmpX in our 
sample. Although the lipid composition used was not exactly the same, pure DMPC in 
our sample and DMPC/DMPG (3:1) in the ∆H5 nanodiscs,150 the TROSY spectrum of 
OmpX in SapA-DMPC nanoparticles shares strong similarities with that recorded in 
∆H5-DMPC/DMPG nanodiscs (BMRB: 18796)150. In contrast, considerable differences 
exist throughout when compared against the spectrum obtained in DPC micelles 
(BMRB: 18797)150. This can be clearly observed for some peaks, e.g. G64, R29, I65, 
V5, by zooming in to some well resolved regions (Figure 3-4 B–D). These results 
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confirm that OmpX was surrounded by the DMPC lipid bilayer offered by SapA-DMPC 
nanoparticles and was no longer in the DPC detergent micelles, which were removed 
during the protein incorporation and nanoparticle assembly process. 
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Figure 3-4 (opposite): NMR spectrum of OmpX in SapA-DMPC nanoparticles. 
A) 2D [1H,15N]-SOFAST-TROSY spectrum of non-deuterated 15N-labelled OmpX 
in SapA3-DMPC nanoparticles. The spectrum was recorded at 318 K on a Bruker 
Avance AVIII 800 spectrometer (1H frequency of 800 MHz) equipped with a 5 mm 
TXI HCN/z cryoprobe. The experiment was recorded with 3,078 scans, resulting in 
an experiment time of 36 h. Selected Region 1 and Region 2 are indicted in dashed 
box. B) Enlarged Region 1 (left) and Region 2 (right). Region 1 and Region 2 of 
previously reported NMR peak assignments of OmpX in C) ∆H5-DMPC/DMPG 
nanodiscs (BMRB: 18796) and D) in DPC micelles (BMRB: 18797).150 
For a better comparison, another sample with the exact same lipid composition, 
DMPC/DMPG (3:1), was prepared. The experimental data including the size exclusion 
chromatogram (Figure 3-10 A) and the corresponding TROSY spectrum (Figure 
3-11 blue) are discussed in section 3.2.4. All the assignments from the SapA-DMPC 
spectrum could be transferred onto the SapA-DMPC/DMPG (3:1) spectrum. In order to 
provide a more quantitative comparison, weighted chemical shift perturbations (CSP) 
were calculated for every residue between OmpX in SapA and ∆H5 and between OmpX 
in SapA and DPC using the formula: ∆𝛿(,* = 	+(∆𝛿(). + 0.13	 ×	 (∆𝛿*). 
where ∆𝛿(,* is the CSP, and ∆𝛿( and ∆𝛿* are the chemical shift differences along the 
proton and nitrogen dimensions, respectively. All the CSPs are plotted as scatter plots in 
Figure 3-5. The results show a smaller and more uniform CSP between the SapA-
DMPC/DMPG and ∆H5-DMPC/DMPG spectra, with a mean value of 0.13 ± 0.08 ppm. 
A much wider distribution with a mean value of 0.21 ± 0.18 ppm is observed in the 
comparison of SapA nanoparticles with DPC micelles. These results show that the 
spectrum of OmpX in SapA-DMPC/DMPG is more similar to the spectrum of OmpX in 
∆H5-DMPC/DMPG. This again is supportive of a proper incorporation of the protein 
into the DMPC/DMPG bilayer provided by SapA-DMPC/DMPG nanoparticles.  
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Figure 3-5: Spectral similarities of OmpX in different membrane mimetics. 
Comparison of backbone amide chemical shifts of OmpX in SapA-DMPC/DMPG 
nanoparticles with OmpX solubilized in DPC micelles (red) or MSP1D1∆H5-
DMPC/DMPG nanodiscs (blue).77 Weighted chemical shift perturbations (CSPs) 
were calculated for all the assigned residues and plotted as scatter plot. The mean 
value and the standard deviation are indicated. 
This section has confirmed the suitability of SapA lipid nanoparticles for solution NMR 
studies and their ability to provide high resolution membrane protein NMR spectra. The 
comparison of protein occupied SapA3-DMPC nanoparticles and ∆H5-DMPC nanodiscs 
revealed that OmpX was in a similar chemical environment, consisting of a DMPC lipid 
bilayer. In the case of OmpX, comparable nanoparticles were smaller than their 
typically used nanodisc counterparts 
3.2.3 Influence of the phospholipid aliphatic chain on OmpX 
Following the successful incorporation of OmpX into SapA3-DMPC nanoparticles we 
started to investigate the influence of phospholipid side-chain length and side-chain 
saturation level on OmpX. Expanding on the results obtained using DMPC, we decided 
to test DPPC and POPC, both of which contain the same PC headgroup, to assess the 
influence of aliphatic chain length and the degree of unsaturation. The molecular 
structures of DMPC, DPPC, and POPC are depicted in Figure 3-6 A-C at the same 
overall scale. A comparison between DMPC and DPPC shows an increase in the length 
of the side chain through the introduction of an additional ethyl group, while a 
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comparison of DPPC and POPC shows the effect of an additional double bond in the 
aliphatic side-chain at position nine.  
 
Figure 3-6: The structure of the lipids used in this study.  
A) DMPC, B) DPPC, C) POPC, D) DMPG, and E) POPG. Carbon (green), oxygen 
(red), phosphorus (orange), nitrogen (blue), and hydrogen (white) are shown in 
sphere representation.  
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Figure 3-7: SEC of OmpX in different phosphocholine lipids. 
The SEC profile of OmpX in SapA-DMPC (red), SapA-DPPC (blue), and SapA-
POPC (green) are overlaid. The profile of OmpX in SapA-DMPC (red) is the same 
one as in Figure 3-3 A with A280 values scaled up 2.3 times for easier comparison 
in this figure. 
OmpX was incorporated into SapA-DPPC nanoparticles and SapA-POPC nanoparticles 
using the same protocol and same SapA:lipid:OmpX ratio as that used for SapA-DMPC 
nanoparticles. SEC showed similar elution profiles with a little variation in the peak 
position (Figure 3-7). The exact reason for this variation is unclear. It could be that the 
longer aliphatic chain, which should produce a lower transition temperature would 
generate a less dynamic, more ordered and compact bilayer, leading to slightly smaller 
SapA lipid nanoparticles. Nevertheless, the sizes of the OmpX embedded nanoparticles 
are all in the same region, so it is clear that OmpX is in SapA3 lipid nanoparticles 
regardless of the lipids used for incorporation. Elution fractions 13–16 mL were 
collected and concentrated for NMR experiments. 
Figure 3-8 (opposite): NMR spectra of OmpX in DPPC and POPC. 
2D [1H,15N]-SOFAST-TROSY spectra of non-deuterated 15N-labelled OmpX in A) 
SapA-DPPC nanoparticles and B) SapA-POPC nanoparticles. The spectra were 
recorded at 318 K on a Bruker Avance AVIII 800 spectrometer (1H frequency of 
800 MHz) equipped with a 5 mm TXI HCN/z cryoprobe. The experiments were 
recorded with 3,078 scans, resulting in an experiment time of 36 h. 
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A 2D [1H,15N]-SOFAST-TROSY spectrum was recorded for each nanoparticle sample 
containing OmpX embedded in either DPPC or POPC (Figure 3-8). Because the spectra 
of OmpX in DPPC and POPC are very similar to that in DMPC, the original 121 OmpX 
backbone assignments from the DMPC spectrum (Figure 3-4 A) could all be transferred 
unambiguously onto the new spectra based on peak position similarity. The weighted 
chemical shift perturbations were then calculated for each residue to report on the 
influence of the lipid side chain on the OmpX structure. 
Firstly, the TROSY spectrum of OmpX in DPPC was examined. The resulting spectrum 
was very similar in terms of the peak position to that for DMPC, allowing all the 
assignments to be transferred unambiguously. The weighted chemical shift 
perturbations relative to the DMPC spectrum are shown in Figure 3-9 A. Based on these 
chemical shift differences, the chemical environment that DPPC provides is overall very 
similar to that of DMPC, with only approximately 2% of the peaks shifting by more 
than 0.1 ppm. This indicates that within the small range explored in this work, aliphatic 
chain length has only a minor effect on the structure of OmpX. In a situation of 
hydrophobic mismatch,152 i.e. where the thickness of the hydrophobic transmembrane 
region of the protein is larger or smaller than the hydrophobic part of the lipid bilayer, 
there are several possible adaptations that the protein or membrane bilayer can make in 
order to avoid the unfavourable exposure of hydrophobic regions to water. The lipid 
bilayer has the ability to adjust itself by stretching, squashing, and/or tilting of the lipid 
chains to match the hydrophobic surface of the membrane protein.153,154 Membrane 
proteins, on the other hand, can tilt with respect to the membrane bilayer to reduce 
effective hydrophobic thickness, or their hydrophilic and hydrophobic side-chains near 
the membrane-water interface can adopt different conformations. Alternatively, 
membrane proteins can aggregate if the hydrophobic mismatch cannot be compensated. 
However, previous studies on bacteriorhodopsin showed that this protein is rather 
tolerant to changes in membrane thickness and that within a range of 4 Å thicker and 10 Å thinner than the estimated thickness of the protein there was no sign of aggregation.155 
It is not surprising therefore that the chemical environment of OmpX, with a thickness 
of 23.6 ± 2.8 Å estimated by the OPM database,156 remained similar in DMPC with a 
bilayer thickness of 25.4 Å157 and DPPC with a bilayer thickness of 28.4 Å.157 
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Figure 3-9: The effect of lipid aliphatic chain on the chemical environment of 
OmpX. 
Weighted chemical shift perturbation between A) OmpX in DPPC and in DMPC 
and B) OmpX in POPC and in DMPC. Secondary structure is shown with grey 
bars indicating the b-sheet regions. 
A similar type of analysis was repeated for OmpX in POPC. The results of the chemical 
shift perturbation calculation are shown in Figure 3-9 B, revealing that changes against 
DMPC were again only minor. However, larger perturbations were observed for some 
regions, i.e. residues 40–48, 102–111, 129–131, when compared to the effects of DPPC. 
The thickness of the POPC bilayer is reported to be 27.2 Å, in between that of DMPC 
and DPPC,157 hence,  these larger chemical shift perturbations are unlikely to be the 
result of differences in membrane thickness. It has been shown previously that 
introducing a double bond into the lipid acyl chain can not only result in a decrease in 
membrane thickness but also an increase in surface area per lipid, a decrease in direct 
head group interactions, and an increase in membrane fluidity.158 It is possible that the 
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larger differences observed result from a change in membrane fluidity and the transient 
interaction between the double bond and the membrane protein. However, it is not clear 
how the concept of membrane fluidity can be transferred onto small lipid rafts such as 
nanoparticles. In addition, it has to be assumed that the fast exchange of lipid molecules 
within the bilayer would average out such effects and lead to only subtle chemical shift 
changes, unless some very specific interactions were involved that would lead to long 
lipid residence times. It is quite possible that OmpX, as a b-barrel protein, has a 
sufficiently large number of hydrogen bonds that hold the backbone of the protein 
together and thus limit the amount of adaptability of the protein within the 
transmembrane region. Therefore, this stably assembled b-barrel protein might be less 
sensitive to the effects of lipids with different aliphatic chain lengths. In contrast, helical 
membrane proteins are likely to be more dynamic, with individual helices packing 
against each other through weaker side-chain hydrogen bonds and hydrophobic 
interactions. This implies that changes in the lipid bilayer that result from variations in 
aliphatic side chain length would affect helical membrane proteins more dramatically by 
altering weak inter-helix contacts or through changes in membrane fluidity. However, 
these conclusions will need further experimental data to support.   
3.2.4 Influence of anionic lipids on OmpX 
It is becoming increasingly clear that lipids, especially charged ones, in many cases not 
only provide a lipid bilayer environment to accommodate membrane proteins but also 
participate in modulating the structure and function of embedded proteins. For example, 
it was shown in a crystallography study that binding to the negatively charged 
phosphatidylinositol 4,5-bisphosphate (PIP2) induces a large conformational change of 
the cytoplasmic domain of the Kir2.2 channel, which translates into a 6 Å domain 
movement.159 PIP2 also binds to the intracellular side of the b1-adrenergic receptor to 
stabilise its active conformation and enhance selective binding to Gs over binding to 
other G proteins.160 It has also been reported that the b2-adrenergic receptor in PG lipid 
nanodiscs markedly favoured agonist binding and that the negatively charged lipid 
promoted receptor activation, whereas phosphatidylethanolamine favoured antagonist 
binding and stabilised the inactive conformation.161 Despite a large number of 
molecular dynamics (MD) simulation studies that are investigated the ability of charged 
lipids to modulate the structure and function of membrane proteins,162 direct 
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experimental evidence is still scarce and the underlying  molecular basis of these lipid-
induced effects are not clear.  
 
Figure 3-10: Characterisation of OmpX in SapA-DMPC/DMPG nanoparticles. 
A) SEC of OmpX in SapA-DMPC (red), SapA-DMPC/DMPG (3:1) (blue), SapA-
DMPC/DMPG (1:3) (green), and SapA-DMPG (purple). The peaks corresponding 
to empty nanoparticles and free SapA are indicated. The main peaks eluted at 13–
15 mL are OmpX in SapA lipid nanoparticles. B) 1D proton NMR shows the SapA 
Trp indole signal and the choline proton signal originating from DMPC. The 
spectra are normalised based on the SapA Trp indole signals so a quantitative 
analysis of DMPC can be performed. Colour code is the same as A). 
Here, we investigated the effect of introducing lipids with a negatively charged 
headgroup by comparing NMR spectra of OmpX in nanoparticles with anionic DMPG 
with those containing zwitterionic DMPC. As the only difference between these two 
lipids is their headgroup, PG for DMPG and PC for DMPC, any spectral changes 
observed should relate to variation in the headgroups and in particular their differing 
charges.  
OmpX was incorporated into SapA lipid nanoparticles using the same protocol as 
before. Four samples were prepared with different lipid compositions: DMPC, 
DMPC/DMPG (3:1), DMPC/DMPG (1:3) and DMPG. Their resulting particle sizes 
were similar, as determined by size-exclusion chromatography (Figure 3-10 A). The 
overall incorporation yield was similar across the four tested lipid compositions. There 
were much more empty nanoparticles and free SapA in SapA-DMPC/DMPG (1:3) and 
SapA-DMPG due to an experimental error. These two samples contained an 
unintentionally higher ratio of SapA in the initial mixture because of an overestimation 
in the concentration of the SapA stock solution. Nevertheless, this error did not affect 
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the incorporation of OmpX and still produced a similar amount of sample. Size-
exclusion fractions between 13 mL and 15 mL were collected and concentrated for 
NMR measurements. NMR samples with about 200 µM OmpX were obtained in all 
four conditions. The samples were first checked using 1D 1H NMR. The quantity of 
DMPC in the sample could be compared using the peak corresponding to choline 
protons at around 3.3 ppm (Figure 3-10 B). The four spectra were scaled according to 
the SapA tryptophan indole proton signal (Figure 3-10 B, left), normalizing the effect of 
sample concentration, so the choline signal should reflect the amount of DMPC per 
particle. As expected, the choline proton signal of DMPC decreased as the DMPC ratio 
in the sample was reduced. The area under the choline peaks was calculated and 
normalized against the result from the pure DMPC spectrum. The results showed 100%, 
70%, 25%, and 5%, respectively, which are close to what we would expect from the 
mixing ratio. There was still a small signal (5%) in the purple DMPC spectrum probably 
due to a tiny amount of detergent DPC, which also contains choline protons, remaining 
in the sample.  
For each of the samples a 2D [1H, 15N]-SOFAST-TROSY spectrum was also recorded 
(Figure 3-11 A). A gradual shift of peak positions upon an increase in the DMPG 
contribution could be observed as shown in full and selected regions of an overlay of 
the four spectra (Figure 3-11). This suggests that the observed changes correlate with 
changing amounts of DMPG in the lipid bilayer. With the gradual peak shift, we could 
carefully follow the peak movement and transfer all the peak assignments from the 
DMPC spectrum. This allowed us to investigate in more detail which parts of OmpX 
were affected by switching from DMPC to DMPG. Interestingly, the two residues F24 
and Y87, which showed the largest chemical shift perturbations seemed to be strongly 
broadened in the spectra with the larger DMPC content (pure DMPC and 
DMPC/DMPG 3:1), indicating a chemical exchange process on a slow-to-intermediate 
timescale (Figure 3-11 B). In contrast, these residues were much sharper in 
environments with higher DMPG content (DMPC/DMPG 1:3 and pure DMPG). This 
suggests that changes in the lipid composition also affect the dynamics of embedded 
membrane proteins. It could be that in a DMPC bilayer F24 and Y87 exchange between 
multiple conformations, and that increasing amounts of negatively charged DMPG 
stabilise a single conformation resulting in single sharp peaks. In contrast, the W140 
indole sidechain signal showed a linear shift without changing its peak intensity. This 
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means that increasing the amount of DMPG changes the chemical environment around 
W140 sidechain as one might expect, but does not perturb the energy landscape of the 
W140 residue.  
 
Figure 3-11: Comparison of the chemical environment of OmpX in SapA-
DMPC/DMPG nanoparticles. 
Overlays of 2D [1H, 15N]-SOFAST-TROSY experiments of OmpX in SapA-DMPC 
(red), SapA-DMPC/DMPG (3:1) (blue), SapA-DMPC/DMPG (1:3) (green), and 
SapA-DMPG (purple). Selected regions are indicated and zoomed in on the right 
panels. Some of the residues that are significantly affected by the changes in the 
composition of the lipid bilayer are highlighted in the zoomed in spectra. 
The weighted chemical shift perturbations between the pure DMPG and pure DMPC 
samples were calculated and plotted against residue number (Figure 3-12 A). The result 
shows over 20% of the peaks shifting by more than 0.1 ppm. This is clearly much more 
than the 2% observed when comparing the influence of the side chains between DPPC 
and POPC (3.2.3). This means the chemical environment of OmpX is much more 
sensitive to the headgroup charge than to lipid side chain composition. We also 
calculated the standard deviation of all the chemical shift perturbations and defined 
significantly perturbed residues as those with perturbations greater than two standard 
deviations away from the mean value. We mapped the chemical shift perturbations onto 
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the structure with significantly perturbed residues shown in spheres (Figure 3-12 B). 
Several hydrophobic residues (F24, W76, Y87, and W140) located at the membrane-
water interface show significant shifts. It has been proposed that aromatic amino acids 
especially tryptophan and tyrosine with amphipathic characteristics are enriched in 
interfacial regions of membrane proteins,163 where they are thought to help anchor 
proteins at the bilayer-water interface.164,165 Because these residues are close in space to 
lipid headgroups, their chemical shifts are very sensitive to changes in lipid headgroups 
especially from a zwitterionic to an anionic headgroup. It is also possible that DMPG 
with its negatively charged headgroup can affect the orientation of the protein in the 
lipid bilayer, leading to significant chemical shift perturbations for these aromatic 
residues. There are also several residues located on the solvent exposed loops, which are 
strongly affected by DMPG. Some negatively charged residues in the intracellular side 
(E32, D33, E119) show significant perturbations probably due to electrostatic repulsion 
with the negatively charged membrane surface. Some polar residues on the extracellular 
loop (T51, Q91, T92, S103) are affected probably due to interactions with the hydroxyl 
group on the PG.  
 
 
 
 
Figure 3-12 (opposite): The effect of DMPG on the chemical environment of OmpX. 
A) Weighted chemical shift perturbation between OmpX in SapA-DMPG 
nanoparticles and OmpX in SapA-DMPC nanoparticles were calculated and 
plotted against the residue number. The secondary structure of OmpX is shown 
with grey bars. A standard deviation of all the chemical shift perturbations was 
calculated and the value two times the standard deviation is indicated by the red 
dotted line. B) The chemical shift perturbations, d(DMPG) – d(DMPC), are 
mapped onto the structure with increasing changes coloured gradually from blue 
to red. The significantly perturbed residues with chemical shift changes larger 
than two standard deviations are shown in spheres. 
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Additional experiments were performed in order to confirm the observed effect of the 
PG head group on the structure of OmpX. OmpX was incorporated into SapA3-POPG 
nanoparticles using the same protocol and assembly ratio and then a 2D TROSY 
spectrum was recorded. This data in comparison with the SapA3-POPC spectrum in 
section 3.2.3 was expected to confirm again the effect of the PG head group. The 
weighted chemical shift perturbations between POPG and POPC were calculated and 
plotted together with those between DMPG and DMPC (Figure 3-13). The results show 
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a very similar pattern, suggesting that the effect of the lipid headgroup is dominant and 
independent from the aliphatic chain length or the saturation degree of the lipids.  
 
Figure 3-13: The effect of anionic lipid head group on OmpX. 
Weighted chemical shift perturbation of OmpX in SapA3-POPG nanoparticles 
compared to that in POPC (red) are plotted against residue number and overlaid 
with the chemical shift perturbation between DMPG and DMPC (blue).  
3.2.5 Attempt to include lipopolysaccharides into SapA-DMPC 
nanoparticles 
In its natural environment, OmpX is found in the bacterial outer membrane which is 
rich in lipopolysaccharides (LPS). LPS, also known as endotoxins, are molecules 
consisting of a lipid A, a core oligosaccharide, and an O-polysaccharide joined by 
covalent bonds (Figure 3-14). LPS provides structural integrity for the bacteria and 
protects the membrane from certain chemicals that are harmful to bacteria.166 LPS is 
essential for many Gram-negative bacteria, which cannot survive without it.167 It has 
been proposed that LPS interacts directly with OprH, an outer membrane protein of 
Pseudomonas aeruginosa, showing predominantly electrostatic interactions with 
charged residues near the membrane-water interface and loops on the extracellular 
region to be important.168,169 Based on the significant perturbations caused by the PG 
headgroup observed in section 3.2.4, we hypothesised that the extracellular loops of 
OmpX may have specific interactions with LPS, similar to OprH, that might be 
important to its function. Therefore, we aimed to incorporate OmpX into SapA-
DMPC/LPS nanoparticles to see if this would lead to significant differences in the 2D 
NMR spectrum of OmpX. 
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Figure 3-14: Schematic structure of LPS. 
Three main components of LPS, lipid A, Core oligosaccharide, and O-
polysaccharide, are shown in a schematic representation. Carbohydrates are 
simplified to hexagons and phosphate groups are shown in circles annotated by p.  
Together with a Part II student, Daniel Gentle, we first tried to generate SapA-
DMPC/LPS nanoparticles. SapA and DMPC were mixed at a ratio of 1:15, the same as 
previously used in Chapter 2, as this combination was known to generate SapA3-DMPC 
nanoparticles, and were supplemented with 1 mg/mL LPS. The molarity of LPS could 
not be determined accurately as the material used was an extract from E. coli (L8274, 
Sigma) which is a mixture of LPS with different length of O-polysaccharides. DDM 
(0.2%) was added to the mixture before incubation with Amberlite beads. The SapA-
DMPC/LPS sample was then analysed by a SEC experiment (Figure 3-15 A). 
Surprisingly, the sample appeared to be similar in size to SapA3-DMPC nanoparticles 
(Figure 2-12). One would expect a much larger particle size because contributions from 
the extended O-polysaccharides. The SEC fractions were checked using silver stained 
SDS-PAGE, in which an additional band at around 10 kDa was visible. A similar band 
appeared in a lane loaded with the original LPS stock solution, therefore we 
hypothesised that this band corresponds to LPS molecules. Next, we used different 
amounts of LPS in the assembly mixture and performed the same experimental 
procedure. The final SEC fractions showed higher LPS band intensity with increasing 
amounts of LPS in the initial mixture (Figure 3-15 B). However, surprisingly the 
particle size did not change with more LPS in the SapA-DMPC nanoparticle mixture. 
We also attempted to generate larger SapA-DMPC nanoparticles, SapA4-DMPC, with 1 
mg/mL LPS, and indeed the silver-stained gel showed LPS bands in the main peak, 
eluting earlier than that of SapA3-DMPC (Figure 3-15 C).  
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Figure 3-15: Incorporation of LPS into SapA-DMPC nanoparticles. 
A) SEC of 1 mg/mL LPS in SapA3-DMPC nanoparticles. B) SEC of SapA3-DMPC 
nanoparticles prepared in the presence of varying amounts of LPS (0–2 mg/mL). 
The SEC fraction collected between the two dashed lines is analysed by silver-
stained SDS-PAGE. C) SEC of LPS in SapA4-DMPC nanoparticles. SEC trace 
with corresponding silver-stained SDS-PAGE shown below. The bands 
corresponding to LPS and SapA are indicated.  
Although the SDS-PAGE showed that LPS bands always appeared in the same fractions 
as SapA-DMPC and the band intensity was proportional to the amount of LPS used in 
the assembly mixture, we wanted to confirm the presence of LPS by other analytical 
tools such as 1D 1H NMR spectroscopy or electrospray ionisation mass spectrometry 
(ESI-MS). Two samples were examined, SapA-DMPC and SapA-DMPC/LPS. By 
carefully comparing NMR spectra and ESI-MS spectra, however, we were not able to 
observe any differences between these two samples (Figure 3-16). We concluded that 
LPS could not be detected either by NMR spectroscopy or ESI-MS.  
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Figure 3-16: Attempts to identify LPS using analytical tools. 
A) 1D proton NMR spectrum of SapA-DMPC and SapA-DMPC/LPS. ESI-MS 
spectrum of SapA-DMPC and SapA-DMPC/LPS in B) protein region and C) lipid 
region. SapA with the molecular weight of 9.2 kDa and DMPC with the theoretical 
molecular weight of 677.5 Da were identified in both samples. Both NMR and mass 
did not indicate any differences between these two samples. 
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Figure 3-17: SEC of OmpX in SapA3-DMPC/LPS nanoparticles. 
OmpX was incorporated into SapA3-DMPC in the presence of 1 mg/mL LPS in the 
initial mixture. The resulting sample was checked by SEC shown in the top panel. 
Silver-stained SDS-PAGE of the corresponding SEC fractions are shown at the 
bottom. The bands that correspond to OmpX, LPS, and SapA are indicated.  
Even though two analytical tools did not show the presence of LPS, it is possible that 
the intrinsic limitations of the techniques prevented the detection of LPS. We decided to 
take one step further to incorporate 15N-labelled OmpX into SapA-DMPC/LPS 
nanoparticles and record a 2D NMR spectrum to see if any conformational changes of 
OmpX could be observed. The assembly ratio was 10:50:1 (SapA:DMPC:OmpX), the 
same as in section 3.2.1, with an addition of 1 mg/mL LPS in the mixture. The SEC 
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profile showed a main peak at elution volume 14.3 mL (Figure 3-17), slightly smaller 
than OmpX in SapA3-DMPC (14.1 mL, Figure 3-3 A). The same observation was made 
in Figure 3-15 B where the alleged incorporation of LPS hardly changed the particle 
size. A silver-stained SDS-PAGE gel (Figure 3-17) showed the presence of OmpX, 
SapA and LPS in the main peak, suggesting that OmpX had been successfully 
incorporated into SapA-DMPC-LPS nanoparticles. Fractions 14 and 15 contained 
mainly free SapA and the impurities carried from the SapA stock solution. A small 
amount of OmpX was also observed in these fractions which was probably denatured 
OmpX nonspecifically interacting with SapA. We then pooled fractions 9–12 and 
concentrated them to 400 µL for 2D NMR experiments. 
The TROSY spectrum of OmpX in SapA-DMPC/LPS nanoparticles was as good in 
quality as that obtained in SapA-DMPC (Figure 3-18 A). All the assignments could be 
transferred for CSP analysis and the spectra superimposed very well. The chemical shift 
perturbations of the sample that was intended to contain LPS showed only minor 
differences with an average of 0.038 ppm (Figure 3-18 B). This was surprising because 
the effect of LPS appeared to be much smaller than the effect of the PG head group. 
Based on the resulting TROSY spectrum, 1D 1H NMR spectra, mass spectra, and SEC 
analysis, we concluded that LPS was not incorporated into SapA-DMPC nanoparticles. 
We have to assume that the 10 kDa band observed in the silver-stained SDS-PAGE gel 
was something else. It could be nucleotides or proteins carried from the LPS stock 
solution which interact with SapA-DMPC nanoparticles and hence elute together in 
SEC. However, we also could not identify this substance by NMR spectroscopy or mass 
spectrometry.  
Currently, we have only limited information on the composition of the LPS extract from 
Sigma, e.g. O-polysaccharide length and purity, making the interpretation of our data 
difficult. We suspect that the long polysaccharide head group makes LPS highly soluble, 
which removes the driving force that promotes bilayer formation. In the case of SapA-
DMPC nanoparticles, DMPC was solubilised in DDM at the beginning. When DDM 
was removed by Amberlite beads, DMPC molecules were forced to form a bilayer 
surrounded by SapA molecules because of low solubility on their own. LPS in contrast 
is highly soluble in water and can form micelles. Accordingly, it will have a very low 
propensity to form a pure LPS bilayer and hence is unlikely to form lipid nanoparticles 
with SapA. If bilayer formation could be achieved this would require dramatic changes 
to the incorporation protocol as detergent removal does not trigger LPS bilayer 
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incorporation. Therefore, we hypothesised that using a less soluble version of an LPS 
with reduced polysaccharide content, e.g. lipid A or lipid A with core oligosaccharides, 
might increase the possibility of incorporation. These experiments will be conducted in 
the future. In summary, further experiments are necessary to investigate the interactions 
between OmpX and LPS. 
 
 
10 9 8 7
1H  (ppm)
130
125
120
115
110
105
15
N
  (
pp
m
)
S3
T4
V5
T6
G7G8
T9
A10
S12
D13
A14
Q15
G16
Q17
M18
K20
M21
G22
F24
N25
L26
K27
Y28
R29
Y30
E31
E32
D33
N34
S35
L37
G38
I40
G41
S42
F43
T44
Y45
T46
E47
S49
R50
T51
A52
G55
D56Y57
N58
K59
N60
Q61
Y62
Y63
G64
I65
T66
A67
G68
A70
Y71
R72
I73
A77
S78
I79 Y80
G81
V82
V83
G84
V85
G86
Y87
K89
Q91
T92
T93
E94
Y95
T97
Y98
K99
T102
S103
D104
Y105
G106
F107
Y109
G110
A111
G112
L113
M118
E119
N120
V121
A122
L123
D124
F125
Y127
Q129
S130
R131
I132
R133
V135
D136
V137
G138
T139
A142
G143
V144
G145
Y146
R147
F148
W140
W76
0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150
0.00
0.05
0.10
0.15
0.20
residue number
CS
P 
(p
pm
)
δ(DMPC-LPS) – δ(DMPC)
A
B
Development of a saposin A based native-like phospholipid bilayer system for NMR studies 
Chih-Ta Chien- September 2018   79 
 
Figure 3-18 (opposite): NMR spectrum of OmpX in SapA-DMPC-LPS 
nanoparticles. 
A) 2D [1H,15N]-SOFAST-TROSY spectrum of non-deuterated 15N-labelled OmpX 
in SapA-DMPC-LPS nanoparticles. The spectrum was recorded at 318 K on a 
Bruker Avance AVIII 800 spectrometer (1H frequency of 800 MHz) equipped with 
a 5 mm TXI HCN/z cryoprobe. The experiments were recorded with 3,078 scans, 
resulting in an experiment time of 36 h. B) Weighted chemical shift perturbations 
between OmpX in SapA-DMPC-LPS nanoparticles and OmpX in SapA-DMPC 
nanoparticles were calculated and plotted against the residue number. The 
secondary structure of OmpX is shown with grey bars.  
3.3 Conclusions 
This chapter demonstrated the successful incorporation of OmpX into SapA 
nanoparticles. The nanoparticles provide a similar lipid bilayer environment to 
conventional MSP nanodiscs. Incorporation yields were consistently high and allowed 
us to obtain high-quality [1H,15N] NMR spectra even in the absence of deuteration. 
Further, the good incorporation yields enabled a systematic investigation of the impact 
of lipid composition on OmpX structure. OmpX was incorporated into nanoparticles 
containing the lipids DMPC, DPPC, POPC, DMPG and POPG. By comparing the 
resulting NMR spectra, we concluded that aliphatic chain length and double bond 
content exert only a very moderate influence on the chemical environment of OmpX. In 
contrast, the negatively charged PG headgroups in DMPG and POPG significantly 
changed the chemical environment of the protein, especially for aromatic residues at the 
membrane-water interface and some of the charged residues in the loops. These 
spectroscopic studies confirmed the composition of the lipid bilayer as an important 
determinant of membrane protein dynamics and conformation and suggest that 
variations in lipid composition will affect protein function. A specific lipid environment 
might be necessary for a membrane protein to function, or the lipid environment may be 
able to modulate the function of a membrane protein through specific protein-lipid 
interactions possibly in the context of allostery. In view of the above-mentioned reasons, 
we attempted to incorporate LPS into the bilayer to better mimic the bacterial outer 
membrane and allow investigation of any interactions between OmpX and LPS. Our 
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preliminary data shows that the LPS did not go into the bilayer. We hypothesised that 
this was due to high solubility of LPS. Further experiments using shorter versions of 
LPS will have to be performed to delineate the interactions between OmpX and LPS. 
Nevertheless, SapA lipid nanoparticles provide an opportunity to investigate the effect 
of lipids. Variations in lipid composition might be important in localization and might 
change in different phases of the cell cycle. This study could open up a new research 
area investigating the effect of lipid modulation on protein function, where further 
spectroscopic studies would be paired with functional assay data.  
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4 INCORPORATION OF SEVEN-
TRANSMEMBRANE PROTEINS 
INTO SAPA LIPID 
NANOPARTICLES 
4.1 Introduction 
4.1.1 Using Microbial rhodopsins as a model protein for incorporation 
Chapter 3 showed that a b-barrel protein, OmpX, can be stabilised in SapA lipid 
nanoparticles and studied by NMR spectroscopy. To be a generalised membrane 
mimetic, it was hoped that SapA lipid nanoparticles could also be used to study a-
helical transmembrane proteins by NMR spectroscopy. The microbial rhodopsins, 
Anabaena sensory rhodopsin (ASR) and Natronomonas pharaonis sensory rhodopsin II 
(pSRII), are suitable model systems for several reasons. Firstly, they are small enough 
for NMR and have been studied in detergent micelles by NMR in the past. Similar to 
the case for OmpX, this not only provides us with a good starting point in view of the 
construct and knowledge of protein production being available but also with regard to 
the NMR parameters being at hand for comparison. Secondly, ASR and pSRII can be 
expressed using the E. coli expression system with high yield. This is advantageous 
because isotope labelling, which is necessary for NMR studies, is well established in the 
E. coli expression system. Finally, microbial rhodopsins absorb visible light via their 
bound retinal chromophore which results in a sample with a visible colour and a 
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characteristic UV-visible light absorption profile. These aspects make it very easy to 
track the protein during experimental steps. 
4.1.2 Microbial rhodopsins 
Microbial rhodopsins are a group of light-sensitive membrane proteins that sense and 
respond to light. They are found in Archaea, Bacteria, and Eukaryota.170 Microbial 
rhodopsins share a characteristic seven-transmembrane a-helical fold with a retinal 
chromophore covalently attached, which gives rise to the ability to sense light. The 
retinal isomerises as it absorbs a photon with wavelength 400–500 nm, initiating a 
conformational change in the microbial rhodopsin and triggering a down-stream 
signalling cascade. Microbial rhodopsins have a wide variety of functions. For example, 
bacteriorhodopsin is a light-driven proton pump,171 halorhodopsin is an anion pump,172 
channelrhodopsin is an ion channel,173 and sensory rhodopsin II is a negative phototaxis 
receptor.174 Although microbial rhodopsins have no evolutionary link to GPCRs,175 the 
overall seven-transmembrane helical architecture is similar, and they are therefore often 
considered as GPCR structural analogues or a model system for structural studies. We 
used two microbial rhodopsins in this chapter, ASR and pSRII. 
4.1.3 Structure and function of ASR 
ASR is a 30 kDa protein which covalently binds retinal at lysine 210, resulting in a 
strong absorbance at around 550 nm. ASR was the first microbial rhodopsin identified 
in bacteria that carries out a sensory function.176 The distinct characteristic of ASR is its 
photochromism which does not exist in previously characterised microbial rhodopsins. 
The retinal chromophore in ASR exists in stable all-trans and 13-cis states and the two 
forms can be interconverted by light activation, at 550 nm to activate the all-trans state 
and at 537 nm for the 13-cis state.177,178 All other microbial rhodopsins present a single 
stable all-trans state which is activated to 13-cis by light absorption and eventually 
relaxes back to the all-trans state. Given that ASR can sense different wavelengths of 
light, it has been proposed that the function of ASR is to optimise light harvesting 
according to the environment by modulating the gene expression level through its 
transducer ASRT.178  
The structure of ASR has been solved by X-ray crystallography179 and solid-state NMR 
in a lipid environment.35 The oligomeric state of ASR observed in the two structures 
was different. A bacteriorhodopsin-like symmetric trimer was observed in the solid-
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state NMR structure, in contrast to a dimer in the crystal structure. Additional 
paramagnetic relaxation enhancement data also supported a trimeric arrangement of 
ASR in both detergents and lipids.180 
4.1.4 Structure and function of pSRII 
pSRII is a 26 kDa protein that binds a retinal chromophore at lysine 205 which absorbs 
blue-green light at 498 nm. pSRII is responsible for phototaxis signalling. The 
signalling begins from blue light detected by pSRII leading to a conformational change 
in pSRII and its transducer protein (pHtrII). pHtrII initiates a His/Asp kinase signalling 
cascade, and the kinases regulate rotation of flagellum by phosphorylation, which 
eventually results in the archaeon moving away from the light.174 pSRII is found 
expressed when the cell is in an environment that has sufficient oxygen supply and the 
respiratory activity is high, allowing the archaeon to migrate to the dark in order to 
avoid sunlight and potential photo-oxidative damage.181 When the oxygen level drops, 
pSRII expression is suppressed and bacteriorhodopsin and halorhodopsin are 
synthesized to harvest orange light for energy (by ion pumping). In addition, the 
expression of SRI, having the opposite function to SRII, encourages the cell to move 
into a region containing orange light where the ion pumps can be maximally 
activated.181  
The high stability and high expression yield of pSRII has allowed extensive structural 
studies including two crystal structures182,183 and one solution NMR structure 
determined in our group.30 The crystal structure of pSRII in complex with pHtrII was 
also solved, revealing a 2:2 stoichiometry.184 The structure also shows that pHtrII is a 
membrane spanning protein with a long coiled-coil cytoplasmic domain. A number of 
crystal structures are also available of the protein in different light-activated states.185 
4.1.5 Aim 
The previous chapter established that SapA lipid nanoparticles can be used as a 
membrane mimetic system for NMR studies of the b-barrel protein OmpX. In order to 
confirm that the SapA system is a versatile tool that can be applied to membrane 
proteins with different folds, we wished to explore its applicability to a-helical 
transmembrane proteins. ASR and pSRII were consider to be perfect candidates because 
of several desirable characteristics. We aimed to incorporate these two microbial 
rhodopsins into SapA lipid nanoparticles and perform NMR experiments. pSRII has 
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been studied in our lab for a long time and the expression and purification of the protein 
as well as its characterisation by NMR are well-established.30 Therefore, detergent 
solubilised pSRII could be produced using existing protocols ready for incorporation 
into SapA lipid nanoparticles. ASR, on the other hand, required optimisation of 
expression and purification. We hoped to find an optimal condition that produced a high 
quality detergent solubilized ASR sample for solution NMR. After this, ASR would be 
incorporated into SapA lipid nanoparticles for studies by NMR of the membrane protein 
in a lipid bilayer environment. 
4.2 Results and discussion 
4.2.1 Optimisation of ASR expression 
For NMR structural studies, a large quantity of sample is usually required. In order to 
study ASR using solution NMR spectroscopy, we started by screening for optimal 
conditions for ASR expression in the E. coli expression system. This included screening 
different E. coli strains for optimal ASR expression yield, the flask type used for E. coli 
culture, the induction point, and the concentration of IPTG used for induction. Three 
BL21 derivatives were tested for ASR expression. Cells were lysed and the membrane 
fractions were solubilized with 2% LMNG. The amount of ASR in the soluble fractions 
was determined by UV-Vis absorbance at 549 nm. The result showed that BL21-RIL 
yielded about 1.4 mg per litre culture, more than double the yields of BL21-rosetta and 
BL21-tuner cells (Figure 4-1 A). During the expression trials, we also found that the 
yield was significantly affected by the types of flask used. The yield was again 
determined by the characteristic absorbance of ASR at 549 nm during the Ni-NTA 
elution step. The results showed that flasks with dimpled baffles yielded 45% more than 
those with long baffles (Figure 4-1 B). Next, we screened the best time point for 
induction (Figure 4-1 C) and the IPTG concentration used for induction (Figure 4-1 D). 
Five O.D. points were tested for induction and O.D. = 0.51 had the highest yield, while 
lower or higher O.D. yields were less than 80% of this. We also found that the IPTG 
concentration affected the ASR yield as 0.2 mM IPTG only yielded around 60% of that 
at 0.5 mM and 1mM. Therefore, at least 0.5 mM IPTG needed to be supplied for 
optimal ASR expression. Overall, we screened for the best expression strain, the best 
culture flask and induction conditions that should give us the optimal ASR production 
level. The next step was to optimise the purification protocol.  
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Figure 4-1: Optimisation of ASR expression for maximum yield. 
A) Expression strain, B) flask type, C) induction point, and D) IPTG concentration 
were screened. Each condition was tested in 1 L culture. Ni-NTA purification was 
performed and UV-Vis absorbance at 549 nm was monitored to indicate correctly 
folded ASR.  
4.2.2 Optimisation of ASR purification 
After optimising the expression of ASR, we attempted to find the most suitable 
detergent for extracting ASR from the E. coli membrane. Six detergents were tested 
including 1.5% DDM, 3% DM, 2% OG, 2% LMNG, 2% C7-DHPC, 2% C6-DHPC. 
One benefit of working with ASR is that it has an observable purple colour enabling the 
amount of protein to be estimated immediately by eye. Six samples containing the same 
amount of cell pellet were solubilised separately at 4 ºC overnight. Soluble fractions 
were collected by ultracentrifugation (100,000 g, 90 min). OG and C7-DHPC samples 
showed the darkest purple colour indicating the highest extraction efficiency. DDM and 
LMNG extracted medium amounts of ASR, whereas DM and C6-DHPC showed low 
levels of extraction (Figure 4-2 A). The same trend was observed from the pellet in 
which less purple indicated better extraction. OG and C7-DHPC created pellets with the 
faintest purple colour, while DM and C6-DHPC left pellets that were dark purple. 
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Interestingly, we also observed some white material in the centre of each pellet which is 
likely to contain other endogenous proteins due to the lack of colour (Figure 4-2 B). OG 
and C7-DHPC showed the smallest amount of white material, suggesting that they not 
only solubilised ASR but also other E. coli endogenous proteins. This conclusion was 
supported by SDS-PAGE analysis (Figure 4-2 C). Samples solubilised by OG and C7-
DHPC showed many other bands on the SDS-PAGE gel even after two steps of 
purification, Ni-NTA and size-exclusion chromatography. DDM and LMNG showed 
sufficient purity after Ni-NTA chromatography, but DDM seemed to promote the 
formation of higher oligomers. We hypothesised that short chain detergents such as OG 
and C7-DHPC have a strong ability to disrupt membranes and extract proteins. 
However, this implies that many other impurities would also be solubilised by these 
detergents. Other proteins that were in the same micelles as ASR would be very difficult 
to remove. Considering both yield and purity of the ASR product, LMNG showed the 
most promising result, solubilising sufficient amounts of ASR while remaining mild 
enough to produce a high purity sample.   
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Figure 4-2 (opposite): Screening detergents for ASR extraction. 
The membrane fraction from 6 L cell culture was resuspended and equally 
distributed into six samples. The samples were solubilised in 1.5% DDM, 3% DM, 
2% OG, 2% LMNG, 2% C7-DHPC, and 2% C6-DHPC. The samples were 
centrifuged using ultracentrifuge to separate A) Soluble fractions and B) Insoluble 
fractions. The extraction efficiency can be judged directly from the colour of the 
soluble fractions. C) SDS-PAGE of samples from DDM and LMNG after Ni-NTA 
purification as well as samples from OG and C7-DHPC after Ni-NTA and size-
exclusion purification. 
The incubation temperature during ASR extraction also proved to be important. Higher 
temperature should in theory make the extraction more efficient by providing more 
energy. However, higher temperatures could also lead to the precipitation of unstable 
proteins. To explore the balance between these two effect, two temperatures were tested, 
4 ºC and 25 ºC, during the LMNG solubilisation step. The result shows that 25 ºC 
solubilised 40% more ASR than 4 ºC as judged by Ni-NTA purification (Figure 4-3). In 
addition, the sample purity was not compromised, as confirmed by SDS-PAGE (Figure 
4-3). 
 
Figure 4-3: Screening the solubilisation temperature for optimal ASR extraction. 
Cell pellets from 1 L culture containing ASR were solubilised using LMNG 
incubated at 4 ºC (red) and 25 ºC (blue) followed by cell lysis and Ni-NTA 
purification. ASR yields and sample purity were checked by the absorbance at 549 
nm and SDS-PAGE.  
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This section shows the results of ASR extraction using six detergents. We found that 
LMNG had the most promising properties, and was able to extract a medium amount of 
ASR but produced a very high purity sample. Increasing the incubation temperature 
during solubilisation from 4 ºC to 25 ºC further improved the ASR yield by 40%.  
4.2.3 Optimisation of ASR sample condition for NMR experiments 
Having established a protocol to express and extract the maximum amount of ASR from 
E. coli, the next step was to find the best buffer condition that would optimise the 
quality of NMR spectra. A few criteria of the sample are preferred for solution NMR 
experiments, including small particle size, high stability, and low salt. Three detergents, 
LMNG, HEGA-10 and C7-DHPC, were tested to see which one would stabilise ASR 
the most. The starting material was LMNG-solubilised ASR produced as described in 
the previous section. For the HEGA-10 and C7-DHPC samples, on-column detergent 
exchange was performed using an Ni-NTA column. For each of the three detergent 
samples, we screened a range of salt concentrations and pH values by diluting the 
concentrated ASR sample 20 times into the desired buffer compositions. The stability of 
ASR was determined by quantifying the characteristic UV-vis absorbance of ASR at 
549 nm, which should correlate with the proportion of correctly folded ASR. The 
absorbance at 549 nm was measured just after sample preparation as the starting point, 
then again after 65 h of incubation at 50 ºC. The ratio of the two measurements 
indicated the percentage of correctly folded ASR remaining in the sample. The results 
showed that LMNG could offer the most stabilising effect, with more than 80% of ASR 
remaining structured in low pH and high salt conditions. However, LMNG-solubilised 
ASR seemed to be very sensitive to the buffer condition as less than 20% ASR survived 
in a high pH and low salt condition (Figure 4-4 A). In contrast, the stability of ASR in 
HEGA-10 was affected to a lesser extent by the buffer condition: 30% to 70% of ASR 
remained structured in all conditions tested here. In addition, a clear trend that higher 
salt was more stabilising could be observed for HEGA-10 (Figure 4-4 B). C7-DHPC 
showed the least stabilising effect. Almost all the conditions gave less than 30% 
structured ASR with the exception of the conditions with 1 M salt which gave around 
50%. Overall, ASR in LMNG with high NaCl concentrations showed the most 
promising results. However, as the NaCl concentration decreased, the stability 
significantly reduced. High salt concentration is generally not good for NMR 
measurements because it increases the pulse length, and hence reduces the sensitivity. In 
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HEGA-10, the stability of ASR was relatively unaffected by changes in salt 
concentration. 
 
Figure 4-4: Screening for the optimal stability of ASR solubilised in three 
detergents. 
ASR in A) 0.002% LMNG, B) 0.5% HEGA-10, and C) 0.1% C7-DHPC were 
mixed with buffer with different NaCl concentration and pH. The concentration of 
correctly folded ASR in each condition was measured using the UV-vis absorbance 
at 549 nm before and after 65 h incubation at 50 ºC. The ratio are presented in a 
heat map format, showing the remaining percentage of correctly folded ASR. 
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The particle size is also a very important factor for NMR experiments. Larger particles 
should have a longer correlation time (𝜏5) leading to faster transverse relaxation and 
hence broader lines leading to a reduced signal-to-noise ratio. Therefore, we assessed 
the particle size of ASR in LMNG and in HEGA-10, two promising candidates, using 
translational diffusion measurement by pulsed field gradient (PFG) 1H NMR and 
dynamic light scattering (DLS). Larger particles diffuse slower leading to a smaller 
diffusion coefficient. The diffusion coefficients of ASR in HEGA-10 and LMNG were 
determined and plotted against temperature. The results (Figure 4-5) showed that ASR 
in HEGA-10 appeared to be much smaller than in LMNG. The diffusion coefficients of 
pSRII in C7-DHPC measured by Dr. Mark Bostock were included for comparison. The 
structure of pSRII in C7-DHPC has been solved by solution NMR previously in our 
lab,30 therefore its diffusion coefficient was set to be a standard that we hoped would 
lead to high NMR spectral quality. ASR in HEGA-10 appeared to be slightly larger than 
pSRII in C7-DHPC30 but was still in the same region, whereas ASR in LMNG appeared 
to be much larger (Figure 4-5 A, filled circles). The size difference was probably due to 
the properties of the detergents. Empty LMNG micelles should be much bigger than 
HEGA-10 micelles and C7-DHPC micelles because of the longer chain length (Figure 
4-5 A, empty circles). However, we cannot exclude the possibility of ASR forming 
higher-order oligomers in LMNG micelles, which could also contribute to a larger 
apparent particle size. Diffusion coefficient measurements can be theoretically 
translated into effective molecular weight estimates based on the solvent viscosity and 
the assumption that the molecular assembly is a sphere of constant density. The 
standard set of assumptions is, however, not useful for membrane protein cases because 
the detergent molecules that surround the membrane protein mean the particle cannot be 
approximated as spherical and the density would not be the same as that of a pure 
protein. The presence of protein-free micelles in the solution would also make the 
estimation of solvent viscosity inaccurate. The observation of a larger ASR species in 
LMNG is also supported by DLS data in various salt concentrations which suggested a 
diameter of about 13 nm, whereas ASR in HEGA-10 appeared to be around 9 nm 
(Figure 4-5 B). Overall, ASR in HEGA-10 appeared to be significantly smaller than 
ASR in LMNG, and slightly larger than pSRII in C7-DHPC. Therefore, HEGA-10 was 
expected to be favourable for NMR experiments in terms of the particle size. 
In summary, ASR in HEGA-10 was sufficiently stable and was able to tolerate low salt 
concentrations. More importantly, ASR in HEGA-10 also produced particles with a 
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much smaller apparent size than comparable preparations using LMNG. Combining 
these results, HEGA-10 was considered favourable for further investigation of ASR 
using NMR. 
 
Figure 4-5: Assessment of particle size of ASR in LMNG and in HEGA-10.  
A) Translational diffusion coefficient of empty detergent micelles (open circles) 
and ASR containing micelles (filled circles). Diffusion coefficients for empty C7-
DHPC micelles and pSRII in C7-DHPC micelles, which yields good quality NMR 
spectra, are included for comparison. B) DLS measurements of ASR in HEGA-10 
and LMNG with different salt concentrations. 
4.2.4 NMR spectrum of ASR in HEGA-10 
Based on the screening results discussed above, HEGA-10 showed the most favourable 
characteristics for NMR experiments. We decided to express 15N-labelled ASR for 2D 
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[1H, 15N]-TROSY measurements. The spectrum for ASR in 1.5% DDM was recorded 
previously by Dr. Duncan Crick in our group (Figure 4-6).186 The spectral quality was 
poor and only a few peaks could be observed, far fewer than the expected 235 backbone 
amide signals. These intense signals are from highly flexible regions of the protein, 
probably loops, and the N-terminal, or C-terminal regions. The rest of the signals were 
too broad to be observed due to the large particle size. One possible explanation was the 
formation of higher order oligomers as shown before by SDS-PAGE (Figure 4-2 C). 
The large particle size and inhomogeneous nature of the sample resulted in poor spectral 
quality and sensitivity.  
 
Figure 4-6: NMR spectrum of ASR in DDM. 
2D [1H, 15N]-TROSY spectrum of ASR in 1.5% DDM. The spectrum was recorded 
at 323 K on an 800 MHz spectrometer (1H frequency of 800 MHz) with 64 scans.  
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In comparison to the spectrum in DDM, ASR in HEGA-10 clearly showed an improved 
spectral quality (Figure 4-7 A). The sample contained 200 µM ASR solubilised in 20 
mM sodium phosphate, pH 6.5, 200 mM NaCl, 0.5% HEGA-10, and the spectrum was 
recorded at 318 K using a conventional 5 mm diameter NMR tube. The number of 
resolved peaks increased significantly and around 200 peaks are now visible. The 
relatively high salt concentration, which was necessary to stabilise ASR, substantially 
reduced the NMR sensitivity. In order to increase the sensitivity, the same sample was 
concentrated further to 325 µM, 60% higher than the original, and a 3 mm NMR tube, 
which only requires 175 µL sample, was used. The use of a smaller diameter NMR tube 
substantially increases the salt tolerance and hence is of benefit when measuring high 
salt samples. We also increased the number of scans by 25% to improve the signal-to-
noise ratio. Together, these new parameters significantly improved the spectral quality 
(Figure 4-7 B). Several new peaks became visible as shown in the selected regions.  
In conclusion, we have found that ASR in HEGA-10 showed characteristics that were 
most suitable for NMR experiments. Indeed, the spectral quality was much better than 
for the spectrum of ASR in DDM recorded previously. The number of peaks was close 
to the expected maximum of 235 backbone amide signals. Although the spectrum looks 
very promising, the quality was not sufficient enough to allow the recording of three-
dimensional NMR experiments for backbone assignment purposes. Deuteration of the 
protein would be required to improve the spectral quality to an extent that would allow 
resonance assignment to be possible. 
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Figure 4-7 (opposite): NMR spectra of ASR in HEGA-10. 
2D [1H, 15N]-SOFAST-TROSY spectrum of ASR in 0.5% HEGA-10. The spectrum 
was recorded at 318 K on a 800 MHz spectrometer (1H frequency of 800 MHz) A) 
The spectrum was recorded using a conventional 5 mm NMR tube with the ASR 
concentration of 200 µM with 768 scans, corresponding to 14 h recording time. B) 
The same sample was concentrated to 325 µM, and the spectrum was recorded 
using a 3 mm NMR tube with 1024 scans, corresponding to 18 h acquisition time. 
Three boxes indicate the same selected regions in two spectra for comparison.  
4.2.5 Incorporation of ASR into SapA lipid nanoparticles 
In order to study the effect of a lipid bilayer on the structure and function of ASR, we 
attempted to incorporate ASR into SapA-DMPC nanoparticles. The SapA:DMPC:ASR 
ratio used in the assembly mixture was 2:56:1 and LMNG was removed by 2 h 
incubation with 80% Amberlite beads. The resulting chromatogram showed 
inhomogeneous ASR-containing particles, as indicated by the UV absorbance at 549 nm 
(Figure 4-8). Several reasons have lead to this result. First, the mixing ratio was not 
optimised; too many ASR molecules per nanoparticle would promote ASR oligomer 
formation in one nanoparticle. Second, the detergent might not have been removed 
completely as an A280 peak at around 16.5 mL could be observed which was likely to 
be SapA-LMNG based on similarity to the SapA-DDM SEC profile in Figure 2-5 A. 
Therefore, the multiple peaks seen in the A549 trace may have corresponded to a 
mixture of ASR in LMNG, ASR in SapA-DMPC, ASR in SapA-LMNG, or ASR in 
SapA-DMPC/LMNG. At the time this experiment was performed, we had not 
established the 2,6-dimethylphenol assay to check the detergent concentration, as 
discussed in Chapter 2. A working protocol for removing LMNG was established after 
this experiment, as discussed in Chapter 5. Finally, it is possible that ASR was able to 
exchange between monomeric, dimeric, and trimeric states in the bilayer. We did not 
pursue the incorporation of ASR further, but instead focused on the incorporation of 
pSRII because its sample preparation and NMR experiments were well-characterised in 
our lab.   
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Figure 4-8: SEC of ASR in SapA-DMPC nanoparticles.  
Absorbance at 280 nm (blue) and 549 nm (purple) are indicated. The molecular 
weight standards are shown on top of the graph. 
4.2.6 Incorporation of pSRII into SapA lipid nanoparticles 
pSRII was expressed and purified by following the previously reported protocol.30 The 
final sample was prepared in DDM which was much more easily removed by Amberlite 
beads compared to LMNG as shown in Chapter 2. The incorporation protocol we used 
for pSRII was exactly the same as for OmpX described in Chapter 2. SapA, DMPC, and 
pSRII were mixed in a ratio of 10:50:1 with the addition of 0.2% DDM in pH 6 buffer. 
The assembly mixture was then incubated with 80% (w/v) Amberlite XAD2 detergent 
removal beads at 25 °C for 2 h. The sample was harvested and checked by SEC to 
confirm successful pSRII incorporation showing a single, homogeneous peak at 12.3 
mL, corresponding to an apparent molecular weight of about 200 kDa (Figure 4-9 A). 
The presence of pSRII was assessed by the orange colour or the absorbance at 498 nm, 
the characteristic absorbance of the correctly folded pSRII (Figure 4-9 A). The UV 
spectrum of the sample was measured and overlaid with the spectrum for pSRII in 
DDM (Figure 4-9 B). The extra absorbance at 280 nm in SapA-DMPC nanoparticles 
originates from SapA scaffold proteins. The sample homogeneity was also confirmed 
by negative-stained electron microscopy images showing well-distributed particles with 
similar size (Figure 4-9 C). 
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Figure 4-9: Characterisation of pSRII in SapA-DMPC nanoparticles. 
A) SEC of pSRII in SapA-DMPC nanoparticles. Molecular weight standards are 
indicated on top of the graph. B) UV-Vis spectrum of pSRII in DDM (blue) and in 
SapA-DMPC nanoparticles (red). C) Negative-stain electron microscopy images of 
pSRII in SapA-DMPC nanoparticles. Scale bar, 50 nm. 
Although the particle size was estimated to be around 200 kDa, this was significantly 
larger than we anticipated for a monomer of pSRII (26.4 kDa) in SapA-DMPC 
nanoparticles. Therefore, we decided to investigate the stoichiometry of the particle. 
The concentration of pSRII could be determined from the absorbance at 498 nm which 
shows 1.8 µM for this sample (Figure 4-10). The concentration of SapA in the sample 
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was determined by quantifying the band intensity on an SDS-PAGE gel. A series of 
SapA only samples with known concentration were run as standards together with the 
unknown sample on the same SDS-PAGE. The band intensities of the standard samples 
were plotted against the concentration and a linear regression was performed to obtain 
the correlation between the band intensity and the concentration (Figure 4-10). The 
SapA concentration in the pSRII sample was then back calculated using the regression 
formula (SapA band intensity = 2112 × [SapA] + 13501), showing 3.3 µM. Therefore, 
we concluded that the SapA:pSRII ratio was 2:1. Based on the 200 kDa particle size 
estimate and the SapA:pSRII ratio of 2:1, the nanoparticles were composed of two 
pSRII and four SapA, consistent with dimeric pSRII in SapA4-DMPC nanoparticles. 
SapA4-DMPC nanoparticles on their own displayed an effective molecular weight of 
about 170 kDa as shown in section 2.2.4, which supports of the proposed composition. 
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4.2.7 NMR spectrum of pSRII in SapA-DMPC nanoparticles 
Despite the large particle size, we still attempted to obtain an NMR spectrum using 15N-
labelled pSRII in SapA4-DMPC nanoparticles. The result showed that although the 
NMR spectral quality was worse compared to that of monomeric pSRII in C7-DHPC 
micelles, as expected due to the larger apparent molecular weight, a similar overall 
backbone fingerprint was observed (Figure 4-11). The strong signals in particular 
overlaid perfectly because they correspond to residues in the loop region and the N and 
C-termini, which are completely solvent exposed, and hence not affected by changing 
the membrane mimetic. In contrast, the well dispersed peaks shifted significantly, 
suggesting that the lipid bilayer changed the chemical environment of the hydrophobic 
part of the protein. Moreover, the tryptophan side-chain signals at around 10 ppm (1H) 
also showed distinct chemical shifts. We have shown previously in Figure 3-11 using 
OmpX that tryptophan side-chains are very sensitive to the membrane mimetic used 
because they always position at the membrane-water interface.164 Although the spectral 
quality was not good enough to perform 3D NMR experiments for backbone 
assignment, perdeuteration would be expected to further improve the spectral quality for 
more extensive solution NMR studies of pSRII in SapA4-DMPC nanoparticles. 
 
 
 
 
Figure 4-10 (opposite): Determination of the SapA:pSRII ratio for pSRII in SapA-
DMPC nanoparticles.  
Using the absorbance at 498 nm and the extinction coefficient of 48000 M-1cm-1, 
the concentration of pSRII in the sample was determined to be 1.8 µM. The 
concentration of SapA in the sample was determined by comparing the band 
intensity to SapA standards with known concentration via SDS-PAGE (upper 
panel). The band intensity of the SapA bands was quantified using ImageJ, plotted 
against the SapA concentration in black open circles, and fitted by linear 
regression (bottom panel). The SapA concentration in the pSRII in SapA-DMPC 
nanoparticles was calculated to be 3.3 µM using the fitted result. The results show 
the SapA:pSRII ratio is 2:1.  
Chapter 4: Incorporation of seven-transmembrane proteins into SapA lipid nanoparticles  
100  Chih-Ta Chien – September 2018 
 
 
Figure 4-11: NMR spectra of pSRII in different membrane mimetics. 
Overlay of 2D-[15N, 1H]-SOFAST-TROSY spectra of 15N-labelled pSRII in C7-
DHPC micelles (blue) and in SapA4-DMPC nanoparticles (orange). Tryptophan 
region is indicated in grey box. Four representative strong signals from both 
spectra that overlaid perfectly are indicated by red arrows. The spectra were 
recorded at 800 MHz (1H) and 318 K. 
4.3 Conclusions 
This section described the optimisation of ASR NMR sample production including 
protein expression, purification, and determination of the detergent that was most 
suitable for NMR experiments. HEGA-10 gave acceptable NMR spectral quality that 
was dramatically improved compared to spectra in DDM. Partial incorporation of ASR 
into SapA-DMPC nanoparticles was observed. The reason for the incomplete 
incorporation could potentially be an incorrect ratio used in the assembly mixture or 
incomplete LMNG removal. Despite these inconclusive results for ASR, successful 
incorporation of pSRII into SapA-DMPC nanoparticles was obtained, yielding a single 
homogeneous particle with an effective size of 200 kDa. The properties of the particle 
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were consistent with two pSRII molecules surrounded by four copies of SapA. The 2D-
[15N, 1H] spectrum showed significant perturbation of the peak positions compared to 
those in C7-DHPC micelles, indicating the impact of the lipid environment on the 
protein’s conformation. In conclusion, SapA lipid nanoparticles are a very versatile 
membrane mimetic that can accommodate a range of different seven-transmembrane 
proteins making them suitable for studies of GPCRs in a more native-like environment. 
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5 NMR STUDIES OF β1-
ADRENERGIC RECEPTOR IN 
LIPID BILAYER 
5.1 Introduction 
5.1.1 b1-adrenergic receptors 
β-adrenergic receptors (bAR) are class A GPCRs and can activate intracellular 
heterotrimeric G proteins upon binding to adrenaline or noradrenaline. There are three 
subtypes: β1AR, β2AR, and β3AR and all recognise Gs G proteins in the activated state, 
which connect to adenylate cyclase, thus increasing the intracellular concentration of 
cAMP. b1AR is the dominant bAR in normal heart tissue while b2AR is the main 
regulatory receptor in vascular and non-vascular smooth muscle. Activation of the b1AR 
leads to an increase in contractile force and the heart rate. On the other hand, activation 
of b2AR results in relaxation of vascular and non-vascular smooth muscle. Despite such 
distinct functions within the bAR family, the receptors are highly similar both in 
structure and sequence between subtypes. For example, a sequence comparison of β1AR 
and β2AR shows 67% identity in the transmembrane region and the residues directly 
contacting the agonist in the ligand-binding pocket are the same. For drug development, 
it is important to modify a ligand into a more specific binder to the target, so that side 
effects during treatment can be reduced. β1AR selective antagonists such as CGP 
20712A bind to β1AR 500-fold stronger than to β2AR; the β2AR selective antagonist, 
ICI 118551, is 550-fold and 661-fold selective over β1AR and β3AR, respectively.187 
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Understanding the molecular mechanisms of both targets is important for further 
development of drugs with high specificity. Knowledge of the structure and dynamics 
of β1AR is still lacking compared to the extensively studied β2AR, therefore we aimed 
to understand more detail about b1AR.  
5.1.2 Structural studies of b1-adrenergic receptor 
The human b1AR, unlike b2AR discussed in section 1.3.2, is more difficult to purify 
because of its instability in detergent.188 The first crystal structure of β1AR from turkey 
(Meleagris gallopavo) was solved using a modified construct. The modifications 
included truncation of the flexible N- and C- terminal regions and intracellular loop 3, 
the introduction of six thermostabilising mutations (R68S, M90V, Y227A, A282L, 
F327A, and F338M), and two other mutations to improve protein expression (C116L) 
and eliminate the palmitoylation site (C358A).188 Since then, 18 crystal structures of 
thermostabilised β1AR bound to different ligands have been solved.188–193 Similar to 
observations made about b2AR, the agonist bound form of b1AR does not show the 
expected outward movement of TM6 (Figure 5-1). Only a local contraction by 2–3 Å of 
the binding pocket is observed in full agonist bound structures when compared to the 
antagonist bound state.189 Unlike b2AR, there are currently no crystal structures of b1AR 
bound to an intracellular binding partner, G protein or G protein mimicking nanobody 
available. 
Similar to the studies of b2AR the landscape of conformations that are accessible to 
b1AR is not visible in crystal structures. An NMR spectroscopy approach has been used 
to study thermostabilised b1AR, by investigating 15N labelled valine residues. The 
chemical shifts of residue V226 in TM5 of b1AR were found to correlate with the 
efficacy of the surveyed ligands, indicating the presence of several conformations and 
the population in each state was modulated by the ligands.194 A 13C methyl methionine 
NMR study of b1AR was performed and published by our group.195 We observed 
similar behaviour giving evidence for extensive µs-to-ms timescale dynamics in the full 
agonist bound state.195 Based on our data, agonists not only modulate the population of 
active-like conformations in the absence of an intracellular binding partner, i.e. a G 
protein mimicking nanobody, but also induce different conformations in the ternary 
agonist-b1AR-nanobody complex. A model was proposed in which ligand efficacy 
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determines the quality of the interaction between b1AR and the G protein leading to 
different signalling levels.195 
 
 
Figure 5-1: Crystal structures of b1AR. 
Overlay of crystal structure of agonist bound b1AR (green) (PDB ID: 2Y03), 
partial agonist bound b1AR (cyan) (PDB ID: 2Y04), antagonist bound b1AR 
(purple) (PDB ID: 2YCW), and inverse agonist bound b1AR (yellow) (PDB ID: 
5A8E).  
5.1.3 GPCR in lipid bilayer 
Most of the previous GPCR studies were done using detergents as the membrane 
mimetic because these are easier to handle experimentally. Detergents are simply 
included in the buffer as additives and spontaneously form micelles to solubilise the 
membrane protein. However, studying GPCRs in a lipid environment has become more 
Green (2Y03):  β1AR + agonist
Cyan (2Y04):  β1AR + partial agonist
purple (2YCW):  β1AR + antagonist
Yellow (5A8E): β1AR + inverse agonist
TM6
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and more popular recently due to technological advances and a realisation of the 
importance of lipids in GPCR activation.  
A comparison between different membrane mimetics has been reported for b2AR, 
revealing a much slower exchange rate between active and inactive states and a higher 
population of the active state when bound to full agonists in lipid bilayer nanodiscs 
compared to DDM micelles.105 Another study showed that lipids with a PG head group 
significantly favoured agonist binding and encouraged b2AR activation, whereas 
phosphatidylethanolamine favoured antagonist binding and stabilised the inactive form 
of b2AR.161 Two independent MD simulation works support the idea that anionic lipids 
stabilise the active-like state of b2AR making it more likely to dock with a G 
protein.196,197 A mechanism was proposed in which the lipid molecule binds to b2AR 
through an electrostatic interaction between the anionic head group and R3.50 of the 
DRY motif (superscripts refer to Ballesteros–Weinstein numbering198), resulting in 
transient stabilisation of an active-like conformation.197 The effect of lipid composition 
on the structure and function of b2AR is not limited to phospholipids. Two cholesterol 
molecules were observed in a crystal structure of b2AR interacting with conserved 
residues.199 This result lead to a prediction that 44% of human class A GPCRs would 
contain a cholesterol consensus motif.199 NMR studies suggest that there are two classes 
of cholesterol interaction with one on nanosecond and one on microsecond 
timescales.200 Specific binding of cholesterol near helices 5–7 appears to limit the 
conformational variability of b2AR, as revealed by experimental data201 and atomistic 
simulation.202 
There are also several studies investigating the effect of lipids on GPCRs other than 
b2AR. Three class A GPCRs, NTSR1, b1AR, A2AR, were found to bind PIP2, and this 
interaction selectively stabilises active states and enhances Gs selectivity.160 Negatively 
charged POPG dramatically affects the NTSR1-catalysed GDP/GTP nucleotide 
exchange rates for Gq.203  Cholesterol has been shown to affect the BLT2 
conformational landscape.204   
5.1.4 Cell-free expression system of membrane proteins 
Most NMR studies of GPCRs have used the baculovirus-insect cell expression system 
to produce functional and selectively labelled GPCR.66,194,195 However, the ability to 
introduce selective isotope labelling using this expression system is still limited because 
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of the high costs of the required media and isotope scrambling. Isotope scrambling 
occurs when one amino acid is the precursor for the synthesis of another. Ten out of the 
twenty genome-encoded amino acids, which locate at the end of the metabolic pathways 
(Ala, Arg, Asn, Cys, His, Ile, Lys, Met, Pro, and Trp) exhibit minimal isotope 
scrambling when they are added to growth media, but inter-conversion occurs for the 
remaining amino acids.205 In this regard, the cell-free expression system has the 
advantage of very low levels of scrambling and requiring only a small amount of 
isotope labelled amino acids to be added making this system substantially cheaper. Cell-
free systems provide a powerful new tool for NMR studies offering flexibility for a 
wide range of possible NMR labelling strategies. 
The cell-free expression system is an in-vitro protein synthesis method that uses 
biological machinery to produce a protein of interest. Expression based on E. coli 
extracts is the most commonly used system206 but extracts from other eukaryotic cells 
including wheat germ embryos207,208 or rabbit reticulocytes209 are also used. These 
reaction systems have been optimised for several years such that for some proteins they 
can consistently produce milligram quantities of protein per mL reaction volume. The 
most revolutionary advancement was the introduction of a dialysis implementation, also 
known as continuous-exchange cell-free expression. Dialysis mode vessels consist of 
two compartments, containing the reaction mixture (RM) and the feeding mixture (FM) 
separated by a dialysis membrane (Figure 5-2). RM, which is where the protein 
production happens, contains large molecules such as enzymes and nucleic acids. FM, 
on the other hand, holds small molecules such as precursors including amino acids, 
nucleotides, and other energy sources. This design can extend the reaction time to 12–
24 h, because the FM continuously supplies fresh precursors into the RM and removed 
inhibitory breakdown products from the RM.  
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Figure 5-2: The design of a dialysis mode cell-free expression. 
Reaction mixture (RM) with a sample volume of 100 µL is in the container at the 
top (orange). A dialysis membrane with 12–15 kDa cut-off is at the bottom of the 
container. This container is placed on top of a 2 mL tube where feeding mixture 
(FM) is. The components in RM and FM are indicated in the boxes.  
Cell-free expression offers many advantages over other expression systems and is 
highly suitable for the expression of toxic proteins or where additives are required such 
as chaperones, detergents, cofactors and others during protein expression. These can be 
used without the need to consider potential problems related to transport into the cell. 
This approach is especially attractive for NMR studies because its low level of 
metabolic conversion (scrambling) enables selective isotope labelling strategies.210,211 
Cell-free expression combined with combinatorial triple-selective labelling strategies212 
has enabled the backbone resonance assignment of detergent-solubilized membrane 
proteins,213 which is impossible via conventional triple resonance backbone assignment 
due to low NMR sensitivity. 
Cell-free expression systems are highly suited for the production of membrane proteins, 
which in E. coli frequently express into inclusion bodies. The three main strategies for 
expressing membrane proteins using cell-free methodology are detergent-based cell-free 
Reaction mixture (RM)
> E. coli extract: 
    necessary cell machinery
> T7 RNA polymerase
> DNA
> tRNA
Dialysis membrane
with 12-15 kDa cut-off
Feeding mixture (FM)
> folinic acid
> salts
> acetyl phosphate
> phosphoenol pyruvic acid
> amino acids
> dNTPs
> DTT
> protease inhibitor
> Mg2+, K+
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expression (D-CF), lipid-based cell-free expression (L-CF), and precipitate-based cell-
free expression (P-CF).206 D-CF conducts the cell-free reaction in the presence of 
protein-solubilising detergents and enables the direct translation of membrane proteins 
into detergent micelles, producing solubilised membrane proteins. Alternatively, 
artificial liposomes can also be added to cell-free reaction mixtures (L-CF), generating 
membrane protein embedded liposomes. Functional proteins can be obtained without 
refolding steps from D-CF and L-CF. In contrast, the reaction is carried out in the 
absence of protein solubilising compounds in P-CF mode, thus generating membrane 
proteins that precipitate. As a result, a refolding step that reconstitutes the membrane 
protein into a membrane mimetic is necessary to produce functional samples. Providing 
that a suitable refolding method is available, the P-CF method is a more attractive 
approach as expression yields are generally higher in the absence of inhibiting 
hydrophobic compounds such as detergents and the reaction product is typically rather 
pure when obtained as a precipitate. A number of GPCRs have been expressed as 
functional proteins in cell-free expression system for structural studies209 but in most 
cases D-CF or L-CF were used. Although, no high resolution GPCR structures have 
been solved using cell-free as the expression system yet, two seven-transmembrane-
helical protein structures have been published; an NMR structure of bacterial 
proteorhodopsin214 and a crystal structure of Acetabularia rhodopsin II.215 Overall, it 
has been shown that cell-free synthesis has become an important expression method that 
has the potential to play a crucial role for structural studies of GPCRs. 
5.1.5 Aims 
Although it has been shown that lipids can play an important role in modulating GPCR 
activity, information for a detailed molecular mechanism is still lacking. Previous 
studies of b1AR in the detergent LMNG using solution NMR in our group have revealed 
a complex energy landscape of b1AR activation.195 Knowledge of b1AR expression and 
purification, constructs of b1AR designed for methionine selective labelling 
experiments, and the corresponding NMR spectra are all established in our laboratory 
giving us a good starting point to explore the effect of the lipid bilayer on b1AR. Since 
Chapter 3 showed the suitability of SapA lipid nanoparticles for NMR studies and the 
promising ability of this system to study the impact of different lipid compositions, we 
hoped to employ SapA lipid nanoparticles to study the activation mechanism of b1AR in 
lipid bilayer. Comparing the results for b1AR in a lipid bilayer with our previous data 
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for b1AR in LMNG would allow us to investigate if lipid molecules are important and 
are part of the mechanism that allosterically modulates b1AR activity. Once we had 
established a working protocol for incorporating b1AR into SapA lipid nanoparticles, 
we aimed to explore the effect of lipid compositions on the activation of b1AR, in order 
to understand the fundamental mechanism of lipid modulation on GPCR activity.  
The expression system used in our previous study was the baculovirus-insect cell 
system. However, producing selectively isotope labelled b1AR by this method is rather 
costly. Therefore, the first aim was to explore the possibility of expressing functional 
b1AR using the cell-free system because of its ability to economically isotope label 
proteins for NMR studies. First of all, we needed to establish the system and validate it 
by expressing a model protein, green fluorescence protein (GFP). Then the expression 
of b1AR was tested using different modes of the cell-free expression system, P-CF, D-
CF, L-CF.  
5.2 Results and discussion 
5.2.1 Optimisation of cell-free expression system 
For condition screening and system optimisation, a GFP plasmid was used in the cell-
free expression system. This is because the quantification of GFP is very 
straightforward by fluorescence spectroscopy. In addition, the characteristic 
fluorescence of GFP, excitation at 395 nm, emission at 509 nm, is unique, so the cell-
free product can be measured without any need for prior purification. Hence GFP is 
utilized as a standard protein for determining the expression yield of a certain setup.  
The most expensive component in the cell-free system was the purified T7 RNA 
polymerase (T7RNAP). We decided to prepare it in-house following previously 
established protocols.206 The T7RNAP was overexpressed in BL21 (DE3) Rosetta cells. 
The T7RNAP product did not have to be very pure because the cells were the same as 
those used for preparing E. coli extract. This meant that any impurities in the T7RNAP 
preparation would also be present in the extract, therefore a single ion exchange 
purification was expected to provide T7RNAP with adequate purity. T7RNAP eluted at 
approximately 150 mM NaCl as shown in the chromatogram (Figure 5-3). Fractions 
from the elution were checked by SDS-PAGE. Large bands at around 100 kDa were 
observed at the expected molecular weight of T7RNAP. The yield was approximately 
40 mg/L cell culture with low sample purity. Analytical scale cell-free expression used 
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to test the activity of T7RNAP in 5% glycerol and compared with a purchased sample 
of T7RNAP. The result showed that the T7RNAP activity was three times higher than 
that achieved using commercially available T7RNAP. However, T7RNAP in 50% 
glycerol had only 60% of the activity of the commercial enzyme. These results 
suggested that a high concentration of glycerol may inhibit T7RNAP activity in the cell-
free expression reaction mixture. Nevertheless, 50% glycerol was used for long-term 
storage of home-made T7RNAP at -80 ˚C. The results also indicated that 33 µg/mL 
T7RNAP would suffice for successful production of GFP i.e. the yield from one litre of 
cell culture would provide enough for 300 mL of cell-free expression. 
 
Figure 5-3: Purification and cell-free activity test of T7RNAP. 
A) Anion exchange chromatogram of T7RNAP purification. T7RNAP was eluted 
at 150 mM NaCl. B) SDS-PAGE of fractions from the anion exchange purification. 
The molecular weight (kDa) of the protein standards is noted on the left. (C) Cell-
free expression activity test of T7RNAP in 5% glycerol (upper panel) and 50% 
glycerol (bottom panel) using GFP as the standard. Fluorescence at 509 nm was 
measured and normalized by the highest intensity. 
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The concentration of Mg2+ concentration in cell-free expression reaction mixture is an 
important factor that should be optimised for every batch of the E. coli extract or 
T7RNAP in order to reach the highest protein yield. First we screened for the optimal 
Mg2+ concentration for commercial T7RNAP using concentrations of Mg(OAc)2 from 
4.9 mM to 22.9 mM (Figure 5-4). The fluorescence results showed the highest yields of 
GFP with 12.9 mM Mg2+ in the reaction mixture. The yield dropped to below 30% 
when a Mg2+ concentration higher than 16.9 mM was used. The same screening 
procedure was performed for T7RNAP prepared in-house, which showed an optimal 
Mg2+ concentration of 12 mM. Interestingly, the yield halved when the concentration 
was increased from 12 mM to 13 mM Mg2+, which was the best value for the 
commercial T7RNAP. These results highlight the importance of optimising the Mg2+ 
concentration after any change in the composition of the cell-free system. According to 
this data, 12 mM Mg2+ should be used for the following cell-free expression with this 
specific batch of T7RNAP and E. coli extract prepared in-house. 
 
Figure 5-4: Mg2+ concentration optimisation for cell-free expression system. 
A) Commercial T7RNAP and B) T7RNAP prepared in-house were tested with 
different Mg2+ concentration. The level of GFP expression was quantified by 
fluorescence intensity at 509 nm and normalised by the highest intensity. 
5.2.2 Precipitate-based cell-free expression and refolding of b1AR  
With our E. coli-based cell-free expression system established and optimised, P-CF of 
b1AR was carried out and the resulting precipitate was solubilised in 15 mM SDS. An 
anti-histidine western blot was used to identify whether the His6-tagged b1AR had been 
expressed. The result showed a clear band between 25 and 30 kDa (Figure 5-5 A). It is 
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common for helical membrane proteins to show a smaller molecular weight than 
expected (38 kDa) because the a-helices remain formed in 15 mM SDS as shown in far-
UV CD experiments on this sample (Figure 5-5 B), which makes them more compact 
than the fully denatured form hence smaller according to the SDS-PAGE. The band was 
also characterised by peptide fingerprinting analysis using trypsin digestion and 
MALDI-TOF mass spectrometry (Figure 5-5 C). This approach was able to identify 
peptides that covered 13% of the b1AR sequence. Such low coverage was expected for 
an integral membrane protein because trypsin digestion can only occur in solvent 
accessible hydrophilic loop regions. As a result, the identified peptides were all in the 
loop regions when they were mapped onto the β1AR topology. Overall, our data 
confirmed that the full β1AR sequence had been expressed correctly in P-CF. 
Based on this successful preliminary result, we scaled up the expression in order to 
produce more protein for characterisation and refolding trials. The β1AR precipitates 
were first solubilised in 15 mM SDS followed by Ni column purification to remove all 
other impurities. SDS-PAGE of the fractions showed that β1AR was present in both 
wash and elution fractions indicating that there was not much non-specific binding 
(Figure 5-5 D,E). The higher MW bands were oligomeric β1AR as confirmed by mass 
fingerprinting. These might have resulted from intermolecular disulphide bond 
formation. The overall yield of β1AR by P-CF was approximately 1 mg per 1 mL 
reaction, as estimated by UV-Vis spectroscopy. 
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Figure 5-5: Precipitate-based cell-free expression and purification of b1AR. 
A) Anti-His western blot of analytical scale cell-free expression with and without 
b1AR plasmid. The molecular weight in kDa is noted on the left and bands showing 
b1AR are indicated on the right. B) Far-UV circular dichroism spectrum of b1AR 
in 15 mM SDS. C) Peptide mass spectrometry fingerprinting of the b1AR construct 
used in this work. Peptides that are recognised in MALDI-TOF mass spectrometry 
are mapped onto the b1AR topology in blue. D) Purification of His-tagged b1AR 
using a Ni-NTA column. E) SDS-PAGE of the fractions obtained from the Ni-NTA 
purification. Bands showing monomeric and dimeric b1AR are indicated. 
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With the purified β1AR product dissolved in SDS, we investigated the possibility of 
refolding it back into a functional state. The functionality of β1AR can be determined by 
its binding to alprenolol, a b-blocker that binds to functional bAR.216 We used a 
commercial alprenolol resin in a spin column, loaded the sample, eluted using 
alprenolol with a concentration of 0.8 mM, and checked the amount of b1AR in each 
fraction using an anti-His western blot. A positive control of b1AR expressed from 
baculovirus-insect cells showed clear bands in the elution fractions (Figure 5-6 A). In 
contrast, the negative control of b1AR in SDS was not able to bind to the alprenolol 
resin, as we expected the protein to be in a non-native conformation in such a harsh 
detergent (Figure 5-6 B). Although this assay is not able to provide a quantitative 
measure of functional b1AR, it should show qualitatively if the sample prepared is 
functional. With this validated functional assay, two refolding protocols were explored 
here: reconstitution of β1AR into small isotropic bicelles composed of C7-DHPC and 
DMPC (q = 0.25) and on-column refolding in the presence of the detergent LMNG. 
Both refolding methods have been extensively used for other membrane proteins.217,218 
The functional assay showed that the bicelle sample did not bind to alprenolol resin, 
whereas LMNG on-column refolding showed that part of the b1AR was successfully 
refolded and was present in the elution fractions (Figure 5-6 C,D). With this preliminary 
on-column refolding test showing positive results, the parameters of this protocol such 
as incubation time, incubation temperature, salt concentration and others needed to be 
optimised, to improve the refolding efficiency. 
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Figure 5-6: Anti-His western blot of the fractions from alprenolol spin column. 
The assay was performed for A) b1AR expressed in insect cells which is expected to 
be native and B) denatured b1AR in 15 mM SDS as the positive and negative 
control, respectively. The fractions are noted at the bottom, W1-W4 are wash 
fractions and E1-E4 are elution fractions. Functional assay of b1AR refolding trials 
by C) bicelle refolding using C7-DHPC and DMPC and D) on-column refolding 
with detergent LMNG. 
5.2.3 Detergent-based cell-free expression of b1AR 
As the refolding of b1AR was partially successful, an alternative D-CF was carried out 
to screen suitable detergents for solubilising b1AR during the cell-free reaction, an 
approach similar to that used in a case study where the suitability of various detergents 
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was screened for D-CF GPCR production.219 A similar procedure was conducted for 
β1AR using five detergents DDM, LMNG, C6-DHPC, C7-DHPC and CHAPS. 
Equivalent amounts of each sample were loaded onto an SDS-PAGE gel and an anti-
histidine western blot was performed to check the amount of β1AR in the soluble 
fraction and in the precipitate. Despite the low quality of the western blot due to sample 
overload, it was clear that DDM, C6-DHPC, and CHAPS inhibited the protein 
production as the intensity of the band, which smeared across the whole lane, 
significantly decreased compared to the control. On the other hand, the yields from 
LMNG and C7-DHPC were more or less similar, and a small proportion of β1AR was 
observed in the soluble fractions, which indicated that some β1AR successfully 
translated into micelles during the cell-free expression. The solubilised β1AR in LMNG 
and C7-DHPC were loaded onto the alprenolol spin column to check for sample 
functionality. The sample in C7-DHPC did not show alprenolol binding, whereas the 
LMNG sample looked promising. Different concentrations of LMNG in D-CF were 
screened to further optimise the amount of solubilised β1AR. The results showed that 
the reactions were strongly inhibited when the LMNG concentration was higher than 
200 µM. 10 µM and 20 µM seemed to solubilise similar amounts of β1AR. 
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Figure 5-7: Anti-His western blot of b1AR expressed in D-CF. 
A) b1AR was expressed in D-CF using different detergents. Detergents used for 
screening are shown in lane labels. Soluble and precipitate fractions are labelled as 
S and P, respectively. B) Functional assay of the soluble fractions of D-CF in 
LMNG (left) and C7-DHPC (right). C) LMNG concentration screening, ranging 
from 0 to 1500 µM, for b1AR expression using D-CF. 
5.2.4 Incorporation of b1AR in DDM into SapA lipid nanoparticles 
Despite our promising preliminary results for the cell-free expression of b1AR, the yield 
of the overall functional receptor was still too low for NMR experiments. Therefore, we 
started using b1AR samples that had been expressed in baculovirus-insect cells by 
another Ph.D. student, Andras Solt, in our lab. b1AR was extracted and purified by Ni-
NTA purification using DDM buffer. DDM is the preferred detergent for the purpose of 
incorporation into SapA lipid nanoparticles because it is easier to remove by detergent 
absorbent beads later on in the incorporation procedure. The purified DDM-solubilised 
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b1AR was mixed with SapA and DMPC in a SapA:DMPC:b1AR ratio of 10:250:1 at pH 
7.4 (Table 5-1). Neutral pH was used because of the limited stability of b1AR at lower 
pH values. The detergent removal step was then applied to this preparation by mixing 
with 80% w/v Amberlite XAD2 beads for 2 h at 25 ºC. Complete detergent removal was 
confirmed by the 2,6-dimethylphenol assay. Precipitates in the samples were pelleted 
and the supernatant was checked by SDS-PAGE (Figure 5-8 A). In the presence of 
SapA-DMPC (Figure 5-8 A lane 2), the b1AR remained in solution indicating a 
successful incorporation (Figure 5-8 A). A negative control was performed with only 
DDM-solubilised b1AR and Amberlite beads which showed no band on the SDS-PAGE 
gel. This was due to b1AR precipitating when the DDM molecules were completely 
removed by the beads. b1AR in the SapA-DMPC sample was then characterised by 
analytical size-exclusion chromatography (Figure 5-8 B). The chromatogram shows a 
homogeneous peak with a shoulder on the right, which corresponds to the empty SapA-
DMPC nanoparticles. The resulting b1AR in SapA-DMPC nanoparticles had an 
apparent molecular weight of about 160 kDa. The SDS-PAGE gel showed two faint 
bands at 13 kDa and 22 kDa, which we occasionally observed, corresponding to 
fragments of b1AR from protease cleavage at ICL2.  
Table 5-1: Composition of the b1AR incorporation assembly mixture. 
	 Volume	 Final	concentration	SapA	(3	mM)	 20	µL	 120	µM	DMPC	(10	mM)	 150	µL	 3	mM	
b1AR	(100	µM)	 60	µL	 12	µM	DDM	(10%)	 10	µL	 0.2%	Buffer‡	 260	µL	 	Total	volume	 500	µL	 	
‡ The buffer used in the b1AR incorporation is 50 mM Tris-HCl (pH 7.4), 150 mM NaCl. 
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Figure 5-8: Incorporation of b1AR into SapA-DMPC nanoparticles. 
A) SDS-PAGE of samples before and after the incorporation procedure. A 
negative control of b1AR incubated with Amberlite beads showing that b1AR 
crashed out of solution hence no bands on the SDS-PAGE. B) Analytical size-
exclusion chromatography of b1AR in SapA-DMPC nanoparticles and the SDS-
PAGE of the peak fractions. The peak indicated by + represents b1AR in SapA-
DMPC nanoparticles; the peak indicated by * represents empty SapA-DMPC 
nanoparticles.  
5.2.5 NMR spectra of b1AR in SapA-DMPC nanoparticles 
The interaction between detergent-solubilised b1AR, the full agonist isoprenaline and 
the G-protein mimicking nanobody Nb80 was studied previously using NMR 
spectroscopy.194,195 Due to the large molecular weight of the b1AR-detergent complex, a 
selective labelling strategy was necessary to produce interpretable NMR spectra. 
Following the previous study on b1AR conducted in our lab, [13Cε-methionine]-b1AR 
was used to investigate the activation process of b1AR in lipid bilayers by NMR. [13Cε-
methionine]-b1AR was incorporated into SapA-DMPC nanoparticles and purified by 
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size-exclusion chromatography using the method described in the previous section 
(5.2.4). The construct used here had 12 methionine residues (M1, M44, M48, M90, 
M153, M178, M179, M223, M281, M283, M296, M338) shown in Figure 5-9, except 
M1 because it is not visible in the structure.  
 
Figure 5-9: b1AR constructs used in this study. 
The original b1AR construct contains 12 methionines. All methionines except M1, 
not resolved in the crystal structure, are mapped onto the crystal structure (PDB 
ID: 4BVN) shown in orange spheres. b1AR-D5 with five methionine mutated 
(M44L, M48L, M179L, M281A, M338A) and b1AR-D5-L190M with one 
introduced methionine, L190M, are indicated in the same way for comparison. 
The 13C HMQC spectrum of b1AR in the apo state revealed 13 peaks for the 12 
methionine residues (Figure 5-10 blue). These peaks possess varying intensities, 
indicating that different parts of the receptor have different dynamics. Several peaks 
showed chemical shift perturbation upon isoprenaline binding (Figure 5-10 green), 
indicating that the receptor changes conformation when bound to a full agonist. The 
substantial peak broadening observed for many of the signals also suggests that the 
receptor is able to exchange dynamically between several conformations on a µs-to-ms 
time scale. Addition of the G-protein mimicking Nb80 to form a fully active ternary 
complex induced further dramatic chemical shift perturbations. At the same time the 
recovery of peak intensities seems to indicate that the ternary complex samples fewer 
conformations, comparable to NMR observations for the b2-adrenergic receptor.67 
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Figure 5-10: NMR spectra of b1AR in SapA-DMPC nanoparticles. 
Overlay of the 2D 13C-SOFAST-HMQC spectra of [13Cε-methionine] b1AR with a 
concentration of 40 µM in the apo state (red), the isoprenaline-bound state (blue), 
and the isoprenanline-Nb80 bound ternary complex (green). The spectra were 
recorded at 308 K on a Bruker Avance AVIII 800 spectrometer (1H frequency of 
800 MHz) equipped with a 5 mm TXI HCN/z cryoprobe. Spectra were recorded 
with 128 scans, resulting in an experiment time of 4 h. 
While these results showed the successful incorporation of b1AR into SapA-DMPC 
nanoparticles, individual resonance assignments will be required for further 
interpretation.  
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5.2.6 Optimisation of the incorporation protocol for b1AR in LMNG 
Although we have successfully incorporated b1AR into SapA-DMPC nanoparticles and 
obtained NMR spectra of very good quality, we were not able to make further 
investigations without peak assignments. NMR peak assignments for b1AR in LMNG 
were determined in our laboratory using a derivative b1AR construct, in which five 
methionines are mutated to reduce the spectral complexity including M44L, M48L, 
M179L, M281A, M338A, hereafter called b1AR-D5 (Figure 5-9). Therefore, our aim 
was to incorporate b1AR-D5 into SapA-DMPC nanoparticles permitting the transfer of 
assignments from the LMNG spectra based on peak proximity. The main issue for 
b1AR-D5 incorporation was that this construct is not stable in DDM as we observed 
protein precipitation after a few days at 4 ºC, leaving us with no choice but to use 
LMNG to solubilise b1AR-D5. With LMNG, detergent removal was much more 
challenging using adsorbent beads as shown in Chapter 2. In order to be able to study 
b1AR-D5 in SapA lipid nanoparticles, we had to establish an efficient protocol for 
removing LMNG first. 
Together with a Part II student, Daniel Gentle, we started screening for the best 
condition to incorporate LMNG solubilised b1AR into SapA-DMPC nanoparticles in 
order to find a procedure which removes LMNG completely but also keeps b1AR in 
solution. The LMNG concentration was monitored by the 2,6-dimethylphenol assay and 
the b1AR concentration was quantified by the band intensity in an SDS-PAGE gel 
prepared after the detergent removal step. The numbers were then normalised against 
the initial LMNG concentration and b1AR concentration in the original LMNG 
solubilised b1AR sample, respectively, showing the percentage of molecules left after 
treatment with Amberlite XAD2 beads. A successful incorporation was expected to 
show no LMNG left in the sample as well as b1AR remaining in solution. We also 
carried out negative control experiments for all the conditions screened here, using the 
same parameters but in the absence of SapA-DMPC. The negative control for LMNG 
removal should show no LMNG and no b1AR in solution because b1AR should 
precipitate out of solution once all the LMNG molecules are completely removed by the 
beads.  
We started by testing incubation times of four to five hours at 25 ºC (Figure 5-11, A) 
which were double the time required for DDM removal. The negative control showed 
that even though the beads were able to remove more than 70% LMNG, there was still a 
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detectable amount of b1AR left in the sample, indicating the presence of residual 
LMNG micelles stabilising some b1AR in solution. In the presence of SapA-DMPC, a 
significant amount of both LMNG and b1AR was detected after the detergent removal 
process. Incomplete LMNG removal was observed regardless of changing for fresh 
beads half way through the incubation or doubling the amount of beads used, suggesting 
that this occurred because of the slow rate of removal but not due to reaching the 
capacity of the beads. In agreement with this, a 24 h incubation was able to remove all 
of the LMNG (Figure 5-11, B). The negative control showed 0% LMNG and 0% b1AR 
left in the sample. In the presence of SapA-DMPC, LMNG was completely removed 
while b1AR remained in solution showing that it was stabilised by the SapA-DMPC 
nanoparticles. This was evidence for successful b1AR incorporation into SapA-DMPC 
nanoparticles.  
 
 
 
 
Figure 5-11 (opposite): Optimisation of the LMNG removal for the b1AR 
incorporation. 
LMNG solubilised b1AR with (right panel) or without (left panel) SapA-DMPC 
were incubated with 80% (w/v) Amberlite beads for a total A) 4 h or B) 24 h 
incubation time. The incubation temperature was 25 ºC unless indicated otherwise. 
Some conditions involved several steps meaning changing fresh Amberlite beads in 
between. LMNG concentration was determined by the 2,6-dimethylphenol assay. 
b1AR concentration was determined by quantification of the corresponding band 
on SDS-PAGE. Both concentrations are normalised against the concentration of 
the original b1AR sample, i.e. the percentage of LMNG or b1AR left in the sample 
after the treatment. The data are presented in a heat map format showing 0% 
(purple) to 100% (yellow) in gradient. C) Investigation of the effect of incubation 
temperature (4 ºC or 25 ºC) on LMNG removal using the same experimental 
procedure. This experiment was performed using POPC/POPG (3:2) instead of 
DMPC. 
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In another set of experiments, we investigated the effect of temperature during 
incorporation of b1AR into SapA-POPC/POPG (3:2) nanoparticles (Figure 5-11, C). It 
is generally believed that the incubation temperature in the detergent removal step must 
be near the phase-transition temperature of the lipids being used, which for 
POPC/POPG is around 0 ºC.129 Therefore, the detergent removal for the assembly of 
MSP-POPC/POPG nanodiscs is often performed at 4 ºC in the reported literature.105,135 
However, we observed that barely any LMNG was removed at 4 ºC (almost 100% left 
shown in yellow). In contrast, at 25 ºC the process worked so well that no LMNG was 
left (purple) in the sample both with and without SapA-POPC/POPG. Our results also 
suggest that incorporation was achieved at 25 ºC as b1AR remained in solution in the 
presence of SapA-POPC/POPG. We have shown previously that LMNG removal is 
very slow and we speculated that this is due to the very low CMC (0.001%) of LMNG. 
We hypothesised that a lower temperature would reduce the CMC resulting in little 
monomeric LMNG being present in solution where it could be absorbed by the beads. It 
is also possible that the low temperature reduced the exchange rate between LMNG 
monomers and LMNG micelles which became the rate-limiting step. These two factors 
are potential reasons for the extremely slow removal of LMNG. 
 
This chapter has established a protocol for incorporating LMNG-solubilised b1AR into 
SapA lipid nanoparticles. Incubation at 25 ºC for 24 h was necessary to completely 
remove LMNG, and b1AR remained in solution after the incubation step indicating a 
successful incorporation. This allowed us to proceed with the incorporation of LMNG-
solubilised b1AR mutants for which we had NMR peak assignment information.  
5.2.7 NMR peak assignment of b1AR-D5-L190M in lipid bilayer 
We used the protocol established in the previous section to incorporate b1AR-D5-
L190M into SapA-DMPC nanoparticles. This was a derivative construct based on 
b1AR-D5 which has another introduced methionine on the extracellular loop 2 (Figure 
5-9) for the purpose of monitoring agonist binding events. b1AR-D5-L190M was 
solubilised in LMNG, therefore the incorporation procedure was performed for 24 h to 
ensure complete detergent removal. We also included an additional Ni-NTA 
purification step, which was not included previously, to remove empty SapA-DMPC 
nanoparticles (Figure 5-12 A). The flow-through fraction showed a SapA band 
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corresponding to empty SapA-DMPC nanoparticles. The elution fraction from the Ni-
NTA purification step showed the presence of both b1AR-D5-L190M and SapA, 
meaning SapA, without a His6-tag, was in complex with the His6-tagged b1AR-D5-
L190M. This result provided a strong indication that the incorporation step has 
proceeded successfully. The elution fraction was then analysed by analytical size-
exclusion chromatography to check the particle size and the homogeneity (Figure 5-12 
B). The chromatogram showed a single symmetrical peak at around 13.6 mL. The SDS-
PAGE gel again confirmed the presence of SapA and b1AR-D5-L190M. This data also 
confirmed that the shoulder peak indicated by * in the previous chromatogram (Figure 
5-8 B) was indeed empty SapA-DMPC nanoparticles because the peak disappeared after 
the Ni-NTA separation step. 
 
 
Figure 5-12: Purification of b1AR-D5-L190M in SapA-DMPC nanoparticles. 
A) Ni-NTA chromatogram of the assembly mixture shows the separation of empty 
SapA-DMPC nanoparticle from b1AR-D5-L190M in SapA-DMPC nanoparticles. 
Flow-through and elution fractions were analysed using SDS-PAGE. B) SEC of the 
elution fractions from A). SDS-PAGE of the corresponding fractions is shown at 
the bottom. 
 
0 5 10 15 20 25 30
0
200
400
600
0
50
100
150
200
250
elution volume (mL)
A2
80
 (m
Au
)
A280
[imidazole] [im
idazole], m
M
8 10 12 14 16 18 20
0
10
20
30
40
50
elution volume (mL)
A2
80
 (m
Au
)
Ni purification SEC purification
10
15
25
30
40
A B
10
15
25
30
40
Chapter 5: NMR studies of β1-adrenergic receptor in lipid bilayer  
128  Chih-Ta Chien – September 2018 
 
Figure 5-13: NMR peak assignments transfer for b1AR-D5-L190M. 
Overlay of the 2D 13C-SOFAST-HMQC spectra of [13Cε-methionine] apo b1AR-D5-
L190M in SapA-DMPC nanoparticles (red) and in LMNG (blue). The peak 
assignments for b1AR-D5-L190M in LMNG that were obtained previously from 
mutagenesis are indicated. The spectra were recorded at 308 K on a Bruker 
Avance AVIII 800 spectrometer (1H frequency of 800 MHz) equipped with a 5 mm 
TXI HCN/z cryoprobe. Spectra were recorded with 368 scans using a 60% non-
uniform sampling (NUS) scheme, resulting in an experiment time of ~6 h. 
A 2D 13C-HMQC experiment was recorded for the sample and overlaid with the 
spectrum of the same construct in LMNG for which we already had the peak 
assignments (Figure 5-13). The peaks did not overlay perfectly in the two spectra which 
is what we would expect due to the different chemical environments provided by the 
membrane mimetic systems. The signal-to-noise ratio was worse in the SapA-DMPC 
spectrum because of the larger particle size and lower sample concentration. 
Nevertheless, the assignments were unambiguously transferred for M153, M190, M223, 
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and M296 based on peak proximity because these resonances were all isolated and well-
resolved. However, the resonances for M283, M1, and M178 were in a crowded region 
and largely overlapped making the assignment transfer difficult. In addition, there was 
no observable peak near M90. All the peaks, except the most intense one, which is 
assigned to M283/M1 in the LMNG spectrum, shift significantly suggesting that the 
lipid bilayer indeed offers a distinct environment compared to detergent. M283 is 
located at a very dynamic and water-accessible loop region which should not be 
affected by different membrane mimetics used hence resulted in no significant 
perturbations.  
Based on this spectrum, we were not able to assign a resonance for M178 because there 
are two peaks equally close to the M178 peak in the LMNG spectrum. M178 shows two 
peaks in the spectrum in LMNG micelles, a distinct behaviour, which indicates two 
conformations of M178 in the b1AR apo state. This was an interesting finding and we 
hoped to obtain M178 assignments for the SapA-DMPC spectrum as well. Therefore, a 
b1AR-D5-M178A construct was used to clarify the peak assignment for M178. Note 
that this construct did not contain M190 or M178 and thus the spectrum was expected to 
lack signals for M190 and M178. The same incorporation procedure and NMR 
experiment were performed. An overlay of the NMR spectra of b1AR-D5-L190M and 
b1AR-D5-M178A showed the disappearance of two peaks in addition to the 
disappearance of the resonance corresponding to M190 (Figure 5-14). Therefore, we 
assigned the remaining two peaks to M178. Although similar behaviour is observed, in 
that M178 shows two peaks as found in the LMNG spectrum, the intensity ratio 
between the two peaks is different (Figure 5-13). This suggests that the lipid bilayer has 
an effect on the equilibrium between these two conformations of M178. Here, we 
obtained assignments for five key residues that provide well-distributed reporters on 
b1AR, M153 on the intracellular side, M223 and M296 in the membrane region, and 
M178 and M190 on the extracellular side. The next step was to investigate the 
conformational changes of b1AR upon activation by monitoring the chemical shift of 
these assigned methionine residues.  
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Figure 5-14: Identification of peaks for M178 in the spectrum of b1AR-D5-L190M. 
Overlay of the 2D 13C-SOFAST-HMQC spectra of [13Cε-methionine] b1AR-D5-
L190M (red) and b1AR-D5-M178A (blue) in SapA-DMPC nanoparticles. The peak 
assignments are indicated. Two peaks are assigned to M178 due to the 
disappearance in the M178A spectrum. The spectra were recorded at 308 K on a 
Bruker Avance AVIII 800 spectrometer (1H frequency of 800 MHz) equipped with 
a 5 mm TXI HCN/z cryoprobe. Spectra were recorded with 368 scans using a 60% 
non-uniform sampling (NUS) scheme, resulting in an experiment time of ~6 h. 
5.2.8 Activation of b1AR in lipid bilayer 
With the methionine peaks assigned, next we monitored the movement of these peaks 
upon sequential addition of the full agonist, isoprenaline, and the G protein mimicking 
nanobody, Nb6B9. This experiment was previously performed on b1AR-D5-L190M in 
LMNG by Andras Solt (Figure 5-15 A). The isoprenaline bound spectrum (Figure 5-15 
A, blue) showed no perturbations for M178 and M190, and only a subtle shift for M153. 
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M223 and M296, on the other hand, shifted significantly together with a decrease in 
intensity. A drop in intensity or peak broadening is an indication of a very dynamic state 
in which the receptor exchanges between multiple conformations at a rate comparable to 
the chemical shift difference between them. This result is consistent with the previous 
observation for b2AR that the full agonist-bound state showed a dynamic characteristic, 
which is thought to be essential for G protein recognition.105,135 In LMNG detergent in 
the spectrum of the ternary complex (Figure 5-15 A, green) in which the receptor is 
bound to isoprenaline and Nb6B9, both M223 and M296 showed a large peak shift 
indicating a large conformational change upon binding to Nb6B9. In addition, the 
intensities of both peaks were restored suggesting that b1AR was in a more uniform 
environment compared to the isoprenaline bound state. M153 and one of the M178 
peaks, which showed little perturbation upon binding isoprenaline, also showed 
significant peak shifts from the isoprenaline bound to the ternary complex state. This 
suggests that major conformational changes of M153 and M178 only happen in 
complex with an intracellular binding partner. 
In order to investigate the effect of the lipid bilayer on the activation of b1AR, the same 
set of experiments was performed for b1AR-D5-L190M in SapA-DMPC nanoparticles 
(Figure 5-15 B). In the 2D 13C-HMQC spectrum with isoprenaline bound (Figure 5-15 
B, blue), M223 and M296 were not detectable, whereas very weak peaks were observed 
in the LMNG spectrum (Figure 5-15 A, blue). This is probably due to the very low 
sample concentration and larger particle size which degraded the sensitivity of the 
experiment so much that it could not pick up peaks with such low intensity. Although 
the signals from M223 and M296 were too weak to be observed, the disappearance of 
peaks suggests that the conformational exchange in the full agonist bound state as 
discussed above for the LMNG sample was preserved in the lipid bilayer. Interestingly, 
we observed signals from M153 and M178 shifting significantly when the receptor 
bound to full-agonist in the lipid bilayer; in addition, the second M178 resonance 
disappeared. This was a different behaviour to that in LMNG where either subtle shifts 
or no changes were observed, and the second M178 peak remained in the same position. 
This suggests that the conformational change induced by agonist binding probably 
needed the participation of the lipid bilayer. This data supports the generally believed 
GPCR activation model that binding the full-agonist on the extracellular side induces a 
conformational change on the intracellular side which then promotes G-protein 
binding.48 Next, the G-protein mimicking nanobody Nb6B9 was added into the sample 
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for 2D 13C-HMQC measurement of the ternary complex (Figure 5-15 A, green). A large 
chemical shift change as well as the restoration of peak intensities for M223 and M296 
was observed, similar to our observations for the spectra recorded in LMNG micelles. 
The resonance for M153 remained at the same position as in the spectrum with 
isoprenaline bound, whereas M178 signals shifted further in the same direction. Overall, 
we observed the same pattern of intensity changes and the same direction of chemical 
shift changes following the sequential addition of the full agonist isoprenaline and the G 
protein mimicking nanobody Nb6B9 indicating that the general activation mechanism 
for b1AR in LMNG micelles and in the DMPC bilayer is similar.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5-15 (opposite): Activation of b1AR-D5-L190M in different membrane 
mimetics. 
Overlay of the 2D 13C-SOFAST-HMQC spectra of [13Cε-methionine] b1AR-D5-
L190M in A) LMNG and B) SapA-DMPC nanoparticles. Spectra of the apo state 
(red), the isoprenaline-bound state (blue), and the isoprenanline-Nb6b9 bound 
ternary complex (green) are overlaid. Peak assignments and the peak shifts are 
indicated. The spectra were recorded at 308 K on a Bruker Avance AVIII 800 
spectrometer (1H frequency of 800 MHz) equipped with a 5 mm TXI HCN/z 
cryoprobe. Spectra were recorded with 368 scans using 60% non-uniform 
sampling (NUS) scheme, resulting in an experiment time of ~6 h. 
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Figure 5-16: Adrenaline activation of b1AR-D5 in SapA-DMPC nanoparticles. 
2D 13C-SOFAST-HMQC spectra of [13Cε-methionine] b1AR-D5 in SapA-DMPC 
nanoparticles. Spectra of the apo state (red), the adrenaline-bound state (blue), 
and the adrenaline-Nb6b9 bound ternary complex (green) are overlaid. Peak 
assignments and the peak shifts are indicated. The spectra were recorded at 308 K 
on a Bruker Avance AVIII HD 950 spectrometer (1H frequency of 950 MHz) 
equipped with a 5 mm TXI HCN/z cryoprobe. Spectra were recorded with 368 
scans using 60% non-uniform sampling (NUS) scheme, resulting in an experiment 
time of ~6 h. 
In another set of experiments, we looked at the activation of b1AR-D5 in SapA-DMPC 
nanoparticles using the endogenous activating ligand, adrenaline (Figure 5-16). The 
signals from M223 and M296 still showed the same behaviour and the corresponding 
peaks in the adrenaline bound form were not observable. In the adrenaline-bound state, 
the signal from M153 perfectly overlaid the equivalent peak in the spectrum of the 
adrenaline-bound ternary complex. This result suggests that, in the absence of IBP, 
adrenaline can activate the receptor to a higher level than isoprenaline. In the 
adrenaline-bound state, the peak for M178 also shifted to a position closer to that found 
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in the ternary complex state. From these observations about the signals from M153 and 
M178 it can be concluded that, adrenaline induces a more active-like conformation than 
isoprenaline. Despite subtle conformational differences in the ligand bound state 
between adrenaline and isoprenaline, the overall activation mechanism appears to be the 
same, so these ligands cause very similar spectral changes. 
5.3 Conclusions 
This Chapter began by establishing a cell-free expression system in which all the 
components were optimised. Then it explored the possibility of expressing b1AR using 
the cell-free expression system. The expression yield was high but most of the 
expressed protein precipitated, and only a small fraction of the precipitated b1AR could 
be successfully refolded and shown to be functional. Including detergent molecules in 
the cell-free setup also produced a small amount of functional b1AR, but unfortunately 
not enough for NMR studies. Therefore, we used b1AR produced by the more 
conventional baculovirus-insect cell expression system for incorporation into SapA-
DMPC nanoparticles. The incorporation proved to be successful and the appearance of 
the NMR spectra indicate that the activation mechanism was similar to that observed in 
LMNG micelles. However, M153 (IL2) on the intracellular side of b1AR appeared to 
adopt a more active-like conformation when bound to the agonist isoprenaline in the 
nanoparticle system. Taken together, these results suggest that the lipid bilayer plays an 
important role in receptor activation and that interactions with specific lipids may 
participate in this process.  
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6 CONCLUSIONS 
In this thesis, I established SapA lipid nanoparticles as an alternative membrane 
mimetic system for NMR studies of membrane proteins. Firstly, the molecular 
mechanism of SapA opening was explored. Both pH and detergents are important 
factors that facilitate the formation of SapA lipid nanoparticles. The size-flexibility of 
SapA and its ability to interact with a wide range of lipids were shown, and these 
properties make SapA lipid nanoparticles a promising membrane mimetic system. Next, 
we demonstrated that the chemical environment of OmpX, a b-barrel model protein, 
in SapA lipid nanoparticles is consistent with the MSP nanodiscs, indicating the same 
lipid bilayer environments. The SapA system allowed us to investigate the effect of 
lipid composition on the conformation of OmpX because of their high incorporation 
yield and high NMR spectral quality. A negatively charged lipid showed strong effects 
on the charged residues in the loop regions as well as aromatic residues which are 
usually found at the membrane-water interface. This experiment revealed that 
membrane proteins can be studied in various lipid compositions using the SapA system, 
advancing the research into how the structure and function of membrane proteins are 
regulated by lipids. To confirm the versatility of SapA lipid nanoparticles, a microbial 
rhodopsin pSRII that has seven transmembrane helical structure was incorporated, 
yielding a dimeric pSRII in SapA4-DMPC nanoparticles. The NMR spectrum showed a 
marked pattern compared to the same protein in C7-DHPC detergent micelles, 
exhibiting a different conformation and oligomeric state in lipid bilayer. This result 
justified that SapA lipid nanoparticles are versatile and can accommodate a wide variety 
of membrane proteins with different sizes and structures for solution NMR studies, and 
yet the incorporation process is very straightforward. Finally, the agonist-bound b1AR 
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in SapA-DMPC nanoparticles was shown to adopt a more active-like conformation 
compared to that in detergent, suggesting that lipids directly or indirectly participate in 
the activation process of GPCRs. NMR studies of biologically important membrane 
proteins in SapA lipid nanoparticles provide valuable structure and dynamics 
information that are necessary for understanding their functions. Overall, SapA 
phospholipid nanoparticles provide a promising membrane bilayer mimetic in which 
functionally important NMR studies can be conducted in the future.  
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7 METHODS 
7.1 Protein expression and purification 
7.1.1 Small-scale expression test 
For test expression, a 1 mL LB culture supplemented with the corresponding antibiotics 
was inoculated with a single colony from the plate which was prepared from 
transformed E. coli cells. The cells were grown at the desired temperature for 4 h 
followed by addition of 1 mM IPTG. After 2 h of incubation, the cells were collected by 
centrifugation (20,000 g, 10 min) and the supernatant was discarded. 50 µL of 
BugBuster® (Merck) was mixed with the cells by pipetting up and down until the 
solution became clear. The resulting sample was checked by SDS-PAGE.  
7.1.2 SapA 
Saposin-A (SapA) was expressed and purified using the protocol reported previously.128 
The SapA plasmid was a kind gift from Dr. Janet Deane. The sequence of the construct 
is as following: 
MGSLPCDICKDVVTAAGDMLKDNATEEEILVYLEKTCDWLPKPNMSASCKEIV
DSYLPVILDIIKGEMSRPGEVCSALNLCESLQ  
SapA was expressed using E. coli SHuffle® T7 cells. Cells were grown at 30 ˚C in LB 
supplemented with 100 µg/mL ampicillin for approximately 5 h to reach OD600 of 0.8. 
Cells were then induced with 1 mM IPTG, and incubated overnight at 16 ˚C. The cells 
were harvested by centrifugation (5,000 g, 30 min). Cell pellets were resuspended in 
anion-exchange buffer (50 mM Tris-HCl, pH 7.4, 25 mM NaCl) with protease inhibitor 
cocktail (Sigma-Aldrich) and lysed by applying three runs on EmulsiFlex-C5 (Avestin). 
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Soluble proteins were separated by centrifugation (40,000 g, 30 min, 4 ˚C). The 
supernatant was incubated at 85 ˚C with gentle mixing for 15 min to denature other 
proteins. The solution should become cloudy after the heating step. Precipitated proteins 
were pelleted by centrifugation (40,000 g, 30 min, 4 ˚C) and discarded. The anion-
exchange purification was performed using a 5 mL HiTrap QSepharose column (GE 
Healthcare) equilibrated with anion-exchange buffer. Elution used a 0–50% linear 
gradient of elution buffer (50 mM Tris-HCl, pH 7.4, 1 M NaCl). Fractions were 
checked by SDS-PAGE and those containing SapA were pooled and concentrated using 
Amicon Ultra-15 (3,000 MWCO). The sample was further purified by size-exclusion 
chromatography using a HiPrep 16/60 Sephacryl S-200 (GE Healthcare). The purity of 
the sample was checked by SDS-PAGE before concentrating to a final concentration of 
approximately 3 mM. The sample was aliquoted, flash frozen and stored in the -80 ˚C 
freezer. 
7.1.3 OmpX  
[U-15N]-OmpX sample was kindly provided by my colleague, Yi Lei Tan. The sequence 
used in this study is as following: 
MATSTVTGGYAQSDAQGQMNKMGGFNLKYRYEEDNSPLGVIGSFTYTEKSRT
ASSGDYNKNQYYGITAGPAYRINDWASIYGVVGVGYGKFQTTEYPTYKHDTS
DYGFSYGAGLQFNPMENVALDFSYEQSRIRSVDVGTWIAGVGYRF  
The protocol she used was adapted from a previous study.77 Briefly, transformed E. coli 
BL21 (DE3) cells were grown at 37 °C in M9 medium supplemented with 1g/L [U-
99%15N]-NH4Cl. Protein expression was induced at an OD600 of 0.3 by the addition of 1 
mM IPTG followed by 5 h incubation at 37 °C. Cells were collected by centrifugation 
(4,300 g, 20 min) and lysed using Emulsiflex. Inclusion body was prepared by 
centrifugation (4,300 g, 1 h) and resuspension with buffer (20 mM Tris-HCl, pH 8.0, 5 
mM EDTA) three times. The protein was finally solubilised in 6 M GuHCl, 50 mM 
Tris/HCl pH 8.5, 100 mM NaCl, 5 mM EDTA for 2 h at 37 ºC. Sample in the 
supernatant was collected after the centrifugation (14,300 g, 20 min). Sample was 
purified using a Superdex S200 16/60 HR (GE Healthcare) equilibrated with buffer (20 
mM Tris-HCl, pH 8.5, 5 mM EDTA, 8 M Urea). OmpX refolding was performed at 
room temperature by dropwise dilution of 5 mL 300 µM OmpX into 50 mL of refolding 
buffer (0.5% dodecylphosphocholine (DPC), 50 mM Tris-HCl, pH 8.5, 5 mM EDTA, 
500 mM L-arginine followed by stirring at room temperature overnight. Refolded 
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protein was dialysed against 5 L of 20 mM Tris-HCl, pH 8.5, 100 mM NaCl, 5 mM 
EDTA. DPC with a final concentration of 0.1% was added before the second dialysis 
against 5 L of 20 mM sodium phosphate, pH 6.8, 100 mM NaCl, 5 mM EDTA. The 
protein sample was concentrated to 1mL using a Vivaspin concentrator (10,000 
MWCO) and stored at 4 ºC. 
7.1.4 b1AR 
b1AR expression was performed by my colleague, Andras Solt. The sequence of the 
thermostabilised turkey b1AR construct used in this study is as following: 
MGAELLSQQWEAGMSLLMALVVLLIVAGNVLVIAAIGSTQRLQTLTNLFITSLA
CADLVMGLLVVPFGATLVVRGTWLWGSFLCELWTSLDVLCVTASIWTLCVIAI
DRYLAITSPFRYQSLMTRARAKVIICTVWAISALVSFLPIMMHWWRDEDPQALK
CYQDPGCCDFVTNRAYAIASSIISFYIPLLIMIFVYLRVYREAKEQIRKIDRASKR
KTSRVMAMREHKALKTLGIIMGVFTLCWLPFFLVNIVNVFNRDLVPKWLFVAF
NWLGYANSAMNPIIY CRSPDFRKAFKRLLAFPRKADRRLHHHHHHHH 
For 13C-methyl methionine labelled β1AR expression, Sf9 cells, grown in serum free 
SF4 media were centrifuged (500 g, 10 min) and washed with sterile PBS, to reduce the 
carry-over of unlabelled methionine. The washed cells were diluted to a density of 
3x106 cells/mL into methionine deficient SF4 media at half the intended final culture 
volume. The culture was then infected with 4 mL/L of high density viral stock, and 
incubated for 5 h, before supplementing the culture with 250 mg/L of 13C-methyl 
methionine and diluting to a final density of 1.5x106 cells/mL. The initial reduction in 
culture volume ensures optimal aeration in the initial phase of the viral infection. Cells 
were grown at 27 ᵒC for 48 h and were harvested by centrifugation (3,500 g, 15 min).  
The frozen insect cell pellet was thawed with solubilisation buffer (20 mM Tris-HCl pH 
8.0, 350 mM NaCl, 3 mM imidazole, Complete Protease Inhibitor Cocktail (Roche), 
1% DDM or 2% LMNG) and stirred for 1 h. The solubilised cells were briefly sonicated 
for 1.5 min and then clarified by centrifugation (175,000 g, 45 min). The supernatant 
was loaded onto a nickel affinity column equilibrated with the buffer (20 mM Tris-HCl 
pH 8.0, 350 mM NaCl, 3 mM imidazole, 0.06% DDM or 0.02% LMNG). The protein 
was eluted with the same buffer supplemented with 250 mM imidazole. The sample 
purity of the elution was checked by SDS-PAGE. The fractions contained b1AR were 
pooled and concentrated. A buffer exchange step was included to remove imidazole 
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using either dilute-concentrate or desalting chromatography. The final sample was in 
10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.06% DDM or 0.02% LMNG. 
7.1.5 T7 RNA polymerase 
pAR1219 plasmid containing the T7 RNA polymerase (T7RNAP) sequence was used to 
transform competent BL21 (Rosetta) cells. Cells were incubated at 37  ̊C with 200 rpm 
shaking, and induced by addition of 1 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at OD600 of 0.8. Cells were incubated for 5 hours before harvesting by 
centrifugation (4,500 g, 15 min, 4  ̊C). Cell lysis was done by passing through an 
Emulsiex-C5 High Pressure Homogeniser (Avestin) four times. Cell debris were 
removed by centrifugation (20,000 g, 30 min, 4  ̊C). There is no tag in T7RNAP 
plasmid, therefore ammonium sulfate precipitation was used to purify T7RNAP. Protein 
purification started by addition of 200 mM ammonium sulfate and 1% polyethylenimine 
(PEI) in the final concentration to precipitate unwanted protein and DNA. After 
removing the pellet by centrifugation (39,000 g, 15 min, 4  ̊C), 140 mL of saturated 
ammonium sulfate was added to precipitate T7RNAP. The pellet was collected by 
centrifugation (12,000 g, 10 min, 4  ̊C) and dissolved in 20 mM sodium phosphate (pH 
7.7), 1 mM EDTA, 1 mM DTT, 5% glycerol and 100 mM NaCl. Anion exchange 
purification was carried out using a Hitrap Q HP (1 mL) with a gradient from 50 mM 
NaCl to 500 mM NaCl in 30 column volumes (CV). Sample quality was confirmed by 
SDS-PAGE. T7RNAP was concentrated to approximately 4 mg/mL, dialyzed into 50% 
glycerol, dispensed into aliquots, flash-frozen, and stored at -80  ̊C. 
7.1.6 pSRII 
The sequence of the pSRII in this study is as following: 
MVGLTTLFWLGAIGMLVGTLAFAWAGRDAGSGERRYYVTLVGISGIAAVAYA
VMALGVGWVPVAERTVFVPRYIDWILTTPLIVYFLGLLAGLDSREFGIVITLNTV
VMLAGFAGAMVPGIERYALFGMGAVAFIGLVYYLVGPMTESASQRSSGIKSLY
VRLRNLTVVLWAIYPFIWLLGPPGVALLTPTVDVALIVYLDLVTKVGFGFIALD
AAATLRAEHGESLAGVDTDTPAVADLEHHHHHH 
The E. coli expression strain BL21 Tuner (DE3) Cells were transformed using the pET-
28b(+) vector containing the pSRII gene and grown in LB medium at 37 °C. The 
expression was induced at an OD600 of 1.0 by the addition of 1 mM IPTG. All-trans 
retinal was also added at this point to a final concentration of 10 µM. The culture was 
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incubated at 25 ºC for 10 h with the addition of 10 µM all-trans retinal every 2 h. Cells 
were collected by centrifugation (4,000 g, 20 min, 4 ºC). The cell pellet was 
resuspended in buffer (50 mM Tris-HCl, pH 8, 5 mM MgCl2) with protease inhibitor 
cocktail (Sigma-Aldrich) and lysed using an Emulsiex-C5 High Pressure Homogeniser 
(Avestin). Crude membranes were collected by ultracentrifugation (100,000g, 90 min, 4 
°C) and resuspended in solubilisation buffer (50 mM MES, pH 6.5, 300 mM NaCl, 5 
mM Imidazole, 1.5% DDM). The mixture was incubated overnight in the cold room. 
Insoluble material was removed by ultracentrifugation (100,000g, 1 h, 4 °C). 
Solubilized pSRII was mixed with Ni-NTA affinity beads (Novagen) for 2 h in the cold 
room. The beads were washed with 25 column volumes of the same buffer containing 
0.06% DDM and then two additional washing steps with the same buffer containing 25 
mM and 50 mM Imidazole. The protein was eluted in 50 mM Tris-HCl, pH 7.0, 300 
mM NaCl, 0.1% DDM, 150 mM imidazole. The imidazole was removed by multiple 
dilute-concentrate steps using an Amicon Ultra-15 (50,000 MWCO). The final sample 
was checked by SDS-PAGE. 
7.1.7 ASR 
The sequence of the ASR used in this study is as following: 
MNLESLLHWIYVAGMTIGALHFWSLSRNPRGVPQYEYLVAMFIPIWSGLAYMA
MAIDQGKVEAAGQIAHYARYIDWMVTTPLLLLSLSWTAMQFIKKDWTLIGFL
MSTQIVVITSGLIADLSERDWVRYLWYICGVCAFLIILWGIWNPLRAKTRTQSSE
LANLYDKLVTYFTVLWIGYPIVWIIGPSGFGWINQTIDTFLFCLLPFFSKVGFSFL
DLHGLRNLNDSRQHHHHHH 
Optimisation of the protocol for expressing and purifying ASR is explored in section 
4.2.1 and 4.2.2, respectively. The final optimised protocol is described here. BL21-RIL 
competent cells were transformed with pKJ606 plasmid containing the ASR sequence. 
Cells were grown in LB culture supplemented with chloramphenicol and ampicillin at 
37 ºC until OD600 of 0.4. Cells were induced by addition of 1 mM IPTG and 10 µM all-
trans retinal (Merck) and incubated for 22 h at 30 ºC. Cells were collected by 
centrifugation (4,500 g, 20 min, 4ºC). The cell pellet from one litre culture is 
resuspended with 25 mL lysis buffer (20 mM NaPi, pH 6.5, 500 mM NaCl, 0.002% 
LMNG) with protease inhibitor cocktail (Sigma-Aldrich). Cells were lysed by three 
passes through an Emulsiex-C5 High Pressure Homogeniser (Avestin). The lysate was 
centrifuged (100,000 g, 90 min, 4 ºC) and the supernatant was discarded. The pellet was 
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resuspended and homogenised in buffer (50 mM MES, pH 6.5, 300 mM NaCl, 2% 
LMNG) and mixed using a rotating wheel overnight at room temperature. The 
solubilised sample was collected by centrifugation (100,000 g, 60 min, 4 ºC) and loaded 
onto a 5 mL Ni-NTA column which was equilibrated with buffer (20 mM NaPi, pH 6.5, 
500 mM NaCl, 0.002% LMNG). The column was washed with the same buffer with 50 
mM and 100 mM imidazole before elution with 500 mM imidazole. 
For elution into HEGA-10 or C7-DHPC, the column was washed with 10 CV of buffer 
(20 mM NaPi, pH 6.5, 500 mM NaCl) containing no detergents. Then the column was 
washed with 5 CV of the buffer with desired detergent (20 mM NaPi, pH 6.5, 500 mM 
NaCl, 0.5% HEGA-10/ 0.1% C7-DHPC) followed by a washing step with the same 
buffer with 50 mM and 100 mM imidazole and the elution step with 500 mM imidazole. 
Imidazole was removed by multiple dilute-concentrate using an Amicon Ultra-15 
(50,000 MWCO). The ASR concentration was calculated from the UV-Vis absorbance 
at 549 nm (A549) using the extinction coefficient at 549 nm (e549) of 48,000 M-1cm-1. 
The purity of the ASR sample was estimated by measuring the ratio of A549 and A280 
assuming 100% being e549/e280, where A280 is the absorbance at 280 nm and e280 is the 
extinction coefficients at 280 nm of 88,000 M-1cm-1. The samples were also checked by 
SDS-PAGE.  
7.1.8 15N-labelled protein production for NMR experiments 
15N labelled proteins used in this study were produced in the same way as described in 
the section above except for using the M9 minimal medium instead of LB medium. M9 
minimal medium for expressing 15N labelled proteins composed of 47.7 mM Na2HPO4, 
22 mM KH2PO4, 8.6 mM NaCl, 2 µM FeCl3, 4 µM ZnSO4, 1 µM MnCl2, 0.7 µM 
H3BO3, 0.7 µM CuSO4, 5 µM MgSO4, 100 µM CaCl2, 0.5% (w/v) Glucose, and 0.1% 
(w/v) 15NH4Cl. All the components are sterilised by either autoclaving or filtering 
through 0.2 µm filter (Millipore)  
7.2 Protein characterisation  
7.2.1 SDS-PAGE 
Polyacrylamide gel electrophoresis was performed using 12% handcasting Bis-Tris 
gels. The gels were prepared using the established protocol and casted in the empty gel 
cassette (Invitrogen). Gels were run in NuPAGE™ MES running buffer (Invitrogen) for 
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35 min at 200 mV. If the sample contains SapA, the gel was run only for 28 min to 
make sure the small proteins remain visible on the gel. PageRuler™ prestained protein 
ladder (Thermo Scientific) were used and gels were stained in Instant Blue™ coomassie 
stain (Expedeon). 
7.2.2 Western blot 
The western blots showed in this study were all detecting His tag on the protein using 
SuperSignal® West HisProbe™Kit (Thermo Scientific). The gel was first transferred 
onto PVDF membrane in buffer (25 mM Tris, pH 8.3, 192 mM Glycine, 
20% Methanol) using the transfer apparatus (Invitrogen) for 1 h at 175 mA. The 
membrane was blocked with 25 mg/mL BSA in TBST (25 mM Tris, pH 7.6, 150 mM 
NaCl, 0.05% Tween-20) for 1 h at room temperature. The membrane was washed twice 
with 15 mL TBST for 10 min each before incubating with 10 mL HisProbe-HRP 
Working Solution for 1 h. The membrane was washed again four times with 15 mL 
TBST for 10 min each. Finally, the blot was incubated with 7.5 mL SuperSignal West 
Pico Substrate Working Solution for 5 min before film development. 
7.2.3 Analytical size-exclusion and molecular weight calibration 
The analytical size-exclusion chromatography was done using an S200 Increase 10/300 
column (GE Healthcare) in the cold room. Calibration was done using the Gel filtration 
Molecular Weight Calibration Kit (Sigma, #MWGF200). The standard protein mixture 
containing 2 mg/mL Cytochrome c, 3 mg/mL Carbonic anhydrase, 10 mg/mL Albumin, 
5 mg/mL Alcohol dehydrogenase, and 4 mg/mL b-amylase was dissolved in 1 mL of 50 
mM Tris-HCl, pH 8, 150 mM KCl. The elution volume of each protein standard was 
obtained from the resulting chromatogram (Figure 7-1, A). The known molecular 
weights were plotted against the elution volumes and fitted with an logarithmic curve 
(Figure 7-1, B). 
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Figure 7-1: Molecular weight calibration of the SEC column. 
A) SEC chromatogram of molecular weight standards. The elution volume and the 
molecular weight of each peak are indicated. B) Molecular weights of the protein 
standards are plotted against the elution volumes and fitted with logarithmic curve. 
The resulting formula and the fitting quality are shown. 
For SEC runs, samples were always centrifuged (21,130 g, 5 min) prior to loading in 
order to remove precipitate. Sample with a volume of 500 µL was injected into the 
column that was equilibrated with the desired buffer. The flow rate was 0.6 mL/min and 
the fractions were collected every 1 mL. Absorbance at 280 nm was always monitored. 
In the case of bacterial rhodopsin, additional absorbance wavelengths were monitored, 
549 nm for ASR and 498 nm for pSRII. 
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7.2.4 DLS measurements 
DLS measurements were performed to check the particle size of ASR in 0.5% HEGA-
10 or in 0.002% LMNG. Each sample contained 70 µL of ASR sample with a 
concentration of 0.625 mg/mL in 20 mM NaPi, pH 6.5. Since the purpose of the DLS 
measurements was to investigate the effect of NaCl concentration on the particle size in 
section 4.2.3, the NaCl concentration was adjusted according to the value screened. The 
measurements were carried out on Zetasizer Nano S (Malvern Panalytical). Five 
separate measurements with 17 scans each were performed for every sample.  
7.2.5 UV-Vis spectroscopy-Nanodrop 
We used UV-Vis spectroscopy to quantify the corrected folded ASR in the sample. For 
the purpose of screening conditions for ASR in section 4.2.3, UV-Vis spectra were 
recorded using a Nanodrop ND-1000 spectrometer (Thermo Scientific) to reduce total 
experimental time because of a large number of samples. Samples were centrifuged at 
22,000 g for 30 s at 20 ºC before each measurement. Triplicate measurements were 
recorded. To assess the stability of ASR, the absorbance at 549 nm (A549) was used as a 
quantification of correctly folded ASR. The percentage of ASR remaining in the sample 
after incubation was calculated by the ratio of A549 after and before the incubation. 
7.2.6 UV-Vis spectroscopy 
To obtain an UV-Vis spectrum with higher spectral quality and sensitivity, samples 
were recorded using a UV-Vis spectrophotometer UV-1800 (SHIMADZU). A sample 
with a volume of 100 µL was transferred to an absorption cuvette (Hellma). Three scans 
from 250 nm to 600 nm with a sampling interval of 1 nm were recorded and averaged to 
produce the final spectrum.  
7.2.7 Intrinsic fluorescence spectroscopy 
Intrinsic fluorescence was measured using a LS 55 fluorescence spectrophotometer 
(PerkinElmer). A sample with 100 µL volume was transferred to a fluorescence cuvette 
(Hellma). The spectrum was recorded from 300 nm to 450 nm with the excitation 
wavelength of 280 nm. The excitation and emission bandwidth was 5 nm and 10 nm, 
respectively. Scanning speed was 100 nm/min.  
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7.2.8 Far-UV Circular dichroism 
Far-UV circular dichroism (CD) measurements were carried out using an Aviv model 
410 CD spectrophotometer at 298 K to monitor the secondary structure of β1AR in 
SDS. Each measurement contained 300 µL of protein solution with a concentration of 
0.1 mg/mL using a 1 mm quartz cell (Hellma). The far-UV CD spectra were collected 
between 200 and 260 nm with a bandwidth of 1 nm.  
7.2.9 Negative-stained electron microscopy 
For the EM grid preparation, sample with a concentration of 10 µg/mL were applied to 
a glow discharged carbon-coated copper grid (400 mesh) (EMresolution) for 30 s. 
Washing was done with three drops of water before staining with 2% (w/v) uranyl 
acetate for 30 s. The grids were blotted dry and stored at room temperature. Negative-
stain image data were collected with a FEI Tecnai F20 field emission gun transmission 
electron microscope at an accelerating voltage of 200 kV fitted with either a 1K × 1K or 
a 4K × 4K CCD camera at the Wolfson Electron Microscopy Suite, University of 
Cambridge. 
7.3 Detergent/lipid quantification 
7.3.1 2,6-dimethylphenol assay 
A 2,6-dimethylphenol assay was employed to determine the concentration of sugar-
based detergents including DDM and LMNG. The protocol was adapted from previous 
reports.130,131 Briefly, a 5 µL sample was first diluted with 320 µL water in an eppendorf 
tube. Then, 25 µL of 20% 2,6-dimethylphenol in absolute ethanol was added under the 
fume hood, followed by 650 µL concentrated sulfuric acid. The tube was mixed by 
inverting a few times. The sample became warm because of the strong exothermic 
reaction. Samples were incubated at room temperature for 1 h. The absorbance at 510 
nm was measured.    
7.3.2 Molybdate assay 
To quantify the phospholipid concentration, we used a molybdate assay described 
previously131 to determine the phosphate concentration in the sample. The reagents 
needed in this assay were prepared in advance including 10% magnesium in 95% 
ethanol, 10% ascorbic acid in water, ammonium molybdate solution, which was 
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prepared by dissolving 0.42 g ammonium molybdate tetrahydrate and 2.86 mL sulfuric 
acid in 100 mL water.  A 5 µL sample was mixed with 30 µL of 10% magnesium nitrate 
followed by ashing over a Bunsen burner. The resulting powder was dissolved in 350 
µL of 0.5 N HCl, and 300 µL of the sample was transferred to a 1.5 mL eppendorf tube 
and boiled for 15 min. After the tube had cooled down, 700 µL of the ascorbic acid/ 
molybdate solution, 100 µL of 10% ascorbic acid in water and 600 µL of ammonium 
molybdate solution, was added and incubated at 45 ºC for 25 min. This produced 
phosphomolybdate complex with blue colour and the absorbance at 825 nm (A825) was 
measured. In order to quantify the concentration of DMPC in an unknown sample, a 
standard curve was produced first. Triplicate DMPC samples with the concentration in 
the range of 0–5 mM were prepared and treated with the molybdate assay described 
above. The A825 of each sample was plotted against the DMPC concentration and fitted 
by linear regression (Figure 7-2). The fitting result describes the relationship between 
A825 and the concentration of DMPC. Sample of interest was treated by molybdate 
assay and the concentration of DMPC was back calculated from A825 using the formula 
obtained from the standard curve. 
 
Figure 7-2: The standard curve for DMPC quantification by molybdate assay. 
Triplicate DMPC samples with known concentration ranging from 0 mM to 5 mM 
were prepared and treated by the molybdate assay. The absorbance at 825 nm of 
each sample was plotted against DMPC concentration. A linear fit was performed, 
and the resulting formula and the fitting quality are shown. The relationship 
between A825 and the concentration of DMPC was used to determine DMPC 
concentration in the samples of interest. 
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7.4 Incorporation of membrane proteins into SapA lipid 
nanoparticles 
7.4.1 Incorporation of OmpX into SapA lipid nanoparticles 
The incorporation of OmpX into SapA lipid nanoparticles was done at pH 6 with the 
SapA:lipid:OmpX ratio of 10:50:1 with a final OmpX concentration of 12 µM. The 
assembly mixture was prepared starting from mixing OmpX solubilised in 0.5% DPC 
and lipid followed by the addition of DDM with a final concentration of 0.2%. SapA 
was then included in the mixture. A clear solution should be observed at this point. 
After the buffer (50 mM sodium acetate, pH 6, 150 mM NaCl) was added, the assembly 
mixture was incubated at room temperature for 10 min. Detergent removal was done by 
addition of 80% w/v washed Amberlite XAD2 beads (Sigma-Aldrich), 500 µL mixture 
with 400 mg beads in a 1.5 mL Eppendorf tube, and was performed at 25 ºC for 2 h 
with gentle shaking. Beads were removed by centrifugation (2,000 g, 10 min). The 
sample was centrifuged to remove precipitate (21,130 g, 5 min) before analysing by 
SEC using a Superdex 200 Increase 10/300 (GE Healthcare) equilibrated with the buffer 
used in the assembly mixture. Large-scale preparation for NMR experiments were 
performed using the same setup in multiple Eppendorf tubes and a concentration step 
using an Amicon Ultra-15 (3,000 MWCO) was added before SEC. The SEC fractions 
corresponding to OmpX in SapA lipid nanoparticles were pooled and concentrated 
again to a volume of 400 µL. The OmpX concentration in the final NMR samples were 
in general around 200 µM. The concentration was estimated by the absorbance at 
280 nm and the contribution from SapA was taken into account. 
7.4.2 Incorporation of b1AR into SapA lipid nanoparticles 
The incorporation of b1AR into SapA lipid nanoparticles was done in a similar way to 
the OmpX case. b1AR solubilised in 0.6% DDM was mixed with SapA and DMPC with 
the SapA:DMPC:b1AR ratio of 10:150:1 with the final b1AR concentration of 12 µM. 
Additional 0.2% DDM was included to encourage the opening of SapA. Buffer (50 mM 
Tris-HCl, pH 7.4, 150 mM) was added into the assembly mixture and incubated at room 
temperature for 10 min. DDM removal was achieved by addition of 80% w/v Amberlite 
XAD2 beads (Sigma-Aldrich) and incubated at 25 ºC for 2 h with gentle shaking. Beads 
were removed by centrifugation (2,000 g, 10 min). The sample was analysed by 
analytical SEC using a Superdex 200 Increase 10/300 (GE Healthcare). 
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The incorporation of other b1AR mutants including D5, D5-L190M was achieved using 
the same ratio and the same buffer. The only difference is that these mutants are purified 
in LMNG because they are not stable in DDM. Therefore, the incubation time in the 
detergent removal step was 24 h instead of 2 h. Other parameters such as the amount of 
beads and the incubation temperature are the same. The assembly mixture was purified 
using a 5 mL Ni-NTA column to separate the empty nanoparticles followed by the SEC. 
The successful incorporation was confirmed by the presence of a SapA band on the 
SDS-PAGE after the purification. For the preparation of NMR samples, only the Ni-
NTA purification was performed to reduce the sample loss in multiple purification steps. 
The elution fractions from Ni-NTA purification were pooled and concentrated using 
Amicon Ultra-15 (3,000 MWCO). Three runs of 10 times dilute-concentration were 
performed to remove imidazole in the sample. The concentration of b1AR in the final 
NMR sample was in general about 40 µM, estimated by the UV absorbance at 280 nm. 
7.5 Cell-free expression 
7.5.1 E. coli extract preparation 
E. coli extract was prepared from BL21 (DE3) Rosetta cells using a fermenter. 
Sterilized 20 L 2x YTPG medium (22 mM KH2PO4, 52 mM K2HPO4, 86 mM NaCl, 
110 mM glucose, 10 g/L yeast extract, 16 g/L tryptone) in a fermenter was inoculated 
with 200 mL starting culture. Fermentation was carried out at 37 ˚C, pH 7, 8 L/min air 
flow, 600–800 rpm shaking. OD600 was monitored every 20 min. Cells were harvested 
at OD600 = 3.5 by centrifugation (4,000 g, 15 min, 4 ˚C). The pellet was re-suspended in 
extract buffer (10 mM Tris, 14 mM magnesium acetate, 60 mM potassium acetate, pH 
8.2). Cells were lysed using an Emulsiflex (Avestin) and cell debris were removed by 
centrifugation (12,000 g, 30 min, 4 ˚C).  Supernatant was incubated (2 h, 300 rpm, 30 
˚C). The sample was dialyzed in extract buffer with 1 mL/L b-mercaptoethanol in the 
cold room overnight. The final product was divided into 1 mL aliquots, flash frozen in 
liquid nitrogen, and stored at -80 ˚C. The whole process should be done on ice or in the 
cold room. All the equipment including centrifuge bottles, beakers, cylinders was 
cleaned by RNAseZap and DEPC water and pre-chilled before use. 
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7.5.2 Expression system setup 
The S30-based cell-free expression system was set up based on a previous protocol.206 
In short, the components in the reaction mixture are 0.04 mg/mL PK, 0.5 mg/mL TRNA, 
6 units/µL T7RNAP, 0.3 units/µL RNAguard, 0.015 µg/mL DNA, 35% S30 extract. In 
addition, the reaction mixture and feeding mixture both have 0.05% NaN3, 2% PEG 
8000, 150 mM KOAc, 12 mM Mg(OAc)2 (concentration was optimized), 0.1 M HEPES 
buffer, 1 x complete protease inhibitor cocktail (Roche), 0.1 mg/mL folinic acid, 2 mM 
DTT, 1 x NTP mix, 20 mM PEP, 20 mM Acp, 0.5 mM Amino acid mix, 1 mM 
RCWMDE (amino acid mixture). For analytical scale, 2 mL eppendorf tubes were used 
for the feeding mixture compartment and Slide-A-Lyzer™ MINI device (Thermo 
Scientific) with 12–15 kDa molecular weight cutoff membrane was used for the reaction 
mixture compartment. For preparative scale (1 mL), dialysis tubing and 50 mL 
centrifuge tubes were used for the reaction mixture and feeding mixture, respectively. 
The reaction was carried out at 30 ˚C, with shaking at 300 rpm for 24 h. 
7.5.3 GFP fluorescence measurements 
The yield of GFP was quantified by fluorescence measurement using an Infinite® 200 
PRO (Tecan) fluorometer with a plate reader format. The excitation wavelength was set 
to 395 nm, the characteristic excitation wavelength of GFP, and a full spectrum was 
recorded from 475 nm to 625 nm. The emission intensity at 509 nm, where GFP 
fluorescence is the highest, was used as a quantification of GFP.  
7.5.4 Bicelle refolding 
Purified b1AR from the P-CF reaction was originally solubilised in 15 mM SDS, 50 
mM sodium phosphate (pH 8). In order to reduce the SDS concentration, b1AR was 
dialysed overnight using a 30-fold excess of the same buffer without SDS. Subsequently 
the SDS concentration was kept at around 2 mM using overnight dialysis against a 30-
fold excess of the same buffer with 2 mM SDS containing the redox-shuffling system 
GSH/GSSG (reduced and oxidized glutathione, Carl Roth, Karlsruhe, Germany). To 
concentrate the b1AR, 30% (w/v) PEG 20,000 (Sigma Aldrich, Deisenhofen, Germany) 
was added to the dialysis buffer, until the b1AR concentration of 1 mg/ml was reached. 
For the bicelle preparation, 104 mM C7-DHPC and 26 mM DMPC (q = 0.25) (Avanti 
Polar Lipids, Alabaster, USA) were dispersed in 1 mL 50 mM sodium phosphate (pH 8). 
Three 20 min heat/cooling cycles were performed between 42 °C and 4 °C, respectively. 
Development of a saposin A based native-like phospholipid bilayer system for NMR studies 
Chih-Ta Chien- September 2018   153 
The b1AR was added to the prepared bicelle and three additional heat/cooling cycles 
were applied. To remove residual SDS, the bicelle/b1AR sample was dialyzed overnight 
using buffer without SDS.  
7.5.5 On-column refolding 
Purified b1AR from the P-CF reaction was loaded onto a Histrap 5 mL column (GE 
Healthcare). The column was washed with 5 CV of binding buffer (50 mM sodium 
phosphate, 15 mM SDS, pH 8) followed by 5 CV of the same buffer without SDS to 
reduce the SDS concentration. Buffer exchange was carried out with 5 CV of refolding 
buffer (20 mM Tris, 350 mM NaCl, pH 8) followed by 5 CV of refolding buffer with 
0.02% LMNG. Elution buffer (20 mM Tris, 350 mM NaCl, 250 mM imidazole, pH 8) 
was used to elute the protein. The sample was then concentrated and checked by SDS-
PAGE. 
7.6 NMR experiments 
7.6.1 NMR sample preparation 
Protein samples for NMR experiments were concentrated to around 400 µL and mixed 
with 10% D2O required for the lock. The sample was transferred to a 5 mm NMR tube 
(Wilmad). In some cases, a 3 mm NMR tube was used which only needs 160 µL 
sample.   
7.6.2 Translational diffusion measurements 
Pulsed Field Gradient NMR measurements were carried out on a Bruker DRX-500MHz 
spectrometer (Bruker). Experimental temperature and conditions are indicated in the 
results sections. The translational diffusion of molecules can be measured by spatially 
labelling molecules using a pulsed field gradient. This allows the position of the 
molecules in the NMR tube to be encoded. The molecules diffuse during a set period of 
time before applying the second gradient. The farther the molecule moves from its 
original position the weaker the signal. A peak that represents the particle of interest is 
used for determination of the translational diffusion coefficient. For example, the amide 
region of protein samples or choline proton signal for DMPC containing particles.  
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Figure 7-3: Diffusion measurement using the choline proton signal. 
Diffusion measurements were performed using PFG NMR. Two experiments with 
different gradient strength, 345.65 Gs/m (red) and 3110.75 Gs/m (blue), were 
applied to the sample. A representative peak was used to measure the intensity 
ratio between two experiments. In this example, a choline signal originated from 
DMPC was used for measuring the diffusion coefficient of SapA-DMPC 
nanoparticles. 
The signal intensity is described by 
𝐼 = 	 𝐼:𝑒<=>?@?A?BC<DEF , 
where I is the observed signal intensity, I0 is the original signal intensity without 
gradient, D is the diffusion coefficient, g is the gyromagnetic ratio (26752.21 s-1Gs-1), g 
is the gradient strength (346.65 Gs/m and 3110.75 Gs/m),  d is the length of the gradient 
(2 ms), and D is the diffusion time (500 ms). With the signal intensities measured from 
the NMR spectra and the known experimental parameters, the diffusion coefficient can 
be derived from this formula.  
7.6.3 SOFAST-TROSY experiments 
NMR experiments were all recorded on a Bruker Avance AVIII 800 spectrometer (1H 
frequency of 800 MHz) equipped with a 5 mm TXI HCN/z cryoprobe. All the spectra 
were processed with Azara (W. Boucher, unpublished) or NMRPipe220 and analysed 
with SPARKY software (Goddard and Kneller).  
3.1
3110.75 Gs/m
345.65 Gs/m
3.4
ppm
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Spectra for OmpX with a concentration of 200 µM in pH 6 buffer (50 mM sodium 
acetate, pH 6, 150 mM NaCl), were recorded at 318 K using a [1H, 15N]-SOFAST-
TROSY experiment. The direct (1H) dimension was acquired with 10,000 Hz spectral 
width and 1024 points, whereas 2,778 Hz spectral width and 128 points was used for the 
indirect dimension (15N). Spectra were recorded with 3,078 scans, resulting in an 
experiment time of 36 h. 
Spectra for ASR in buffer (20 mM NaPi, pH 6.5, 200 mM NaCl, 0.5% HEGA-10) were 
recorded at 318 K. The experiment was performed using a 5 mm NMR tube with 
500 µL ASR with a protein concentration of 200 µM. To improve the sensitivity, the 
same sample was further concentrated to 325 µM and a volume of 250 µL and the NMR 
experiments recorded for the same experiment time. Both experiments were carried out 
with 1,000 scans and 100 complex points, giving an acquisition time of 17 h. 
7.6.4 SOFAST-HMQC 
In the β1AR experiments, 50 µM 13C methyl-methionine labelled β1AR in pH 7.4 buffer 
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl) was used, and 1 mM isoprenaline and 50 µM 
Nb80 were added sequentially into the sample to record NMR spectra. All the spectra 
were recorded at 308 K using a SOFAST 1H, 13C HMQC experiment221 with gradient 
coherence-order selection222 and non-uniform sampling (NUS) in the 13C dimension. 
The direct (1H) dimension was acquired with 10,000 Hz spectral width and 1024 points. 
A 60% Poisson-Gap sampling schedule was used on the indirect dimension (13C) 
acquisition,223 with 4,000 Hz spectral width. Spectra were recorded with 368 scans, 
giving an acquisition time of 6 h. Multiple 6 h experiments were recorded and added in 
order to obtain spectra with higher signal-to-noise ratio. Spectra were reconstructed 
using the iterative hard thresholding (IHT) compressed sensing (CS) implementation224 
in the Cambridge CS package, an in-house program written by Dr. Mark Bostock. Data 
were analysed using CCPN Analysis v2.225  
7.6.5 Weighted chemical shift perturbation 
Weighted chemical shift perturbations of the backbone amide resonances were defined 
as: ∆𝛿(,* = 	+(∆𝛿(). + 0.13	 ×	 (∆𝛿*). 
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where ∆𝛿( and ∆𝛿* are the observed chemical shift differences along the proton and 
nitrogen dimensions, respectively, with respect to the original spectrum. 
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